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ABSTRACT 
 
Adams, Rebecca N. Ph.D., Purdue University, August 2016. Measures of Cancer-related 
Loneliness and Negative Social Expectations: Development and Preliminary Validation. 
Major Professor: Catherine E. Mosher.  
 
 
 
 Loneliness is a known risk factor for poor mental and physical health outcomes in 
the general population, and preliminary research suggests that loneliness is linked to 
poorer health in cancer patients as well.  Various aspects of the cancer experience (e.g., 
heightened existential concerns) lend themselves to making patients feel alone and 
misunderstood.  Furthermore, loneliness theory suggests that negative social 
expectations, which may specifically relate to the cancer experience, precipitate and 
sustain loneliness.  Thus, loneliness interventions in cancer should be tailored to address 
illness-related social conditions and negative social expectations.  Prior to the 
development of loneliness interventions for cancer populations, cancer-specific tools are 
needed to assess: (1) loneliness attributed to cancer (i.e., cancer-related loneliness), and 
(2) negative social expectations related to cancer.  In the current project I developed 
measures of cancer-related loneliness and cancer-related negative social expectations for 
use in future theory-based loneliness research.  A mixed-methods study design was 
employed.  First, I developed items for the measure of cancer-related loneliness (i.e., the 
Cancer Loneliness Scale) based on theory, prior research, and expert feedback.  Second, I
x 
 
 
 
 conducted a clinic-based qualitative study (n=15) to: (1) obtain cancer patient feedback 
on the Cancer Loneliness Scale items, and (2) inform development of the item pool for 
the measure of negative social expectations (i.e., the Cancer-related Negative Social 
Expectations Scale).  Interviews were audiotaped, transcribed verbatim, and then 
transferred to Atlas.ti for analysis.  Content analysis was used to analyze data regarding 
patient feedback and theoretical thematic analysis was used to analyze data regarding 
negative social expectations.  Overall, patients said they liked the Cancer Loneliness 
Scale and no changes were made to the items based on patient feedback.  Based on 
results, I also created five content domains of negative social expectations that were 
represented in the item pool for the Cancer-related Negative Social Expectations Scale.  
Third, I conducted a telephone and mail-based quantitative study (n=186) to assess 
psychometric properties of the two new measures.  Dimensionality was determined using 
confirmatory factor analysis.  Reliability was assessed by examining internal consistency 
coefficients and construct validity was assessed by examining theoretical relationships 
between the Cancer Loneliness Scale, the Cancer-related Negative Social Expectations 
Scale, and existing reliable and valid measures of health and social well-being.  The final 
products of the project included a 7-item unidimensional Cancer Loneliness Scale and 5-
item unidimensional Cancer-related Negative Social Expectations Scale.  Excellent 
evidence for reliability and validity was found for both measures.  The resulting measures 
have both clinical and research utility. 
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INTRODUCTION 
 
Loneliness is a known risk factor for poor mental and physical health outcomes in 
the general population, and preliminary research suggests that loneliness is linked to 
poorer health in cancer patients as well (Cacioppo & Hawkley, 2009; Cacioppo et al., 
2006; Hawkley & Cacioppo, 2003; Jaremka, Andridge, et al., 2014; Jaremka, Fagundes, 
Glaser, et al., 2013).  Various aspects of the cancer experience lend themselves to making 
patients feel alone and misunderstood.  For example, many cancer patients have 
heightened existential concerns following a cancer diagnosis but feel that family 
members do not share these concerns (Lee, 2008; Rosedale, 2009; Sand, Strang, & 
Milberg, 2008).  In addition, some patients feel constrained in discussing cancer-related 
concerns with others (Lepore & Revenson, 2007).  Furthermore, loneliness theory 
suggests that negative social expectations may precipitate and sustain loneliness 
(Cacioppo & Hawkley, 2009).  Negative social expectations may specifically relate to the 
cancer experience; for instance, patients may expect a high level of support and sympathy 
from friends and family following a cancer diagnosis and feel disappointed when these 
expectations are not met.  In sum, theory and research suggest that loneliness may have 
unique precipitants in cancer patients, as many of the social experiences linked to their 
loneliness may be cancer-related.  Thus, tailoring loneliness interventions to address 
cancer-related experiences may be indicated.  However, the loneliness literature with
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cancer patients is limited and, thus, further research is needed before we can proceed with 
interventions to reduce loneliness in this population.  Current gaps in the literature 
include: (1) assessment of the degree to which patients attribute their loneliness to 
cancer-related experiences; and (2) identification and assessment of cancer-related 
negative social expectations theorized to sustain loneliness (Cacioppo & Hawkley, 2009).  
This study begins to address these gaps by developing two cancer-specific tools for use in 
research to assess: (1) loneliness attributed to cancer (i.e., cancer-related loneliness); and 
(2) negative social expectations related to cancer that may precipitate and sustain 
loneliness.  
First, I will define loneliness, discuss its relationship to poorer mental and 
physical health outcomes, and summarize existing research on interventions to reduce 
loneliness.  Next, I will discuss the current state of the loneliness literature with cancer 
patients, including prevalence, predictors, relationships to psychological and somatic 
symptoms, and interventions.  Following this review, I will present my study aims and 
hypotheses, study methods, results, and discussion.  
 
Loneliness 
Feeling socially connected is a critical aspect of well-being; in the absence of 
social connection, we experience loneliness.  Relationship quality has been found to be 
more predictive of loneliness than relationship quantity (Pinquart & Sorensen, 2001).  
Additionally, some evidence suggests that lonely people spend the same amount of time 
alone or engaging in activities with others as non-lonely people (Cacioppo et al., 2000).  
Although some lonely people may have limited social interactions, loneliness is defined 
3 
 
 
 
by the perception of social isolation and is characterized by dissatisfaction with the 
quality of relationships (Peplau & Perlman, 1982).  
Evolutionary theories of loneliness posit that human interaction is a core human 
motivation (Baumeister & Leary, 1995).  It has been suggested that feelings of loneliness 
might have evolved as a signal to human beings that they need to become more socially 
connected (Cacioppo, Cacioppo, & Boomsma, 2014; Cacioppo et al., 2006).  According 
to these theories, social connection is evolutionarily adaptive, with the genetic 
contribution to loneliness estimated to be 50% (Boomsma, Willemsen, Dolan, Hawkley, 
& Cacioppo, 2005; Distel et al., 2010; Goossens, 2012; McGuire & Clifford, 2000).  The 
dissolution of social relationships leads to social pain, which shares many neural 
mechanisms with the brain’s response to physical pain (Eisenberger & Lieberman, 2004, 
2005).  Thus, although it has negative implications for long-term health (Cacioppo, 
Hawkley, & Thisted, 2010; Hawkley & Cacioppo, 2003), in the short-term loneliness 
may serve as an adaptive reminder to increase social connection.  
Loneliness is a phenotype characterized by a number of cognitive, emotional, and 
behavioral symptoms (Cacioppo & Cacioppo, 2012).  Evidence suggests that lonely 
individuals have maladaptive hypervigilance for social threat (Cacioppo, Norris, Decety, 
Monteleone, & Nusbaum, 2009; Duck, Pond, & Leatham, 1994; Kanai et al., 2012).  For 
example, lonely individuals show greater visual attention to negative social stimuli than 
non-lonely individuals (Cacioppo, Norris, et al., 2009).  Experimental manipulation of 
loneliness via hypnosis showed that loneliness can increase shyness, anxiety, and fear of 
negative evaluation and decrease positive mood and social skills (Cacioppo et al., 2006).  
Further, loneliness may be “contagious” within social networks; one study utilizing 
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continuous surveillance data found that interactions with lonely individuals predicted 
greater feelings of loneliness following interactions (Cacioppo, Fowler, & Christakis, 
2009).  Cacioppo and Hawkley (2009) propose that cognitive features associated with 
loneliness (e.g., hypervigilance for social threat) fit into a regulatory loop that sustains 
loneliness and increases factors, such as poor sleep quality and hypothalamic-pituitary-
adrenocortical [HPA] axis activation, which lead to poor health outcomes.  According to 
this theory, lonely individuals have more negative expectations of others and are viewed 
more negatively by others.  Negative expectations invite more negative interactions that, 
in turn, sustain perceptions of social isolation and hypervigilance to social threat.  The 
persistence of the loop may be affected by social conditions (i.e., whether or not others in 
the environment choose to form connections with the lonely individual).  
Although loneliness has been described as multi-dimensional (i.e., chronic and 
situational loneliness have been distinguished; de Jong-Gierveld & Raadschelders, 1982), 
little research has examined the differential health impact of chronic versus situational 
loneliness.  Shiovitz-Ezra and Ayalon (2010) found that, although both situational and 
chronic loneliness predicted increased risk for mortality, individuals who were 
chronically lonely had greater mortality risk.   
Although the current prevalence of loneliness in the United States is unknown, 
Hawthorne (2008) reported that 9% of Australian adults reported some social isolation, 
and 7% reported more frequent isolation.  Recent studies have found that loneliness is 
most prevalent in older adults and young adults or adolescents (Pinquart & Sorensen, 
2001; Victor & Yang, 2012).  Hence, much of the literature on loneliness focuses on 
these age groups.  Consistent predictors of loneliness include marital status, income, and 
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health status, such that unmarried individuals, those with lower incomes, and those with 
disabilities and functional limitations are more lonely (Cohen-Mansfield, Shmotkin, & 
Goldberg, 2009; Hawkley et al., 2008; Hawthorne, 2008; Pinquart & Sorensen, 2001; 
Rokach, Lechcier-Kimel, & Safarov, 2006; Savikko, Routasalo, Tilvis, Strandberg, & 
Pitkälä, 2005; Theeke, 2009).   
 
Loneliness and Mental Health 
In addition to identifying demographic predictors of loneliness, researchers have 
consistently linked loneliness to poorer mental health (Heinrich & Gullone, 2006).  
Loneliness has been found to be related to greater general psychological distress (Paul, 
Ayis, & Ebrahim, 2006), poorer quality of life (Steptoe & Marmot, 2003), lower self-
esteem and well-being (Cacioppo et al., 2006; Riggio, Watring, & Throckmorton, 1993), 
and greater anxiety, including social anxiety (Anderson & Harvey, 1988; Cacioppo et al., 
2006).  The relationship between loneliness and depression is the most well documented; 
a higher level of loneliness has been linked to greater depressive symptoms in 
adolescents (Mahon, Yarcheski, Yarcheski, Cannella, & Hanks, 2006), college students 
(Swami et al., 2007; Wei, Russell, & Zakalik, 2005), and older adults (Adams, Sanders, 
& Auth, 2004; Alpass & Neville, 2003; Golden et al., 2009; Luanaigh & Lawlor, 2008).  
Five- and ten-year longitudinal studies have shown that higher levels of loneliness predict 
increased depressive symptoms in older adults (Cacioppo et al., 2010; Heikkinen & 
Kauppinen, 2004).  Additionally, greater loneliness appears to be related to thoughts of 
suicide (Stravynski & Boyer, 2001).  Therefore, interventions to reduce loneliness may 
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result in meaningful reductions in depressive symptomatology (VanderWeele, Hawkley, 
Thisted, & Cacioppo, 2011).   
 
Loneliness and Physical Health 
Greater loneliness has also been associated with poorer physical health (Hawkley 
& Cacioppo, 2003).  In particular, having a higher level of loneliness is a risk factor for 
cardiovascular problems (Caspi, Harrington, Moffitt, Milne, & Poulton, 2006).  For 
example, in a 20-year follow-up study of women, being lonely during the day predicted 
myocardial infarction or coronary death (Eaker, Pinsky, & Castelli, 1992).  Another study 
reported that, at 14-year follow-up, greater loneliness predicted cardiovascular mortality 
in men (Olsen, Olsen, Gunner-Svensson, & Waldstrøm, 1991).  Thurston and Kubzansky 
(2009), on the other hand, found that greater loneliness predicted coronary heart disease 
incidence in women, but not men.  Increased loneliness also predicted higher total 
peripheral resistance, which may contribute to hypertension, in young adults (Hawkley, 
Burleson, Berntson, & Cacioppo, 2003).  Furthermore, Caspi et al. (2006) found that 
socially isolated children had a greater number of risk factors for poor health (e.g., 
overweight, high blood pressure, high cholesterol) at 20-year follow-up than children 
who had not been socially isolated at baseline. 
Greater loneliness has also been linked to poorer cognitive functioning (Cacioppo 
& Hawkley, 2009).  Over 5- and 10-year periods, loneliness was related to greater decline 
in cognitive ability and performance and poorer executive functioning (Cacioppo & 
Hawkley, 2009; Tilvis et al., 2004; Wilson et al., 2007).  Additionally, the risk of 
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developing late-life Alzheimer’s disease in older adults is more than double for lonely 
individuals (Wilson et al., 2007).  
 
Why is Loneliness Related to Health Outcomes? 
Although it is clear that greater loneliness is related to poorer health outcomes, the 
explanation for this relationship is unknown.  Hawkley and Cacioppo (2010) have 
proposed several potential mechanisms to explain this relationship including: 
neuroendocrine effects, genetic effects, immune functioning, sleep disturbance, and 
engagement in health behaviors.  
Some research suggests that the potential mechanisms of neuroendocrine, genetic, 
and immune functioning might explain relationships between loneliness and poor health 
outcomes.  For example, higher loneliness is related to increased blood pressure 
(Hawkley, Thisted, Masi, & Cacioppo, 2010) and higher levels of epinephrine (Hawkley, 
Masi, Berry, & Cacioppo, 2006) which, when elevated, have detrimental effects on 
health.  Additionally, levels of the stress hormone cortisol are also heightened in lonely 
individuals (Cacioppo et al., 2000; Doane & Adam, 2010; Kiecolt-Glaser et al., 1984; 
Pressman et al., 2005; Steptoe, Owen, Kunz-Ebrecht, & Brydon, 2004), leading to greater 
activation of the HPA axis.  In a review of stress system disorders, Chrousos and Gold 
(1992) discussed the many medical conditions associated with increased HPA axis 
activity, including hypertension and other chronic diseases.  Increased levels of cortisol in 
lonely people may also desensitize the glucocorticoid receptor pathway, making cells 
insensitive to anti-inflammatory effects.  Therefore, differences in the transcription of 
glucocorticoid response genes and increased activity of pro-inflammatory transcription 
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control pathways between lonely and non-lonely individuals may help explain the impact 
of loneliness on health (Cole et al., 2007).  Furthermore, evidence suggests that greater 
loneliness is related to poorer immune functioning (e.g., lower active killer cell activity, 
poorer T-lymphocyte response, decreased antibody response) (Glaser, Kiecolt-Glaser, 
Speicher, & Holliday, 1985; Kiecolt-Glaser et al., 1984). 
The potential mediating role of sleep disturbance in the relationship between 
loneliness and health has also garnered some attention.  Lonely college students and older 
adults report poorer sleep, experience poorer sleep efficiency, and spend more time 
awake than their non-lonely peers (Cacioppo, Hawkley, Berntson, et al., 2002; Cacioppo, 
Hawkley, Crawford, et al., 2002).  Loneliness was also related to sleep disturbance in 
early and middle adolescents (Mahon, 1994).  Furthermore, in a large study of 
adolescents and adults in seven European countries, Ohayon (2005) found that those less 
satisfied with their social network experienced more nonrestorative sleep than those more 
satisfied with their social network.  Decreased quality and quantity of sleep could make 
lonely individuals less resistant to health threats.  
The mediating role of health behaviors, such as smoking, diet, exercise, and 
alcohol and drug use, in the relationship between loneliness and health has been less 
clear.  Cacioppo, Hawkley, Crawford, et al. (2002) found no difference in alcohol 
consumption, drug use, number of cigarettes smoked, or exercise duration between 
groups of lonely and non-lonely undergraduate students and adults (Cacioppo, Hawkley, 
Crawford, et al., 2002).  However, other studies have suggested that lonely individuals 
engage in less health-promoting behaviors.  For example, Theeke (2010) found that 
chronically lonely older adults used more tobacco and exercised less than those who were 
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not chronically lonely.  Other studies found that lonely people were more likely to smoke, 
be overweight, and have higher body mass indexes (BMIs) than non-lonely people 
(DeWall & Pond, 2011; Lauder, Mummery, Jones, & Caperchione, 2006; Shankar, 
McMunn, Banks, & Steptoe, 2011).  Additionally, loneliness predicted reduced odds of 
engagement in physical activity in adult samples (Reed, Crespo, Harvey, & Andersen, 
2011; Shankar et al., 2011).  Greater loneliness also has been linked to the full spectrum 
of eating disorders (Levine, 2012), and lonely student dieters ate more than non-lonely 
student dieters when offered free food (Rotenberg & Flood, 1999).   
 
Interventions for Loneliness 
Given the poor health outcomes associated with loneliness, a number of 
interventions have been developed to reduce it (Cattan, White, Bond, & Learmouth, 
2005; Findlay, 2003; Masi, Chen, Hawkley, & Cacioppo, 2010).  Loneliness 
interventions have targeted various populations, including children and adolescents (e.g., 
Allen-Kosal, 2008; Bauminger, 2007; Stewart, Craig, MacPherson, & Alexander, 2001), 
college students (e.g., Conoley & Garber, 1985; Seepersad, 2005) older adults (e.g., 
Banks, Willoughby, & Banks, 2008; McAuley et al., 2000; Ollonqvist et al., 2008), 
individuals with severe mental illness (e.g., Bauminger, 2007; Kolko, Loar, & Sturnick, 
1990; Petryshen, Hawkins, & Fronchak, 2001), and individuals with medical conditions 
(e.g., Christian & D'Auria, 2006; Cox, Green, Hobart, Jang, & Seo, 2007; Fukui, Koike, 
Ooba, & Uchitomi, 2003; Heckman et al., 2006), with the majority of studies focusing on 
older adults.   
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Masi et al. (2010) published a systematic review and meta-analysis of loneliness 
reduction interventions.  Their meta-analytic results indicated that studies using a 
randomized comparison design had smaller effect sizes than studies using a pre-post or 
non-randomized comparison design.  Among studies using a randomized comparison trial 
design, a wide range of effect sizes was found, with differences in intervention strategies 
partially accounting for these results.  The authors reported that four primary intervention 
strategies have been used to reduce loneliness: reducing maladaptive social cognitions, 
improving social skills, enhancing social support, and increasing opportunities for social 
contact.  Control groups varied across studies and included usual care, wait-list control, 
and educational control groups.  Among studies using a randomized comparison design, 
interventions that addressed maladaptive social cognitions were most successful.  In fact, 
the mean effect size for these interventions was medium (i.e., d = -.59), whereas the mean 
effect sizes for each of the other three strategies were small (i.e., ds = .02 to -.16).  No 
significant differences were found between the effect sizes of the other three intervention 
strategies, and the only other strategy found to have a significant effect on loneliness was 
enhanced social support (d = -.16).  Overall, these findings are consistent with loneliness 
theory which emphasizes the role of social cognitions in loneliness (Cacioppo et al., 
2014; Cacioppo & Hawkley, 2009; Cacioppo et al., 2006).  
 
Loneliness in Cancer 
About 40% of all men and women will be diagnosed with cancer at some point 
during their lifetime, with approximately 66% surviving 5 years post-diagnosis (SEER, 
2013). Unfortunately, cancer patients experience high rates of psychological and somatic 
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symptoms, existential concerns, and social challenges during and after treatment 
(Brintzenhofe-Szoc, Levin, Li, Kissane, & Zabora, 2009; Kroenke, Johns, Theobald, Wu, 
& Tu, 2013; Pirl, 2004).  In addition, many aspects of the cancer experience lend 
themselves to making patients feel alone and misunderstood.   
 A vulnerability-stress model (Gibb & Coles, 2005) may be a useful framework for 
understanding loneliness in cancer patients.  Genetically-predisposed dysfunctional 
attitudes or expectations regarding social relationships would constitute the vulnerability 
and, when patients with such attitudes encounter cancer (i.e., the stressor), they may be 
more likely to develop loneliness than patients without such attitudes.  Among cancer 
patients, the maladaptive social cognitions and social experiences characteristic of 
loneliness may specifically relate to aspects of the cancer experience.  For example, 
patients may expect a high level of support and sympathy from friends and family 
following a cancer diagnosis; yet many may feel disappointed or alienated when 
members of their social network do not provide the support that they anticipated.   
Although theory suggests that cancer may exacerbate loneliness in some 
individuals (Gibb & Coles, 2005), the empirical literature on loneliness in cancer patients 
is limited.  Significant variability in cancer patients’ loneliness levels exists between 
studies, with some studies suggesting that cancer patients do not experience greater levels 
of loneliness than other populations (i.e., healthy peers, individuals with other chronic 
conditions) (Pendley, Dahlquist, & Dreyer, 1997; Penninx et al., 1999; Rijken, Komproe, 
Ros, Winnubst, & Heesch, 1995), and other studies suggesting that their loneliness levels 
are greater than those found in the general population (Fox, Harper, Hyner, & Lyle, 1994; 
Sahin & Tan, 2012).  Loneliness scores on the UCLA Loneliness Scale have sometimes 
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been categorized as low, moderate, or high (possible range = 20 to 80).  Average 
loneliness levels in cancer patients on the UCLA Loneliness Scale have varied from low 
(scores less than 28) to high (scores greater than 46) between studies, with the majority of 
studies reporting moderate levels of loneliness on average (Fogel, Albert, Schnabel, 
Ditkoff, & Neugut, 2002; Fox et al., 1994; Friedman, Florian, & Zernitsky-Shurka, 1989; 
Jaremka, Fagundes, Peng, et al., 2013; Pehlivan, Ovayolu, Ovayolu, Sevinc, & Camci, 
2012; Perry, 1990; Sahin & Tan, 2012; Sevil, Ertem, Kavlak, & Coban, 2006; Yildirim & 
Kocabiyik, 2010).  Indeed, a recent meta-analysis reported that cancer patients experience 
a moderate level of loneliness on average (Deckx, van den Akker, & Buntinx, 2014). 
 
Demographic and Medical Correlates of Loneliness in Cancer 
Limited research has examined demographic and medical correlates of loneliness 
in cancer patients.  A meta-analytic review of loneliness correlates in cancer patients 
reported that loneliness is more common in unmarried patients and tends to increase as 
more time elapses since the cancer diagnosis (Deckx et al., 2014).  The authors reported 
no relationship between loneliness and cancer type or the mean age of the study sample.  
In primary studies of cancer patients, the majority of studies have found no relationship 
between loneliness and gender, educational level, age, disease stage, or cancer type (Avci 
& Kumcagiz, 2011; Friedman et al., 1989; Jaremka, Fagundes, Glaser, et al., 2013; 
Pehlivan et al., 2012; Perry, 1990; Sevil et al., 2006; Yildirim & Kocabiyik, 2010).  
Relationships between loneliness and marital status and time since diagnosis have been 
mixed, with some studies finding that individuals who are married and more recently 
diagnosed are less lonely than those who are unmarried and less recently diagnosed and 
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other studies finding no significant relationships (Avci & Kumcagiz, 2011; Friedman et 
al., 1989; Pehlivan et al., 2012; Perry, 1990; Yildirim & Kocabiyik, 2010).  
 
Social Correlates of Loneliness in Cancer 
Theory and limited research suggest that social support and social constraints are 
associated loneliness (Deckx et al., 2014; Lepore, 2001; Mosher et al., 2012).  Social 
support is a positive social variable indicating the actual or perceived amount of 
emotional or practical support provided by others (Helgeson & Cohen, 1996).  On the 
other hand, social constraints occur when an individual feels compelled to modify the 
expression of stressor-related thoughts or feelings due to social conditions (i.e., others’ 
actual or perceived behaviors) (Lepore & Revenson, 2007).  According to social 
cognitive processing theory (Lepore, 2001), a socially constraining environment impedes 
adjustment by preventing successful cognitive and emotional processing of new 
information regarding a stressor (e.g., cancer).  Conversely, a supportive social 
environment facilitates the processing of stressor-related information, which in turn 
promotes adjustment.  Cancer patients often process their cancer-related thoughts and 
feelings by talking about their concerns with important others; thus, patients’ 
psychological adjustment may be affected when they feel unable to share their concerns 
(Davison, Pennebaker, & Dickerson, 2000; Gotcher, 1993; Lepore, 2001).  Consistent 
with this theoretical perspective (Lepore, 2001), higher levels of social constraints were 
associated with greater loneliness among cancer patients in one study (Mosher et al., 
2012), whereas higher levels of social support were associated with less loneliness in 
several studies with this population (Mosher et al., 2012; Sahin & Tan, 2012; Yildirim & 
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Kocabiyik, 2010).  Furthermore, in one qualitative study, head and neck cancer patients 
reported that more contact with other cancer patients reduced their feelings of loneliness 
(Egestad, 2013).  
 
Loneliness and Health Outcomes in Cancer 
Loneliness has been associated with a number of psychological and physical 
health outcomes in cancer patients.  Regarding psychological health outcomes, loneliness 
has been positively related to distress and hopelessness and negatively related to quality 
of life, self-esteem, and optimism in medically diverse samples of cancer patients and 
survivors (Jaremka, Fagundes, Glaser, et al., 2013; Mosher et al., 2012; Pace & Stables, 
1997; Pehlivan et al., 2012; Rijken et al., 1995).  In a 1-year study of breast cancer 
patients, greater loneliness predicted increased depressive symptoms longitudinally, 
whereas depression did not predict changes in loneliness over time (Jaremka, Andridge, 
et al., 2014).  Regarding physical health outcomes, loneliness has been positively 
associated with fatigue and pain and negatively associated with sleep quality and self-
reported physical health in recently diagnosed and long-term cancer survivors (Ferrell, 
Dow, & Grant, 1995; Jaremka, Fagundes, Glaser, et al., 2013; Rijken et al., 1995).  In a 
study of breast cancer patients, greater loneliness predicted increases in fatigue and pain 
over time, whereas these symptoms did not predict changes in loneliness (Jaremka, 
Andridge, et al., 2014).  In two studies, loneliness was associated with greater incidence 
of cancer and all-cause mortality (Drageset, Eide, Kirkevold, & Ranhoff, 2013; Fox et al., 
1994), and one recent study found that expression profiles for loneliness-related genes 
predicted survival time in cancer patients, such that patients with high-risk loneliness 
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profiles had a shorter survival time on average than patients with a low-risk loneliness 
profile (You, Yeh, & Su, 2014).  Furthermore, studies have found links between higher 
levels of loneliness and poorer immune functioning in breast cancer patients (Jaremka, 
Fagundes, Peng, et al., 2013; Nausheen et al., 2010).  In contrast, another study found no 
relationship between loneliness and disease markers in breast cancer patients (Giraldi, 
Rodani, Cartei, & Grassi, 1997).  
 
Cancer-related Experiences Associated with Loneliness 
Qualitative researchers have begun to document aspects of the cancer experience 
that patients perceive as precipitants of loneliness.  First, many patients report feeling 
alone in a number of illness-related situations (e.g., during diagnosis, during 
appointments, while making important medical decisions) (Friedman et al., 1989; 
Madsen, Holm, & Riis, 2007).  Second, some patients report that their psychological and 
somatic symptoms have caused them to become more dependent on others; yet, over 
time, they receive less emotional support and have fewer conversations with family 
members concerning their illness, which makes them feel devalued (Sand et al., 2008).  
Further, many patients report heightened existential concerns (e.g., fear of death) during 
and after cancer treatment and feel that those around them do not share their new 
awareness of mortality or understand their concerns (Rosedale, 2009; Sand et al., 2008).  
Additionally, although patients typically report an intensified desire to connect with 
others, many also report withholding fears from others in order to protect them, which 
hinders social connection (Rosedale, 2009).  Thus, qualitative work provides some useful 
insights into the experiences that contribute to feelings of isolation in cancer patients.  
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Theory and research point to other social conditions surrounding cancer that 
might contribute to loneliness as well.  For example, emotional processing of stressful 
information with others is hypothesized to facilitate patients’ adjustment (Park, 2010), yet 
many patients report that their family members and friends avoid discussing the cancer or 
find conversations regarding cancer to be difficult (Lepore & Revenson, 2007).  Some 
family members and friends may feel uncomfortable around patients and avoid them 
altogether (Lepore & Revenson, 2007).  Others may avoid conversations about illness 
and death because they feel it is in the best interest of the patient (Kuijer et al., 2000; 
Langer, Brown, & Syrjala, 2009), though patients tend to report that they want to talk 
about their illness (Davison et al., 2000).  Moreover, some cancer patients report 
experiencing stigma (i.e., exclusion, blame, rejection, and devaluation based on a 
judgment concerning their illness) (Butts Stahly, 1989; Cataldo, Slaughter, Jahan, 
Pongquan, & Hwang, 2011; Muzzin, Anderson, Figueredo, & Gudelis, 1994).  In 
particular, patients whose cancer is perceived to be caused by their own behaviors (i.e., 
lung cancer and to a lesser extent cervical and bowel cancer) tend to experience the most 
stigma (Lebel & Devins, 2008; Marlow, Waller, & Wardle, 2010).  Additionally, some 
patients report stigma following physical changes that often accompany cancer and its 
treatment, such as hair loss (Rosman, 2004).  Given these circumstances, it is not 
surprising that many cancer patients report feeling lonely and misunderstood. 
 
Interventions for Loneliness in Cancer Patients 
Despite evidence presented that (1) loneliness is an important quality-of-life 
concern for cancer patients; (2) greater loneliness is related to poorer mental and physical 
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health in cancer patients and the general population; and (3) some loneliness 
interventions are efficacious in the general population, literature regarding loneliness 
interventions for cancer patients is sparse.  Five studies with cancer patients that 
examined loneliness as an intervention outcome did not specifically tailor the 
intervention to reduce loneliness (Cleary & Stanton, 2015; Coleman et al., 2005; De 
Vries et al., 1997; Marcus, Blazek-O'Neill, & Kopar, 2013; Samarel, Tulman, & Fawcett, 
2002).  Rather, loneliness was one of many outcomes examined, such as distress, 
relational outcomes, and somatic symptoms.  These studies employed standard 
psychotherapy, telephone-based social support, psychoeducation, and Reiki (a type of 
spiritual healing) to improve patient outcomes.  Three of these interventions led to 
decreased loneliness at certain time points (Cleary & Stanton, 2015; Marcus et al., 2013; 
Samarel et al., 2002).  To my knowledge, only one published trial specifically tested an 
intervention to reduce loneliness and increase social support in cancer patients (Fukui et 
al., 2003).  Japanese women with breast cancer participated in this 6-week group-based 
intervention focused on health education, coping skills training, stress management, and 
psychological support.  At the end of the 6-week intervention, women assigned to the 
intervention reported significantly less loneliness and greater satisfaction with confidants 
than the wait-list control group, though differences were modest.  Taken together, 
preliminary evidence indicates that interventions might reduce loneliness in a cancer 
population, but more work is needed to determine whether other intervention strategies 
may lead to greater decreases in loneliness.  For example, no published intervention trials 
with cancer patients have addressed maladaptive social cognitions linked to loneliness, 
which was found to be the most successful strategy for loneliness reduction in the general 
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population (Masi et al., 2010).  Further intervention studies are needed to determine the 
most effective strategies for reducing loneliness in cancer patients.  
 
Present Study 
Cancer patients may experience loneliness specifically related to their cancer 
experience.  For example, patients’ loneliness-related cognitions may refer to the cancer 
experience (e.g., unrealistic expectations regarding others’ level of understanding and 
support during their illness).  Further, different social factors may be associated with 
loneliness in cancer patients relative to non-cancer populations.  For instance, although 
the size of one’s social network and the amount of social contact is not associated with 
loneliness in the general population (Peplau & Perlman, 1982; Russell, 1996), cancer 
patients have reported that more contact with other patients led them to feel less lonely 
(Egestad, 2013).  Thus, interactions with other patients may be an important factor that is 
unique to loneliness in cancer populations.  Loneliness interventions in cancer should be 
tailored to address illness-related social conditions and maladaptive social cognitions 
(e.g., intervention materials should contain cancer-specific examples).  
Prior to the development of loneliness interventions for cancer populations, 
cancer-specific tools are needed to assess: (1) loneliness attributed to cancer (i.e., cancer-
related loneliness), and (2) negative social expectations related to cancer that may 
precipitate and sustain loneliness.  These measures could advance loneliness research in 
multiple respects.  First, a tool assessing loneliness attributed to cancer could allow us to 
identify patients who may warrant a cancer-specific loneliness intervention.  In addition, 
researchers could assess whether the intervention reduced cancer-related loneliness.  
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Second, a measure of patients’ negative social expectations related to cancer could 
contribute to theory development and clinical care.  To my knowledge, a measure of 
negative social expectations associated with loneliness has not been developed for any 
population.  If I found that negative social expectations are correlated with loneliness, it 
would provide further support for theory linking these variables (Cacioppo & Hawkley, 
2009).  Furthermore, therapists could select negative social cognitions upon which to 
intervene based on item responses.  Following the intervention, researchers could 
empirically evaluate whether reduced negative social expectations mediate the effects of 
a cognitive intervention on cancer patients’ loneliness. 
To address the need for cancer-specific tools, I developed and tested measures of 
cancer-related loneliness (aim 1) and cancer-related negative social expectations (aim 2) 
in the current project.  The goal of the cancer-related loneliness measure (i.e., Cancer 
Loneliness Scale) is to assess patients’ loneliness attributed to cancer.  The goal of the 
negative social expectations measure (i.e., Cancer-related Negative Social Expectations 
Scale) is to assess negative social cognitions related to patients’ cancer experiences.  
Development of the item pools for testing was guided by theory, prior research, and 
qualitative interviews conducted as part of this project.  First, I developed the item pool 
for the Cancer Loneliness Scale based on loneliness theory (Cacioppo & Hawkley, 2009; 
Cacioppo et al., 2006; Cutrona, 1982; Peplau & Perlman, 1982), previous general 
loneliness measures (de Jong-Gierveld, 1987; de Jong-Gierveld & Van Tilburg, 2006; 
Russell, 1996; Vincenzi & Grabosky, 1987), and qualitative studies of loneliness in 
cancer patients and survivors (Rosedale, 2009; Sand et al., 2008).  For example, 
qualitative work suggests that reduced illness-related discussion with family members 
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over time contributes to patients’ feelings of loneliness (Sand et al., 2008).  Therefore, 
one item in the Cancer Loneliness Scale item pool was “How often do you feel that 
others cannot provide the support that you need to deal with your cancer?”  Next, 
qualitative interviews were conducted to obtain cancer patients’ feedback on the Cancer 
Loneliness Scale items.  Decisions about item revision were subsequently made based on 
patient feedback.  Additionally, during the qualitative interviews cancer patients were 
asked to describe their experiences of loneliness, including thoughts and situations 
evoking these feelings.  Based on the qualitative interview data, theory (J. Beck, 2011; 
Cacioppo & Hawkley, 2009; Lepore, 2001), and prior research on cancer patients’ 
loneliness (Mosher et al., 2012; Rosedale, 2009; Sand et al., 2008), I developed the item 
pool for the Cancer-related Negative Social Expectations Scale.   
To test the construct validity of the measures, I examined a number of theory-
driven relationships between the measures and social, psychological, and somatic 
variables in a new, larger sample of cancer patients who completed mailed 
questionnaires.  Regarding the Cancer Loneliness Scale, most of these theoretical 
relationships were hypothesized to mirror those found in the general loneliness literature 
and, thus, hypotheses were based on loneliness theory (Cacioppo & Hawkley, 2009; 
Cacioppo et al., 2006; Cutrona, 1982; Peplau & Perlman, 1982) and prior research on 
loneliness (Cacioppo et al., 2006; Hawkley & Cacioppo, 2003; Mosher et al., 2012; 
Russell, 1996).  First, I expected cancer-related loneliness to be positively related to 
anxiety and depressive symptoms, consistent with theory and prior research on general 
loneliness (Cacioppo & Hawkley, 2009; Cacioppo et al., 2006; Hawkley & Cacioppo, 
2003; Peplau & Perlman, 1982).  Second, I expected cancer-related loneliness to be 
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positively associated with general loneliness, as dissatisfaction with relationships is 
central to both types of loneliness.  Third, I expected cancer-related loneliness to be 
positively related to social constraints and negatively related to social support because 
social cognitive processing theory (Lepore, 2001) suggests that the social environment 
impacts psychological adjustment.  In support of this prediction, several studies have 
found that social support and social constraints are associated with general loneliness in 
cancer patients (Deckx et al., 2014; Mosher et al., 2012; Sahin & Tan, 2012; Yildirim & 
Kocabiyik, 2010).  Fourth, I expected cancer-related loneliness to be negatively related to 
quality of life because loneliness has been consistently associated with poor health-
related outcomes in cancer patients and the general population (Hawkley & Cacioppo, 
2003; Jaremka, Andridge, et al., 2014; Pehlivan et al., 2012).  Lastly, I expected cancer-
related loneliness to be negatively associated with the number of cancer patient 
confidants, but unrelated to the size of one’s total network of family and friends.  
According to theory, loneliness is not a result of actual isolation or one’s number of 
social network members, but instead relates to dissatisfaction with relationships (Peplau 
& Perlman, 1982; Russell, 1996).  Accordingly, loneliness has generally been unrelated 
to social network size (Peplau & Perlman, 1982; Russell, 1996).  However, in qualitative 
work, cancer patients have reported that having more contact with other cancer patients 
reduced their feelings of loneliness (Egestad, 2013).  Contact with other cancer patients 
might lead to decreases in cancer-related loneliness because it provides an opportunity for 
patients to communicate with others who are going through similar experiences (e.g., 
heightened existential concerns).  This communication might normalize their 
experiences, leading them to feel more connected to others.  Feeling disconnected is a 
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central aspect of loneliness and, therefore, increased social connection with other cancer 
patients is likely to reduce feelings of cancer-related loneliness.  
To test the construct validity of the Cancer-related Negative Social Expectations 
Scale, I examined theoretical relationships between the new measure and social and 
psychological variables.  First, I expected negative social expectations to be positively 
correlated with loneliness and cancer-related loneliness based on theory linking negative 
social expectations to loneliness (Cacioppo & Hawkley, 2009) and prior research 
showing loneliness-reducing effects of interventions targeting social cognitions in the 
general population (Masi et al., 2010).  Second, I expected negative social expectations to 
be positively correlated with anxiety and depressive symptoms, as negative thought 
patterns are theorized to underlie anxiety and depressive disorders (A. Beck, 1970; Clark 
& Beck, 1989).  Third, I hypothesized that negative social expectations would be 
positively associated with somatic symptoms and negatively associated with quality of 
life, as these expectations are theorized to impact health outcomes by activating 
neurobiological mechanisms that increase HPA axis dysfunction and reduce sleep quality 
(Cacioppo & Hawkley, 2009).  Finally, I expected negative social expectations to be 
positively correlated with social constraints and negatively correlated with emotional 
support.  Negative social expectations are theorized to increase social behaviors that elicit 
negative social interactions (Cacioppo & Hawkley, 2009).  
The specific aims and hypotheses are as follows: 
Qualitative Aim 1: To develop a new measure of cancer-related loneliness (“Cancer 
Loneliness Scale”) and obtain feedback on the items from cancer patients.  
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Qualitative Aim 2: To develop a new measure that identifies negative social expectations 
in cancer patients (“Cancer-related Negative Social Expectations Scale”).  
Quantitative Aim 3. To evaluate the psychometric properties of the Cancer Loneliness 
Scale in a diverse sample of cancer patients.  
Hypothesis 3.1: The Cancer Loneliness Scale will be unidimensional as assessed by 
confirmatory factor analysis.  
Hypothesis 3.2: The Cancer Loneliness Scale will demonstrate an internal consistency 
coefficient of 0.70 or above.  
Hypothesis 3.3: Construct validity of the Cancer Loneliness Scale will be demonstrated 
by support of the following theoretical relationships: 
(a) Cancer-related loneliness will be positively related to general loneliness, social 
constraints, psychological symptoms (i.e., anxiety and depression), and somatic 
symptoms (i.e., sleep disturbance, pain, fatigue). 
(b) Cancer-related loneliness will be negatively related to mental and physical quality 
of life, emotional support, and the number of cancer patient confidants.  
(c) Cancer-related loneliness will be unrelated to general social network size.  
Exploratory Quantitative Aim 4. To evaluate the psychometric properties of the Cancer-
related Negative Social Expectations Scale in a diverse sample of cancer patients.  
Goal 4.1: Based on findings of the qualitative study, conduct confirmatory factor analyses 
to determine the dimensionality of the Cancer-related Negative Social Expectations 
Scale. 
Goal 4.2: To explore internal consistency coefficients for the Cancer-related Negative 
Social Expectations Scale dimensions identified in Goal 4.1.  
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Goal 4.3: To explore whether the following theoretical relationships are found to support 
the construct validity of the Cancer-related Negative Social Expectations Scale:  
(a) Negative social expectations will be positively related to general loneliness, 
cancer-related loneliness, social constraints, psychological symptoms (i.e., anxiety 
and depression), and somatic symptoms (i.e., sleep disturbance, pain, fatigue). 
(b) Negative social expectations will be negatively related to mental and physical 
quality of life and emotional support.  
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QUALITATIVE STUDY METHODS 
 
 
 
Participants 
 
Following institutional review board approval, cancer patients were recruited 
from a hematology/oncology clinic at the Indiana University Simon Cancer Center.  
Eligibility status was determined by medical chart review, consultation with patients’ 
oncologists, and observation during the informed consent process.  Eligibility criteria for 
the study included: (1) having a diagnosis of multiple myeloma or non-Hodgkin’s 
lymphoma; (2) currently undergoing curative or palliative treatment for cancer; (3) being 
18 years of age or older; (4) being able to read and write in English; (5) having no serious 
cognitive impairment (based upon the patient’s ability to describe the study after it had 
been explained during the informed consent process); and (6) being scheduled for an 
upcoming appointment in the oncology clinic.  Patients who were undergoing treatment 
for multiple myeloma or non-Hodgkin’s lymphoma were interviewed because many 
receive treatments involving prolonged isolation, such as hematopoietic stem cell 
transplantation (HSCT), which may be expected to precipitate loneliness.  In addition, 
others’ limited understanding of these less common cancers may contribute to patients’ 
feelings of loneliness. 
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Measures 
 
Demographic and Medical Characteristics 
The following characteristics were collected from participants’ medical records 
following informed consent: age, gender, cancer type(s), date(s) of diagnosis, cancer 
treatments received (e.g., surgery, radiation, chemotherapy), and cancer stage(s) (i.e., 
early vs. late/advanced).  The following characteristics were collected via participant self-
report: marital status, race/ethnicity, education level, employment status, and health 
insurance status.   
 
Loneliness 
General loneliness was measured by the UCLA Loneliness Scale-Version 3 
(Russell, 1996).  This 20-item unidimensional scale is the most widely used measure of 
general loneliness in research.  The measure uses a 4-point Likert-type scale with 
responses ranging from 1 (never) to 4 (always).  A sample item is “How often do you feel 
that people are around you but not with you?”  The UCLA Loneliness Scale has shown 
excellent reliability across studies, including studies of cancer patients (e.g., Fogel et al., 
2002; Yildirim & Kocabiyik, 2010), with one meta-analysis of alpha reliability 
coefficients across populations finding a mean alpha coefficient of 0.92 (SD = .03, range 
= 0.86-0.95; Vassar & Crosby, 2008).  In the current study, internal consistency 
reliability was excellent (α=0.89).  Excellent validity evidence is also available in general 
population and cancer patient samples (Jaremka, Andridge, et al., 2014; Mosher et al., 
2012; Russell, 1996).   
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PROMIS Measures of Depressive and Anxiety Symptoms 
NIH-funded Patient Reported Outcomes Measurement Information System 
(PROMIS) measures were used to assess depressive and anxiety symptoms.  PROMIS 
measures have undergone rigorous reliability and validity testing (e.g., Cella et al., 2010; 
Cella et al., 2007; Magasi et al., 2012) and were developed with cancer populations in 
mind (Garcia et al., 2007).  Depressive and anxiety symptoms during the past 7 days were 
assessed with the PROMIS 4-item Depression measure and 4-item Anxiety measure, 
respectively (Choi, Reise, Pilkonis, Hays, & Cella, 2010; Pilkonis et al., 2011).  The 
measures use a 5-point Likert-type scale with responses ranging from 1 (never) to 5 
(always).  Two 4-item composite scores were calculated by averaging relevant items, 
with higher scores indicating greater depressive and anxiety symptoms.  A sample 
depression item is “In the past 7 days, I felt hopeless,” and a sample anxiety item is “In 
the past 7 days, my worries overwhelmed me.”  In the current study, internal consistency 
reliability was excellent for the depression measure (α=0.82) and good for the anxiety 
measure (α=0.75).  
 
Social Network Characteristics 
Four items adapted from the Social Network Index (Cohen, Doyle, Skoner, Rabin, 
& Gwaltney, 1997) were used to assess social network characteristics.   The primary 
content of Cohen and colleagues’ items was retained, but the social network categories 
(e.g., relatives, friends) differed.  The items included: (1) “How many relatives do you 
see or talk to on the phone at least once every 2 weeks?”; (2) “How many friends do you 
see or talk to on the phone at least once every 2 weeks?”; (3) “How many co-workers do 
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you see or talk to on the phone at least once every 2 weeks?”; and (4) How many cancer 
patients or survivors do you see or talk to on the phone at least once every 2 weeks?”  
Participants who were not currently employed were instructed to skip the item on 
coworkers. 
 
Cancer-related Loneliness 
Participants were asked to provide feedback on the format and content of 15 
potential items for the Cancer Loneliness Scale (see Appendix A).  Some of the items 
were tailored from the UCLA Loneliness Scale-Version 3 and other loneliness measures 
(de Jong-Gierveld, 1987; Russell, 1996; Vincenzi & Grabosky, 1987), whereas other 
items were developed based on loneliness theory (Cacioppo & Hawkley, 2009; Cacioppo 
et al., 2006; Cutrona, 1982; Peplau & Perlman, 1982) and qualitative research on 
loneliness in cancer patients (Rosedale, 2009; Sand et al., 2008).  A 5-point Likert-type 
scale with responses ranging from 1 (never) to 5 (always) was used.  These responses 
were selected because they are similar to those used by the well-validated PROMIS 
measures, which were described previously.  Experts in scale development, loneliness, 
and social aspects of cancer reviewed the items before they were used in the present 
qualitative study.  
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Procedure 
 
Medical Record Screening Procedures 
A waiver of HIPAA authorization was obtained in order to review electronic 
medical records of patients who were scheduled for an upcoming appointment with 
collaborating oncologists at the Indiana University Simon Cancer Center.  Patients’ age, 
cancer diagnosis, and treatment status were determined from medical records in order to 
identify potentially eligible patients prior to recruitment (see Appendix B for screening 
form). 
 
Recruitment Procedures 
  Cancer patients were recruited from the hematology/oncology clinic at the 
Indiana University Simon Cancer Center.  I used purposive sampling (Berg, 2004) based 
on patient gender and age (>65 years vs. <65 years) to ensure approximately equal 
numbers of demographic subgroups.  Following approval from the patient’s oncologist, I 
approached the patient before or after his or her oncology clinic appointment.  The 
informed consent process occurred in a private room in the clinic.  I described the study, 
reviewed the consent and authorization forms (see Appendix C for consent form), 
answered questions, and invited patients to participate.  During the informed consent 
process, I asked the patient to verbalize his or her understanding of the study.  If the 
patient had been unable to clearly describe the study, he or she would have been 
considered ineligible due to likely cognitive impairment or language difficulties.  If 
interested, eligible patients signed the informed consent and authorization forms prior to 
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study participation.  Medical record data were collected after completion of informed 
consent and authorization forms (see Appendix D for medical record data collection 
form).  
 Participants first completed a brief self-report paper questionnaire in clinic (see 
Appendix E for questionnaire).  The questionnaire assessed demographic and medical 
characteristics, general loneliness, depressive and anxiety symptoms, and characteristics 
of the participant’s social network.  I was available to answer any questions.  The 
questionnaire took approximately 5 minutes to complete.  After completing the 
questionnaire, the participant handed it to me, and I checked it for omitted item 
responses.  If there were omissions, I asked the participant whether he or she intended to 
skip the items.  Subsequently, I conducted a brief audiotaped interview with the 
participant using a semi-structured interview guide (see Appendix F for interview guide).  
The goals of the interview were: (1) to identify cognitions associated with participants’ 
loneliness; and (2) to obtain feedback on the cancer-related loneliness items.  First, I 
provided participants with the following definition of loneliness: “loneliness means 
feeling isolated or disconnected from others around you.  It isn’t about how much time 
you spend with others or how many friends you have, but more about how connected you 
feel with others overall.”  Then I asked them to describe any experiences of loneliness 
since their cancer diagnosis.  I probed for any situations precipitating their loneliness and 
thoughts experienced while feeling lonely (e.g., “What thoughts were going through your 
head as you had this experience?”).  Throughout the interview, I asked follow-up 
questions to obtain a detailed narrative.  Next, I showed participants the cancer-related 
loneliness items (see Appendix A for handouts) and asked them to circle items that did 
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not make sense, were not clear, or were missing important content.  Afterwards, we 
discussed each item that they circled.  The interviews ranged from 10 to 30 minutes in 
length.  In total, the questionnaire and interview took up to 35 minutes.  After completing 
the interview, participants were given a $25 Target gift card for their participation.   
An iterative sampling process (i.e., alternating between data collection and 
analysis) was used until saturation was achieved.  Saturation is defined as “the point in 
data collection and analysis when new information produces little or no change to the 
codebook” (Guest, Bunce, & Johnson, 2006, p. 65).  Data collection was complete when 
saturation had been reached.  Prior research suggests that saturation generally occurs after 
data from 12 participants have been analyzed (Guest et al., 2006).   
 
Data Storage and Data Entry 
I entered and checked all data.  Paper questionnaires and consent forms are stored 
in a locked filing cabinet in a lockable office in LD 134.  
 
Analyses 
 
Preliminary Analyses of Quantitative Data 
Descriptive statistics (i.e., means, standard deviations, frequencies, ranges) were 
calculated to characterize the sample with respect to demographics, general loneliness, 
depressive and anxiety symptoms, and social network qualities.   
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Procedure for Qualitative Analysis 
Interviews were transcribed verbatim and transferred to Atlas.ti for analysis.  
First, a basic content analysis was used to analyze the interview data regarding qualitative 
aim 1 (i.e., obtaining feedback on items from the Cancer Loneliness Scale).  Content 
analysis is a descriptive, systematic coding and categorization process by which 
inferences are made from qualitative data (Berg, 2004; Vaismoradi, Turunen, & Bondas, 
2013).  This form of analysis is not typically based on theory.  Then a theoretical 
thematic analysis, defined as “a method for identifying, analysing, and reporting patterns 
(themes) within data” (Braun & Clarke, 2006, p. 6), was used to analyze data regarding 
qualitative aim 2 (i.e., identifying cognitions to inform the Cancer-related Negative 
Social Expectations Scale).  Specifically, the analysis was guided by loneliness theory 
(Cacioppo & Hawkley, 2009; Cacioppo et al., 2006; Peplau & Perlman, 1982) such that 
the analytic goal was to identify thoughts that may have precipitated loneliness.  For 
analyses addressing qualitative aims 1 and 2, an iterative sampling process was used; 
thus, two coders (Dr. Mosher and I) generated codes independently and met on a regular 
basis to discuss them (i.e., after the first 3 interviews and then after every 4 interviews).  
Discrepancies between coders were discussed and reconciled.  Data collection was 
complete when we agreed that saturation had been achieved.  Next, we categorized the 
codes into broader themes.  The themes were checked to ensure that they were internally 
consistent and distinguishable from one another.  The themes informed item adjustment 
and development.
33 
 
 
 
QUALITATIVE STUDY RESULTS 
 
Preliminary Analyses 
Seventeen patients were approached regarding this study.  All 17 were eligible, 
and 15 agreed to participate in the study (an 88% response rate).  Reasons for patient 
refusal included discomfort being audiotaped and insufficient time to complete the 
interview.  As shown in Appendix G, participants were primarily Caucasian (14/15) with 
a mean age of 63 (SD = 12; range = 43-77 years).  Approximately half of the participants 
were male (8/15) and approximately half were diagnosed with multiple myeloma (8/15).  
The majority (10/15) were diagnosed with late-stage disease.  The average time since the 
cancer diagnosis was 2.9 years (SD = 3.2 years; range = 0.2-9.4 years).  On average, 
participants reported that they rarely felt lonely on the UCLA Loneliness Scale.  
Additionally, participants’ scores on the depressive and anxiety symptom measures 
suggested that, on average, they had low levels of depressive symptoms (mean = 2.1; SD 
= 2.1; range = 0-6) and anxiety (mean = 2.7; SD = 2.3; range = 0-7), respectively.  The 
average numbers of relatives, friends, coworkers, and other cancer patients that 
participants reported seeing or talking to on the phone at least once every 2 weeks were 
5.6 (SD = 4.6; range = 0-18), 9.3 (SD = 12.6; range = 0-50), 9.0 (SD = 5.9; range = 1-20), 
and 1.2 (SD = 1.4; range = 0-5), respectively.
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Feedback on the Cancer Loneliness Scale 
 The first set of analyses addressed Qualitative Aim #1, which was to obtain 
feedback from cancer patients on the potential Cancer Loneliness Scale items.  Overall, 
most participants stated that the potential items for the Cancer Loneliness Scale were 
clear and easy to understand and that they had no suggestions regarding content or 
additional items.  However, some participants had suggestions for improving the 
measure.  Specific suggestions included adding items to assess context, adding items 
about positive social experiences, using less extreme language, and defining the word 
“empty.”  Each of these suggestions is described below.  
 
Add Items to Assess Context 
Several participants said that adding items to assess context would provide a more 
comprehensive understanding of cancer patients’ loneliness experiences.  For instance, a 
couple of participants said that their loneliness had fluctuated over their illness trajectory 
and that assessing perceptions of loneliness at different time points would provide more 
information.  As one participant said,  
I would add [instructions to assess loneliness at the] . . . time . . . that I was in the 
hospital and the time that I was home.  I have been out of the hospital for five 
months, so I answer these questions very much like I am home with my family 
and have a good support system.  I’m wondering if . . . they asked me how I felt 
when I was in the hospital, if it might not be a very different answer.  
 Participants suggested that I assess other types of contextual information as well, 
such as social support and the presence of non-cancer stressors that might impact a 
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person’s level of loneliness.  For example, in the following quote, one participant 
recommended assessing marital status: 
It might be helpful if you get a feel of their status-- whether they’re widowed, 
divorced-- that aspect of it.  Because being single, never married, for example, or 
recently widowed, that could certainly impact this. 
 
Add Items to Assess Positive Social Experiences 
Some participants said it would be important for me to assess positive 
experiences, including social experiences, related to the cancer diagnosis.  As one 
participant said, 
You’re just getting a picture of all the people who feel down in the dumps.  You 
need to get a picture of the people trying to keep uplifted about [cancer].  
 
Use Less Extreme Language 
One participant suggested that using extreme language (i.e., “no one” in item 
number four) would make the item less relatable to certain respondents, such as herself.  
She explained:  
[Participant reads item]: “How often do you feel that there is no one you can 
share.”  I mean, I always have my husband and hopefully others have at least one 
person.  But there are not a lot of people [with whom I can share besides my 
husband] . . .  
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Define the Word “Empty” 
One participant said that she was confused by the word “empty,” which was used 
in two items (#5 and #13).  Specifically, she stated: It’s the empty that I think throws off.  
Because my immediate thought was well, what do you mean by empty?  Do you mean 
lonely or do you mean like, nothing is inside of me?  You know, that’s the kind of thing 
that I would probably have to sit there and think about and be like, do I feel empty?  You 
know, it’s just . . . a redundant question since you’re asking about if you feel lonely. . . . 
Just explain what you mean by empty a little bit more.  That’s the one that would trip me 
up, you know, if I was taking the survey. 
 
Thoughts Associated with Loneliness 
In addition to obtaining feedback on the potential Cancer Loneliness Scale items 
for Qualitative Aim #1, I also asked patients to describe thoughts they associated with 
their loneliness to inform development of the Cancer-related Negative Social 
Expectations Scale (Qualitative Aim #2).  Patients reported a number of thought patterns 
during times of loneliness.  Some of the thought patterns involved negative social 
expectations, including unmet expectations for visits or questions about their health, the 
belief that disclosing illness-related information would negatively impact their 
relationships, and the belief that others do not understand their cancer-related 
experiences.  Other thought patterns that patients associated with their loneliness include 
perceptions of socially constraining behaviors from others and thoughts about death.  
These thoughts are described below.  
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Negative Social Expectations Associated with Loneliness 
 
Others Do Not Visit or Ask Questions as Often as I Expect 
 
 
Many participants had unmet expectations for visits and calls from family and 
friends, which resulted in feelings of loneliness.  Perceiving a lack of care and concern 
from others during conversations also contributed to loneliness.  As one woman stated, 
My children haven’t asked me any questions [about the cancer] . . . they just . . . 
change the subject.  I don’t know if they just don’t want to talk about it.  It does 
cross my mind, “Why aren’t they asking any questions?” 
 
My Relationships Would Change for the Worse if I Disclosed My Health Status 
 
 
Some participants believed that informing others of their cancer diagnosis, 
treatment, or symptom severity would lead to unwanted changes in their relationships.  
Withholding this information often led to feelings of isolation, as illustrated by the 
following quote from a woman who did not initially disclose her diagnosis: 
I felt isolated there at first, not wishing to discuss it [the cancer] and sometimes 
just the stigma of having cancer I think scares people away from you… people 
may not want to come around you or just be scared to approach or be afraid of 
what to say to you. 
For other participants, a lack of cancer-related disclosure was motivated by a 
desire to protect others from distress, as illustrated by the following statement:   
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[My husband] gets real depressed, so I . . . don’t share too much of the 
information with him. . . . From these scans, year over year, they seem to get 
worse every time. . . . But I can’t share that with him because he’s going to be 
really upset if I told him. . . . It’d be better if I did have somebody to share it with. 
. . I don’t [think] I can do that. 
 
Others Cannot Understand My Cancer-related Experiences 
 
 
Participants reported feeling misunderstood by others during times of loneliness.  
Specifically, some patients felt that others could not understand various cancer-related 
experiences, such as the process of undergoing cancer treatment and its physical side 
effects.  One patient who underwent two HSCTs described this experience: 
Sometimes you are misunderstood.  People don’t know.  They don’t understand 
my cancer. . . people come up to you and say, “You don’t look sick.”  I’ll tell you, 
only after my second transplant did I really look sick because. . . I lost tons of 
weight.  That is a question where you sit there and think, “I don’t know quite what 
I am supposed to say to that.”  Or people who don’t understand the cancer and 
think you had this transplant and now I’m well.  Well, you don’t want to dwell on 
it and say, “It doesn’t go away. I’m not going to get better.” 
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Other Thoughts Associated with Loneliness 
 
Others Treat Me Poorly Because of My Cancer 
 
 
Loneliness was also associated with perceptions of experiencing socially 
constraining behaviors from family and friends related to their cancer diagnosis.  For 
example, some participants said that loved ones criticized them or blamed them for their 
cancer diagnosis.  Following this criticism, participants often avoided sharing their 
feelings about the cancer, which heightened feelings of loneliness.  In addition, many 
participants stated that family and friends acted in a nervous or uncomfortable manner 
around them, especially when discussing their cancer.  As one woman said, 
 My husband and kids, after hearing about [the cancer], would sometimes feel 
awkward around me and that would make me feel lonely . . . kind of left out. 
 
My Time Might be Limited 
 
 
Some participants reported a new awareness of their mortality following their 
cancer diagnosis.  Existential questions such as “Why me?” and “How much longer do I 
have to live?” led to feelings of disconnection from others who did not face the same 
challenges.  Although this existential awareness increased some patients’ desire to spend 
time with family and friends, others felt that they did not have time for certain 
relationships.  One man described his withdrawal from others: 
I’ve chosen . . . to be isolated . . . I have . . . isolated myself more and more from 
people I know. . . . It’s almost like I have the feeling that I just don’t have time . . . 
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to maintain these relationships. . . . Of course, when you're sixty and you have 
cancer . . . your own mortality becomes a significant issue . . . . I just don't have . . 
. time, however long I'll live. . . . The cancer does play a role because it becomes a 
limiting factor . . . again, the cancer has put an exclamation point on that 
eventuality, that we're all going to die, right? . . .It's really put an exclamation 
point on that for me.
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QUALITATIVE STUDY DISCUSSION 
 
 
The goals of the current study were to (1) obtain feedback on the Cancer 
Loneliness Scale (Qualitative Aim #1), and (2) identify thoughts associated with cancer 
patients’ loneliness to inform the development of a measure of cancer-related negative 
social expectations (Qualitative Aim #2).  First, I will discuss participant feedback on the 
Cancer Loneliness Scale and my decisions regarding revisions to the scale.  Next, I will 
discuss thoughts that patients associated with their loneliness.  Third, I will discuss how I 
developed items for the Cancer-related Negative Social Expectations Scale based on the 
present qualitative findings and prior research and theory.  Finally, I will discuss study 
limitations and implications for theory and future research.  
 
Feedback on the Cancer Loneliness Scale 
Overall, participants said that they liked the Cancer Loneliness Scale; however, 
some suggestions for improvement were provided.  For instance, multiple participants 
suggested adding items to assess context and positive social experiences.  Participants 
said that greater contextual knowledge would help researchers better understand 
circumstances surrounding loneliness.  In addition, some participants felt that assessing 
positive social experiences would provide useful supplemental information.  I agreed 
with these comments and included other variables (e.g., social support, time since
42 
 
 
 
diagnosis) to assess context and positive social experiences in the quantitative study 
detailed below.  In addition, one participant suggested using less extreme language (i.e., 
omitting “no one”) in item #4, and one participant suggested that we define the word 
“empty” in items #5 and #13.  Because only one participant suggested each change, I 
decided to retain the items’ current wording and be attentive to those items’ psychometric 
performance in the subsequent quantitative study.  Thus, no changes were made to the 
Cancer Loneliness Scale based on participant feedback.   
 
Thoughts Associated with Loneliness 
Many patients identified negative social cognitions associated with their 
loneliness. These results are consistent with loneliness theory suggesting that negative 
social cognitions may precipitate or sustain loneliness (Cacioppo & Hawkley, 2009).  We 
identified five themes, or thought patterns, that patients associated with their loneliness.  
First, I will discuss thought patterns involving negative social expectations and then I will 
discuss other thought patterns.  
 
Negative Social Expectations Associated with Loneliness 
First, some participants reported that visits from family and friends and questions 
about their illness did not occur as often as expected, which led to feelings of loneliness.  
Similarly, one qualitative study found that cancer patients felt devalued when they had 
fewer conversations with family members concerning their illness over time (Sand et al., 
2008).  The present finding is also consistent with the definition of loneliness as the 
discrepancy between an individual’s expectations for social support and perceived social 
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support (Peplau & Perlman, 1982; Russell, Peplau, & Cutrona, 1980).  That is, patients in 
this study reported feeling lonely when their social expectations were not met.  
Second, some patients were concerned that disclosing their health status would 
negatively impact their relationships.  Some patients with this thought pattern 
experienced distress and disconnection from others when they failed to discuss cancer-
related concerns.  This finding is consistent with social cognitive processing theory 
(Lepore, 2001; Lepore & Revenson, 2007).  Specifically, non-disclosing patients do not 
have the opportunity to process cancer-related information with others, which has been 
found to facilitate psychological adjustment (Lepore & Helgeson, 1998; Manne et al., 
2004; Mosher et al., 2012).  Relatedly, protective buffering (e.g., hiding concerns and 
worries in an attempt to prevent others from experiencing distress) (Manne et al., 2007), 
has been associated with poorer psychological adjustment and lower levels of 
relationship satisfaction in cancer patients (Langer et al., 2009; Manne et al., 2007).  
Additionally, in a qualitative study, post-treatment breast cancer patients reported feeling 
lonely when they withheld their feelings to protect others (Rosedale, 2009). 
Third, some patients believed that others could not understand their cancer-related 
experiences and subsequently felt lonely.  To date, limited research has studied the 
relationship between loneliness and feeling misunderstood by others.  Specifically, in a 
qualitative study of post-treatment breast cancer patients, patients said that others’ 
misunderstanding of their cancer-related changes made them feel lonely and anxious 
(Rosedale, 2009).  Relatedly, one quantitative study found that healthy spouses’ 
relationship satisfaction, a concept related to loneliness, was associated with feeling 
understood by their partner (Weger, 2005).  
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Other Thoughts Associated with Loneliness 
Some patients also believed that others’ socially constraining behavior towards 
them contributed to loneliness.  These socially constraining behaviors included criticism, 
avoidance, or acting in a nervous or uncomfortable manner around them.  Findings 
converge with theory and research linking social constraints, including perceptions of 
others’ criticism, to loneliness (Lepore, 2001; Mosher et al., 2012).  Specifically, social 
cognitive processing theory posits that social constraints impede the cognitive processing 
of cancer-related stress, which in turn hinders psychological adjustment (e.g., increases 
loneliness) (Lepore, 2001; Lepore & Revenson, 2007).  Accordingly, one study found 
that greater social constraints were associated with greater loneliness among cancer 
patients who underwent HSCT (Mosher et al., 2012).   
Lastly, some patients said that existential thoughts, including a newfound 
awareness of their mortality and unpredictable future, contributed to their loneliness.  
Furthermore, many patients felt that others did not share their heightened awareness 
about mortality.  These findings are comparable to those of Rosedale (2009) who 
reported that breast cancer survivors felt others did not understand ongoing concerns 
about mortality and their future.  Furthermore, a novel finding of the current study was 
that thoughts about mortality may contribute to loneliness by decreasing interest in 
maintaining relationships.  Specifically, some patients prioritized other activities over 
certain relationships when they perceived their time as limited, which led to feelings of 
isolation.  Patients’ withdrawal from certain relationships is consistent with 
socioemotional selectivity theory which posits that one’s perception of how much time 
one has left impacts social goals (Carstensen, Isaacowitz, & Charles, 1999).  Consistent 
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with this theory, one study indicated that cancer patients who perceived themselves as 
having more time left showed greater interest in interacting with new social contacts 
compared to patients who perceived themselves as having less time (Pinquart & 
Silbereisen, 2006).  Our finding is also consistent with clinicians’ observation that, as 
cancer patients’ symptom burden increases and their mortality becomes more salient, 
they often change their priorities.  Many previously meaningful relationships may be 
discarded by necessity.  
 
Development of the Item Pool for the Cancer-Related Negative Social Expectations Scale 
 
 Based on the five themes or thought patterns identified in this study as well as 
theory and literature described previously (Cacioppo & Hawkley, 2009; Lepore, 2001; 
Lepore & Revenson, 2007; Mosher et al., 2012; Rosedale, 2009; Russell, 1996), I 
identified five domains for the Cancer-Related Negative Social Expectations Scale, 
including: (1) expecting others to listen or be available as often as desired; (2) expecting 
a lack of understanding of cancer-related concerns; (3) expecting that others will not 
understand existential thoughts; (4) expecting that the disclosure of cancer-related 
concerns will burden others; and (5) expecting that disclosure of their diagnosis or 
cancer-related concerns will change their relationships for the worse.  A list of the items 
developed to assess each domain is provided in Appendix H.  Current study themes and 
prior research and theory related to each domain of this measure are provided below. 
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Domain 1: Expecting Others to Listen or be Available Whenever the Patient Needs Them 
 
Domain 1 was developed based on the themes “others do not visit or ask 
questions as often as I expect” and “others treat me poorly because of my cancer” as well 
as social cognitive processing theory and prior research discussed previously (Lepore, 
2001; Lepore & Revenson, 2007; Mosher et al., 2012; Peplau & Perlman, 1982; Russell 
et al., 1980; Sand et al., 2008).  A sample item is “I expect other people to listen to me 
whenever I want to talk about my cancer.”   
 
Domain 2: Expecting a Lack of Understanding of Cancer-related Concerns 
Domain 2 was developed based on the theme “others do not understand my 
cancer-related experiences” as well as prior literature discussed previously (Rosedale, 
2009; Weger, 2005).  A sample item is “Other people could not truly understand how I 
feel about my cancer diagnosis.”   
 
Domain 3: Expecting That Others Will Not Understand Existential Thoughts 
Domain 3 was developed based on the theme “my time might be limited,” 
representative of existential thoughts, and prior research discussed previously (Rosedale, 
2009).  A sample item is “Other people would not understand my thoughts about death 
since my cancer diagnosis.”   
 
Domain 4: Expecting Sharing Cancer-related Concerns to Burden Others 
Domain 4 was developed based on the theme “my relationships would change for 
the worse if I disclosed my health status” as well as social cognitive processing theory 
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and prior research (Langer et al., 2009; Lepore, 2001; Manne et al., 2007; Mosher et al., 
2012; Rosedale, 2009).  A sample item is “If I shared my concerns about cancer with 
other people then it would be too hard on them.”   
 
Domain 5: Expecting Disclosure of Their Diagnosis or Cancer-related Concerns to 
Change Their Relationship for the Worse 
 
Domain 5 was developed based on the theme “my relationships would change for 
the worse if I disclosed my health status” as well as social cognitive processing theory 
and prior research (Lepore, 2001; Lepore & Revenson, 2007).  A sample item is “If I 
shared my concerns about cancer with other people then they might hurt me with their 
reactions.” 
 
Limitations 
 Limitations of this study should be noted.  Although the sample was diverse with 
respect to gender, education level, disease stage, and time since diagnosis, participants 
were primarily Caucasian patients from one institution in the Midwest.  Exploring 
loneliness-related thoughts in cancer patients from diverse cultural groups and geographic 
regions is an important direction for future research.  In addition, loneliness has been 
found to be greater at some points in the cancer trajectory than others (Deckx et al., 
2014), and retrospective reporting may not fully capture these changes in loneliness and 
its precipitants.  Furthermore, interviews were relatively brief in length (10-30 minutes) 
because they were completed in a busy clinic setting.  Longitudinal data collection and 
more in-depth interviews would provide more detailed information about loneliness 
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experiences over different phases of the disease trajectory and enhance generalizability.  
In addition, although prior research suggests a sample size as small as 12 is sufficient for 
reaching saturation (Guest et al., 2006), it is possible that more themes may have been 
obtained with a larger sample.  
 
Summary and Implications 
The outcome of the current study is item pools for the Cancer Loneliness Scale 
and the Cancer-related Negative Social Expectations Scale.  To my knowledge, no one 
has previously developed a measure of cancer-related loneliness or a measure of negative 
social expectations for any population.  In future studies, the Cancer Loneliness Scale 
could be used as a screening tool to identify patients warranting a cancer-specific 
loneliness intervention as well as an intervention outcome.  Furthermore, the Cancer-
related Negative Social Expectations Scale could be used to provide an initial test of 
theory linking negative social expectations to loneliness (Cacioppo & Hawkley, 2009).  If 
negative social expectations are indeed associated with loneliness, interventionists could 
use patients’ responses to the measure to select cognitions upon which to intervene.  
Additionally, the negative social expectations measure could be used to assess whether 
changes in these expectations mediate the effect of a cognitive intervention on loneliness.  
Before these measures are used, psychometric testing in a large sample of cancer patients 
is required.  Thus, the goal of my subsequent quantitative study is to examine the 
performance of individual items and the measures’ factor structures, reliability, and 
validity in a large sample of cancer patients.
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QUANTITATIVE STUDY METHODS 
 
Participants 
 Following institutional review board approval, cancer patients were recruited 
from the Indiana Tumor Registry.  Eligibility status was determined by medical chart 
review and observation during a telephone-based informed consent process.  Eligibility 
criteria for the study included: (1) having received a cancer diagnosis in 2013 or 2014; 
(2) being 18 years of age or older at the time of informed consent; (3) being able to read 
and write in English; (5) no evidence of serious cognitive impairment (based upon 
medical chart review and interactions with the patient during the informed consent 
process); and (6) having received care for cancer at an Indiana University Health Hospital 
during 2013 or 2014.  Patients whose primary cancer diagnosis was brain cancer were 
excluded due to possible cognitive or personality changes related to their diagnosis.  
Nearly all cancer types and stages were eligible because loneliness has not been found to 
differ by cancer type or stage (Deckx et al., 2014).  Furthermore, enrolling patients 
diagnosed within the past 2 years increases the internal and content validity of the 
measure.  Specifically, if individuals no longer identify with their cancer diagnosis, they 
may have difficulty responding to items referring to their disease.
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Measures 
 
Demographic and Medical Characteristics 
The following characteristics were collected from participants’ medical records 
following informed consent: age, gender, cancer type, date of diagnosis, cancer 
treatments received (e.g., surgery, radiation, chemotherapy), and cancer stage (i.e., early 
vs. late/advanced).  The following characteristics were collected via participant self-
report: marital status, race/ethnicity, education level, employment status, and health 
insurance status.   
 
PROMIS Measures of Social and Health-related Outcomes 
NIH-funded Patient Reported Outcomes Measurement Information System 
(PROMIS) measures were used to assess emotional support, psychological symptoms, 
somatic symptoms, and quality of life.  The use of PROMIS measures is being 
encouraged by the NIH and has many advantages.  For one, PROMIS measures have 
undergone rigorous reliability and validity testing (Cella et al., 2010; Cella et al., 2007; 
Magasi et al., 2012).  Additionally, standardized T-scores facilitate comparisons with 
general population norms.  Although reliability and validity evidence with cancer patients 
has yet to be obtained for all PROMIS measures, these measures were developed with 
cancer populations in mind.  Specifically, cancer patients provided input so as to ensure 
the measures’ relevance for cancer patients (Garcia et al., 2007).  Full details on PROMIS 
measures are available at www.nihpromis.org. 
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Emotional Support 
 
 
Emotional support was assessed with the 4-item Emotional Support measure 
(Hahn et al., 2014).  The measure uses a 5-point Likert-type scale with responses ranging 
from 1 (never) to 5 (always).  A sample item is “I have someone who will listen to me 
when I need to talk.”  A total score was calculated by summing the four items, with 
higher scores indicating greater emotional support.  Although, to my knowledge, there is 
no published reliability or validity evidence for the 4-item version of this measure in any 
population, in the current study, internal consistency reliability was excellent (α=0.95). 
 
Depressive Symptoms 
 
 
Depressive symptoms were assessed with the 4-item Depression measure (Choi et 
al., 2010; Pilkonis et al., 2011).  The measure uses a 5-point Likert-type scale with 
responses ranging from 1 (never) to (always).  A sample item is “In the past 7 days, I felt 
hopeless.”  A total score was calculated by summing the four items, with higher scores 
indicating greater depressive symptoms.  Adequate reliability and validity evidence has 
been obtained for PROMIS depression items in cancer patient samples (Badr, Smith, 
Goldstein, Gomez, & Redd, 2015; Baum, Basen-Engquist, Swartz, Parker, & Carmack, 
2014; Phelan et al., 2013).  In the current study, internal consistency reliability was 
excellent (α=0.93).    
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Anxiety Symptoms 
 
 
Anxiety symptoms were assessed with the 4-item Anxiety measure (Pilkonis et 
al., 2011).  The measure uses a 5-point Likert-type scale with responses ranging from 1 
(never) to 5 (always).  A sample item is “In the past 7 days, my worries overwhelmed 
me.”  A total score was calculated by summing the four items, with higher scores 
indicating greater anxiety.  Adequate reliability and validity evidence has been obtained 
for PROMIS anxiety items in cancer patient samples (Badr et al., 2015; Baum et al., 
2014).  In the current study, internal consistency reliability was excellent (α=0.90).   
 
Pain 
 
 
The extent to which pain interfered with daily activities was assessed with the 4-
item version of the Pain Interference measure (Amtmann et al., 2010).  The Pain 
Interference measure uses a 5-point Likert-type scale with responses ranging from 1 (not 
at all) to 5 (very much).  A sample item is “How much did pain interfere with your day to 
day activities?”  A total score was calculated by summing the four items, with higher 
scores indicating greater pain interference.  Excellent reliability and validity evidence is 
available for general population samples (Amtmann et al., 2010).  Although the PROMIS 
pain interference items have been administered to cancer patients (Stukenborg et al., 
2014; Wagner et al., 2015; Yost, Eton, Garcia, & Cella, 2011; Zullig et al., 2012), the 
authors did not publish reliability or validity evidence.  In the current study, internal 
consistency reliability was excellent (α=0.97).  
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Fatigue 
 
 
Fatigue severity was assessed with the 4-item version of the Fatigue measure (Lai 
et al., 2011).  The Fatigue measure uses a 5-point Likert-type scale with responses 
ranging from 1 (not at all) to 5 (very much).  A sample item is “In the past 7 days, how 
fatigued were you on average?”  A total score was calculated by summing the four items, 
with higher scores indicating greater fatigue.  Adequate reliability and validity evidence 
has been obtained for PROMIS fatigue items in cancer patient samples (Barsevick et al., 
2013; Junghaenel, Cohen, Schneider, Neerukonda, & Broderick, 2015; Lai, Crane, & 
Cella, 2006; Wagner et al., 2015; Yost et al., 2011; Zullig et al., 2012).  In the current 
study, internal consistency reliability was excellent (α=0.95). 
 
Sleep Disturbance 
 
 
Sleep disturbance was assessed with the 4-item version of the Sleep Disturbance 
measure (Buysse et al., 2010; Yu et al., 2012).  The Sleep Disturbance measure uses two 
5-point Likert-type scales.  For the first 3 items, responses range from 1 (not at all) to 5 
(very much), and for the fourth item responses range from 1 (very poor) to 5 (very good).  
A sample item using the first scale is “In the past 7 days, I had a problem with my sleep.”  
The item using the second scale is “My sleep quality is...”  A total score was calculated 
by summing the four items, after reverse-scoring as needed, with higher scores indicating 
greater sleep disturbance.  Excellent reliability and validity evidence is available for 
general population samples (Yu et al., 2012).  Although the PROMIS sleep disturbance 
items have been administered to cancer patients in prior studies (Rogers et al., 2015; 
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Stachler, Schultz, Nerenz, & Yaremchuk, 2014), reliability and validity evidence was not 
published.  In the current study, internal consistency reliability was excellent (α=0.89).   
 
Quality of Life 
 
 
Quality of life was measured with the 10-item Global Health measure, which can 
be separated into two, 4-item mental and physical health scales, a 1-item overall health 
scale, and a 1-item satisfaction with social roles scale (Hays, Bjorner, Revicki, Spritzer, 
& Cella, 2009).  The 4-item mental and physical health scales were used in the current 
study.  Seven of the items use 5-point Likert-type scales with a variety of response 
options, and one item uses an 11-point visual analog scale.  Total mental and physical 
health scores were calculated according to the instructions described by Hays et al. 
(2009), with higher scores indicating better mental or physical health.  A sample mental 
health item is “In general, how would you rate your mental health, including your mood 
and your ability to think?”  A sample physical health item is “In general, how would you 
rate your physical health?”  Excellent reliability and validity evidence was reported for 
the two subscales for one general population sample (Hays et al., 2009).  However, 
although the mental and physical health subscales have been administered to cancer 
patients in prior research (Weaver et al., 2012), no reliability or validity evidence was 
published.  In the current study, internal consistency reliability for the mental health scale 
was good (α=0.82), whereas it was poor for the physical health scale (α=0.27).  To 
determine whether one item reduced the physical health scale’s alpha, I examined the 
alpha level with and without each item.  When one item was removed (i.e., the 11-point 
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visual analog scale for pain), the alpha increased to 0.84; thus, analyses were conducted 
with and without the item.  Both sets of results are included in the results table, but the 
results with the 3-item physical health subscale are discussed in the text.   
 
Social Constraints 
A 5-item version of the Social Constraints Scale (Lepore, Silver, Wortman, & 
Wayment, 1996) was used to measure social constraints.  The 5-item scale has been 
adapted for use in cancer patients in several studies (Danhauer et al., 2013; Halbert et al., 
2010; Widows, Jacobsen, & Fields, 2000).  The measure uses a 5-point Likert-type scale 
with responses ranging from 1 (almost never) to 5 (almost always).  A sample item is 
“How often did you feel as though you had to keep your feelings about your cancer to 
yourself because they made other people uncomfortable?”  A total score was calculated 
by summing the five items, after reverse-scoring as necessary, with higher scores 
indicating greater social constraints.  Evidence of the scale’s validity and acceptable to 
good internal consistency reliability has been reported in studies of cancer patients 
(Halbert et al., 2010; Widows et al., 2000).  In the current study, internal consistency 
reliability was good (α=0.80).  
 
Loneliness 
General loneliness was measured with the UCLA Loneliness Scale-Version 3 
(Russell, 1996).  This 20-item unidimensional scale is a widely used measure of general 
loneliness in research (Vassar & Crosby, 2008).  The measure uses a 4-point Likert-type 
scale with responses ranging from 1 (never) to 4 (always).  A sample item is “How often 
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do you feel that people are around you but not with you?”  A total score was calculated 
by summing the 20 items, after reverse-scoring as necessary, with higher scores 
indicating greater loneliness.  The UCLA Loneliness Scale has shown excellent reliability 
across studies, including studies of cancer patients (e.g., Fogel et al., 2002; Yildirim & 
Kocabiyik, 2010), with one meta-analysis finding that the mean alpha coefficient was 
0.92 across various populations (SD = .03, range = 0.86-0.95; Vassar & Crosby, 2008).  
In the current study, internal consistency reliability was excellent (α=0.94).  Excellent 
validity evidence is also available from studies of general population and cancer patient 
samples (Jaremka, Andridge, et al., 2014; Mosher et al., 2012; Russell, 1996).   
 
Cancer-related Loneliness 
Cancer-related loneliness was measured with 15 items developed for the Cancer 
Loneliness Scale.  As discussed previously, some of the items were modified from the 
UCLA Loneliness Scale-Version 3 and other loneliness measures (de Jong-Gierveld, 
1987; Russell, 1996; Vincenzi & Grabosky, 1987), whereas other items were developed 
based on loneliness theory (Cacioppo & Hawkley, 2009; Cacioppo et al., 2006; Cutrona, 
1982; Peplau & Perlman, 1982) and qualitative research on loneliness in cancer patients 
(Rosedale, 2009; Sand et al., 2008).  A 5-point Likert-type scale with responses ranging 
from 1 (never) to 5 (always) was used.  These response options were selected because 
they are similar to those used by the PROMIS measures.  A sample item is “How often 
does your cancer diagnosis make you feel isolated from others?” 
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Negative Social Expectations 
Negative social expectations were measured with the 14 items developed for the 
Cancer-related Negative Social Expectations Scale.  As discussed previously, the items 
were developed based on theory, prior research (Cacioppo & Hawkley, 2009; Lepore, 
2001; Lepore & Revenson, 2007; Manne et al., 2007; Mosher et al., 2012; Rosedale, 
2009; Sand et al., 2008), and findings from the qualitative study described previously.  
Items were written to include content in five domains: (1) expecting others to listen or be 
available whenever the patient needs them; (2) expecting a lack of understanding of 
cancer-related concerns; (3) expecting that others will not understand existential 
thoughts; (4) expecting sharing cancer-related concerns to burden others; and (5) 
expecting disclosure of their diagnosis or cancer-related concerns to change their 
relationships for the worse.  A 6-point Likert-type scale with responses ranging from 1 
(strongly disagree) to 6 (strongly agree) was used.  I decided to use six response options 
such that participants could not select a neutral response (Wolfe & Smith Jr, 2006).  A 
sample item is “If people stopped asking about my cancer, I would think that they don’t 
care.”   
 
Social Network Characteristics 
Four items adapted from the Social Network Index (Cohen et al., 1997) were used 
to assess social network characteristics.  The content of Cohen and colleagues’ items was 
retained, but the social network categories (e.g., relatives, friends) differed.  The items 
included: (1) “How many relatives do you see or talk to on the phone at least once every 
2 weeks?”; (2) “How many friends do you see or talk to on the phone at least once every 
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2 weeks?”; (3) “How many coworkers do you see or talk to on the phone at least once 
every 2 weeks?”; and (4) How many cancer patients or survivors do you see or talk to on 
the phone at least once every 2 weeks?”  Participants who were not currently employed 
were instructed to skip the item on coworkers. 
 
Procedure 
Potentially eligible participants were mailed introductory letters notifying them 
about the study.  Interested patients consented to participate by phone.  Consenting 
patients were mailed a survey to complete at home and a pre-paid, addressed envelope for 
returning the survey.   
 
Screening Procedure 
Potential participants were identified through the Indiana Tumor Registry.  A 
tumor registrar sent a list of potentially eligible patients along with their medical record 
number (MRN), address, phone number, sex, birthdate, race/ethnicity, date of diagnosis, 
primary cancer site, and staging information to me in October of 2014.  A waiver of 
HIPAA authorization was obtained in order to review the medical records of patients on 
the list and confirm their eligibility.  Their records were examined for information on: (1) 
age; (2) primary cancer type; (3) diagnosis date; and (4) receipt of treatment at an Indiana 
University Health hospital in 2013 or 2014.  I also searched online obituaries for patients 
whom I suspected were deceased (e.g., did not attend scheduled appointments, were said 
to have a poor prognosis), as the medical records were not always accurate regarding 
vital status.   
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Recruitment Procedures 
I aimed to receive survey data from 140 cancer patients.  Based on prior research 
with a similar recruitment strategy and population (Eakin & Strycker, 2001), I estimated 
a conservative 60% consent rate and a survey return rate of 70% among consenting 
participants.  Thus, I expected to mail approximately 334 introductory letters in order to 
consent 200 participants and obtain 140 completed surveys.  However, consent and return 
rates were initially below expectations, based on examination early in the recruitment 
process.  Therefore, I sent introductory letters in weekly batches of 10 to 40 letters until I 
approached my minimum recruitment goal.  To ensure representation of demographic 
subgroups, I used purposive sampling based on gender and race.  I randomly selected 
potential participants to contact from the Indiana Tumor Registry list, while allowing for 
approximately equal numbers of men and women.  In addition, approximately 68% of the 
participants selected were Caucasian and approximately 32% were minorities, which is 
similar to the demographics of Marion County in 2013 (U.S. Census Bureau, 2015).   
The introductory letter was sent to notify each potentially eligible person about 
the study (see Appendix I for introductory mailings).  A Study Information Sheet (i.e., 
consent form without a signature line) and authorization form were also included in the 
initial mailing with the introductory letter.  Any interested person was invited to call for 
more details.  The letter also had an "opt out" component; thus, patients who were not 
interested in the study could call the undergraduate research assistant (RA) or me to 
indicate that they did not wish to be contacted further.  
 The RA or I called all prospective participants who did not opt out approximately 
five days after the letter was placed in the mail.  We described the study, reviewed the 
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Study Information Sheet and authorization form, and asked if they would like to 
participate (see Appendix J for telephone script).  During that initial call, interested 
patients provided verbal consent for study participation and verbal authorization to 
collect information from their medical records.  Verbal consent was chosen in place of 
written informed consent to minimize the number of documents that linked the 
participant with the research and therefore reduce the risk of a breach of confidentiality.  
If the patient needed more time or wanted more information, a subsequent phone 
appointment was scheduled.  If requested, a new Study Information Sheet and 
authorization form were either mailed or emailed to them (based on their preference).  
Verbal consent was documented by the consenter (see Appendix K for Informed Consent 
Process Documentation form).  If a potential participant did not answer the phone, a brief 
voicemail was left once (see Appendix J for telephone script), and we called again up to 
15 times within approximately 1 to 3 weeks after the first phone call without leaving 
additional voicemail messages.  We searched online obituaries for all patients whom we 
could not contact to see whether they were deceased.   
 For patients who declined participation, we asked if they would be willing to 
provide a reason for their decision.  With the patient’s permission, we also documented 
their age, gender, and race for the purpose of determining potential sample selection 
biases.  When non-participants declined to answer these questions, we discontinued all 
further contact with them.   
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Survey Administration and Follow-up Procedures 
 Participants were mailed a paper survey to complete in the privacy of their homes.  
Participants were also mailed a letter with instructions for completing the survey (see 
Appendix L for the survey mailings) and a pre-paid envelope for returning the survey.  
The survey was pre-marked with the participant’s study ID number, and he or she was 
instructed to not include any identifiable information (e.g., name, address) on the survey 
or return envelope.  The survey took about 10 to 20 minutes to complete and assessed 
demographic variables, depressive and anxiety symptoms, somatic symptoms (i.e., sleep 
disturbance, pain, fatigue), quality of life, general and cancer-related loneliness, negative 
social expectations, emotional support, social constraints, and social network qualities 
(see Appendix L for survey mailings).  If the questionnaire was not received within 
approximately 2 weeks, one to 15 (typically three) reminder calls were made as deemed 
necessary.  When we received the survey, the participant was mailed a $25 Target gift 
card for participating in the study.  Replacement surveys were mailed to participants as 
necessary.  
 
Data Storage and Data Entry 
 An RA entered and checked all data and I also checked the data entry for every 
survey.  Paper questionnaires and informed consent process documentation forms were 
stored in a locked filing cabinet in a lockable office in LD 134.  
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Analyses 
 
 
Data Screening and Preliminary Analyses 
 The data were examined for normality, linearity, outliers, and missingness.  First, 
I examined the assumptions of normality and linearity. According to Kline’s (2011) 
guidelines, the values for each study variable were appropriate, except for the open-ended 
social network size items that had some extreme skew and kurtosis values (discussed 
subsequently).  Second, I examined whether data were missing completely at random 
using Little’s Missing Completely at Random (MCAR) test (Little, 1988).  Because my 
data were shown to be missing completely at random, χ2 (2278) = 2286.8, p =0.44, and I 
had very little missingness (i.e., most variables were missing 0.5% of their values), I used 
imputation to address most missing values.  Specifically, when an individual item was 
missing from a scale, I imputed the value of the strongest correlated item in that scale.  
Single imputation methods, such as the one used, are considered acceptable when few 
data are missing and the data are thought to be MCAR (Greenland & Finkle, 1995).  
When most or all of the items in a scale were missing (e.g., the participant skipped a page 
or measure), I left the values as missing.  The main study analyses were conducted in 
Mplus statistical software (Muthén & Muthén, 2010), which allowed for the use of full 
information maximum likelihood (FIML) data imputation to handle the remaining 
missing values.  FIML generates implied values for missing values based on data patterns 
(Enders, 2001a, 2001b).  This strategy allows retention of the original sample size and 
results in more accurate parameter estimates than deletion methods and single-imputation 
methods (Enders, 2001a).   
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 Third, data were examined for outliers.  Outliers were defined as values greater 
than 3 standard deviations from the mean.  For measures with specified response ranges 
(i.e., Likert-type scaled measures used for the majority of study variables), all values 
were retained because extreme values were thought to represent true variability.  Some 
researchers contend that retaining legitimate outliers results in data that are more 
representative of the true population (Orr, Sackett, & Dubois, 1991).  I used a 
winsorization transformation for outliers on variables without a specified range of 
responses (i.e., the open-ended social network size questions) (Tukey, 1962).  After the 
winsorization transformation was applied, all skew and kurtosis values were within the 
acceptable range (i.e., -3 < skewness < +3, -7 < kurtosis < +7) (Kline, 2011).  Analyses 
including the open-ended social network size items were completed twice: once without 
the winsorization transformation for outliers and once with the winsorization 
transformation.  Both sets of results are included in the results table because they differed 
substantially, but the winsorized results are discussed subsequently in the text.   
 Finally, descriptive statistics (e.g., means, standard deviations) were calculated to 
characterize the sample.  T-scores were also calculated for the PROMIS measures for 
which cancer patient norms were available (i.e., depression, anxiety, pain, fatigue) using 
the online PROMIS scoring service (see www.nihpromis.org for details).  
 
Assessment of Item Performance 
The first step for accomplishing aims 3 and 4 was to assess item quality and 
eliminate items that performed poorly.  I examined the full range of response categories 
for each item using histograms, means, and standard deviations.  In addition, I examined 
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factor loadings, item-total correlations, and inter-item correlations.  Items could be 
removed at any stage of the project based on performance.  For example, items could be 
removed for floor or ceiling effects (i.e., more than 80% endorsed the highest or lowest 
category), low factor loadings (i.e., <0.40), or low item-total correlations (i.e., <0.30) 
(Monahan, Lane, Hayes, McHorney, & Marrero, 2009; Nunnally & Bernstein, 1994; 
Sheskin, 2003).  Items with similar content were compared and the items with the best 
performance were retained for the measures.    
 
Primary Analyses for Quantitative Aims 3 and 4 
The dimensionalities of the Cancer Loneliness Scale and Cancer-related Negative 
Social Expectations Scale were assessed using confirmatory factor analyses in Mplus and 
LISREL 8.8 statistical software.  Regarding the dimensionality of the Cancer Loneliness 
Scale, unidimensionality was hypothesized (hypothesis #3.1) and examined using Mplus.  
Regarding the dimensionality of the Cancer-related Negative Social Expectations Scale, 
three models were compared to determine which model best fit the data (exploratory goal 
#4.1; see Appendix O for the original proposed models).  I examined a 5-dimensional 
model, 4-dimensional model, and unidimensional model.  The 5-dimensional model 
corresponded to the 5 domains identified in the qualitative study discussed previously.  
The 4-dimensional model was similar to the 5-dimensional model except that domains 2 
(expecting a lack of understanding of cancer-related concerns) and 3 (expecting that 
others will not understand existential thoughts) were collapsed due to conceptual 
similarity.  Specifically, both domains involved expectations that others would not 
understand their thoughts.  All models were initially run in Mplus statistical software; 
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however, not positive definite errors were obtained from the multidimensional models, 
yielding invalid parameter estimates.  The not positive definite errors were not obtained 
when the same analyses were performed in LISREL; thus, statistics from LISREL are 
reported subsequently for the multidimensional models.  All models were run using a 
robust maximum likelihood estimator. 
To evaluate the models’ fit, I examined a number of fit indices assessing absolute 
fit, fit adjusting for model parsimony, and comparative fit.  Specifically, I examined the 
standardized root mean square residual (SRMR) statistic to assess absolute fit, the root 
mean square error of approximation (RMSEA) statistic adjusting for model complexity, 
and the comparative fit indices (CFI), as suggested by Hu and Bentler (1999).  Model fit 
guidelines vary, but, in general, acceptable model fit is defined as: (1) SRMR< 0.08; (2) 
RMSEA < 0.06; and (3) CFI > 0.95 (Hu & Bentler, 1999; Kline, 2011).  
Reliability and validity analyses were also conducted.  Alpha coefficients were 
obtained from SPSS statistical software to address hypothesis #3.2 and goal #4.2 related 
to the measures’ internal consistency reliabilities.  Hypothesis #3.3 and goal #4.3 focus 
on the construct validity of the Cancer Loneliness Scale and Cancer-related Negative 
Social Expectations Scale.  I assessed validity evidence using correlational analyses in 
LISREL 8.8 (Joreskog & Sorbom, 2008).  LISREL was used for correlational analyses so 
that remaining missingness could be handled with FIML.  
 
Power Analysis 
The target sample size (N = 140) was determined based on the original proposed 
analyses for the project (i.e., one unidimensional confirmatory factor analysis with 15 
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items and one mediation model).  A sample with a minimum of 5 participants per 
pathway is thought to be required for sufficient power to detect effects based on 
simulations (Kline, 2011).  The original proposed mediation model contained 28 
pathways; thus, following Kline’s (2011) guidelines, a sample of 140 was thought to 
provide sufficient statistical power.  Furthermore, a statistical simulation in MPlus 
indicated that, assuming 15 items and true factor loadings of 0.40, 140 is a sufficient 
number for the proposed factor analysis (P. Monahan, personal communication).  Thus, 
140 was initially selected as the target sample size.  
The actual sample size for the quantitative study was 186, as more patients agreed 
to participate and returned their surveys than initially anticipated based on examination 
early in the recruitment process.  The number of pathways in the examined models 
ranged from 8 (i.e., unidimensional Cancer Loneliness Scale model) to 22 (i.e., 5-
dimensional Cancer-related Negative Social Expectations Scale), suggesting that the final 
sample size of 186 provided sufficient statistical power for all models.
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QUANTITATIVE STUDY RESULTS 
 
Sample Characteristics 
 A total of 380 randomly selected patients were deemed eligible based on my 
medical chart review and were sent introductory letters.  Of the 380 patients sent 
introductory letters, 36 (9%) were discovered to be ineligible based on the phone call.  Of 
the remaining 344 presumably eligible patients, 215 (63%) consented to participate, 47 
(14%) declined participation, and 82 (24%) could not be contacted to determine their 
interest in participating or confirm their eligibility.  Of the 215 consenters, 186 (87%) 
returned their surveys, 1 (0.005%) withdrew from the study, 1 (0.005%) died, and 27 
(13%) were lost to follow-up.  A detailed study flow chart is found in Figure M1 of 
Appendix M.  Excluding the participant who withdrew from the study (because we did 
not collect their personal information) and the participant who died, participants who 
returned their surveys (n=186) did not significantly differ from participants who did not 
return their surveys (n=27) on age, gender, treatment type, and cancer stage; however, 
participants who returned their surveys had a shorter time since diagnosis (M= 16.75 
months, SD = 3.2 months) than those who did not return their surveys (M=18.50 months, 
SD = 3.7 months), t(212)= -2.6, p = .01.
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   Sample characteristics are shown in Table N2 of Appendix N.  Approximately 
half (51%) of the participants were female and the mean age was 59 years (SD=12.6).  
The majority were Caucasian (74%) and married or living with a partner (68%).  Most 
(59%) had received at least some college education, and 42% were employed either full 
or part-time.  Patients had been diagnosed with a wide variety of cancer types, with the 
most common being breast (16%), prostate (11%), skin (8%), uterine (7%), and kidney 
(7%) cancers.  The majority (63%) were diagnosed with early-stage disease.  The average 
time since the cancer diagnosis was approximately 17 months (SD=3.2).  The most 
common cancer treatments included surgery (83%), chemotherapy (38%), radiation 
(33%), and hormone therapy (19%).  
 
Descriptive Statistics 
Descriptive statistics for study variables are shown in Appendix N, Table N3.  On 
average, patients reported that they “sometimes” received emotional social support 
(M=17.0, SD=3.7, range=4.0-20.0).  In addition, patients, on average, reported that they 
“never” felt depressed (M=7.1, SD=3.5, range=4.0-18.0, t-score = 51.0) or anxious 
(M=7.3, SD=3.4, range=4.0-19.0, t-score=51.5), which was comparable to that of a 
representative sample of American cancer patients (see www.nihpromis.com for details 
about the calibration sample).  Furthermore, on average, patients reported experiencing “a 
little bit” of pain (M=7.8, SD=4.5, range=4.0-20.0, t-score=51.7), fatigue (M=7.8, 
SD=4.5, range=4.0-20.0, t-score=52.4), and sleep disturbance (M=9.9, SD=3.9, 
range=4.0-20.0).  Patients’ levels of pain and fatigue were also comparable to those of a 
representative sample of American cancer patients (see www.nihpromis.com for 
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information about the calibration sample).  Patients’ average level of sleep disturbance 
was comparable to levels reported in another study of cancer patients (Stachler et al., 
2014).  Additionally, on average, patients’ mental quality life (M=14.2, SD=3.1, 
range=6.0-20.0) was similar to levels reported by the general population, whereas their 
physical quality of life (M=12.3, SD=2.3, range=6.0-17.0) was slightly greater than levels 
reported by the general population (Hays et al., 2009).  Furthermore, patients reported 
experiencing low levels of social constraints on average (M=9.5, SD=4.2, range=5.0-
25.0), consistent with prior research with cancer patients (Hoyt, 2009; Mosher et al., 
2012).  Patients also experienced moderate levels of loneliness on average (M=37.0, 
SD=11.3, range=20.0-78.0), consistent with the results of a recent meta-analysis of 
studies with cancer patients (Deckx et al., 2014).  Finally, the average numbers of 
relatives, friends, coworkers, and other cancer patients that participants reported seeing or 
talking to on the phone at least once every 2 weeks were 5.9 (SD = 4.3; range = 0.0-30.0), 
7.9 (SD = 11.1; range = 0.0-100.0), 12.4 (SD = 13.0; range = 0.0-60.0), and 1.6 (SD = 
2.5; range = 0.0-25.0), respectively.   
 
Cancer Loneliness Scale Item Selection, Factor Structure, and Reliability 
 First, I selected the items for the Cancer Loneliness Scale.  All of the items from 
the item pool performed well (e.g., all response categories were endorsed, all had 
adequate item-total correlations) (see Appendix P, Table P4 for item descriptive statistics 
and Table P5 for inter-item correlations).  Thus, no items were eliminated due to poor 
performance.  Next, Dr. Mosher and I grouped the items with content overlap and 
selected one representative item from each group with the highest item-total correlation 
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(see Appendix P, Table P6 for the item groups and selected items).  A total of 7 items 
were retained for the final measure.   
 After the items were selected, I examined the hypothesized unidimensional factor 
structure of the Cancer Loneliness Scale (hypothesis #3.1).  Figure P6 in Appendix P 
shows the final model.  Overall, the final model showed adequate fit as determined by the 
goodness of fit indices (i.e., SRMR=0.02; RMSEA=0.09; CFI=0.98; χ2(14)=36.75, 
p=0.0001).  Values for the SRMR and CFI indicated good absolute fit and comparative 
fit, respectively.  However, the RMSEA, assessing parsimony, did not fall within the 
range of values recommended by Hu and Bentler (1999) (i.e., RMSEA < 0.06).  Of note, 
other statisticians have suggested that values closer to the value observed in this study 
(i.e., < 0.08) might indicate adequate fit (Brown, 2006).  Because the overall model fit 
was judged to be adequate, I examined whether the internal consistency coefficient of the 
single-factor scale was greater than 0.70 (hypothesis #3.2).  As hypothesized, internal 
consistency reliability for the Cancer Loneliness Scale was excellent (α=0.94). 
 
Cancer Loneliness Scale Construct Validity 
 To assess the construct validity of the Cancer Loneliness Scale (hypothesis #3.3), 
I examined theoretical relationships between cancer-related loneliness and a number of 
social and health characteristics.  Zero-order correlations appear in Table P12 of 
Appendix P.  First, as hypothesized (hypothesis #3.3a), cancer-related loneliness was 
positively correlated with general loneliness (r=0.67, p<0.0001), social constraints 
(r=0.80, p<0.0001), anxiety symptoms (r=0.55, p<0.0001), depressive symptoms 
(r=0.54, p<0.0001), sleep disturbance (r=0.51, p<0.0001), pain (r=0.50, p<0.0001), and 
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fatigue (r=0.45, p<0.0001).  Second, as hypothesized (hypothesis #3.3b), cancer-related 
loneliness was negatively correlated with mental quality of life (r=-0.54, p<0.0001), 
physical quality of life (r=-0.33, p=0.001), and emotional support (r=-0.66, p<0.0001); 
however, contrary to my hypothesis, cancer-related loneliness was not correlated with the 
number of cancer patients with whom participants had spoken via phone or seen at least 
once every 2 weeks when the winsorization transformation was applied (r=-0.14, 
p=0.06).  Finally, as hypothesized (hypothesis #3.3c), cancer-related loneliness was 
unrelated to the number of coworkers with whom participants had contact at least once 
every 2 weeks after the winsorization transformation was applied (r=-0.14, p=0.06); 
however, contrary to my hypothesis, cancer-related loneliness was positively correlated 
with the number of relatives (r=0.41, p<0.0001) and friends (r=0.44, p<0.0001) with 
whom participants had contact at least once every 2 weeks. 
 
Cancer-Related Negative Social Expectations Scale Item Selection, Factor Structure, and 
Reliability 
 
 First, I examined the performance of potential items for the Cancer-related 
Negative Social Expectations Scale (see Appendix P, Table P9 for the item descriptive 
statistics and Table P8 for inter-item correlations).  Items 5 and 11 had particularly low 
inter-item correlations (i.e., many ps>0.05) and low item-total correlations (i.e., 0.16 and 
0.29, respectively); thus, I opted to remove those items from the pool.  The other items 
appeared to perform well and were initially retained.  
 Next, I examined the three contending factor structure models (goal #4.1).  The 
resulting models are shown in Figures P7-9 of Appendix P.  Regarding the 5-dimensional 
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model, the model fit was adequate as determined by goodness of fit indices (i.e., 
SRMR=0.06; RMSEA=0.07; CFI=0.99; χ2(47)=92.68, p<0.001).  Values for the SRMR 
and CFI indicated good absolute fit and comparative fit, respectively.  However, similar 
to the Cancer Loneliness Scale model, the RMSEA, assessing parsimony, did not fall 
within the range of values recommended by Hu and Bentler (1999) (i.e., RMSEA < 0.06).  
Furthermore, there were high correlations among some of the factors (see Appendix P, 
Table P9), with some invalid values above one.  High correlations suggested that the 
factors were not separate.  Similar to the 5-dimensional model, the 4-dimensional model 
showed adequate fit as determined by goodness of fit indices (i.e., SRMR=0.04; 
RMSEA=0.07; CFI=0.99; χ2(49)=92.10, p<0.001).  Again, the values for the SRMR and 
CFI indicated good fit, whereas the RMSEA fell slightly above the recommended range 
of values.  High correlations between the 4 factors (e.g., 0.99, see Figure P8) again were 
problematic and suggested that the factors were not separate.  Finally, I examined the 
unidimensional factor structure model.  Figure P9 of Appendix P displays the factor 
loadings.  Goodness of fit indices suggested that the unidimensional model had adequate 
absolute fit (SRMR=0.04), but was inadequate in regards to parsimony (RMSEA=0.09) 
and comparative fit (CFI=0.94).  The chi-square was significant (χ2(54)=130.30, 
p<0.001).  The values for these fit indices fell just outside of the range of values 
recommended by Hu and Bentler (1999).  A comparison of the model fit indices for all 
examined models is shown in Table P10 of Appendix P.  After reviewing the three 
models, I decided to reject the 5- and 4-dimensional models because the correlations 
between the factors were too high and sometimes invalid (i.e., greater than one).  I also 
decided to not combine any subsets of the factors with high correlations because I had no 
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theoretical rationale for doing so.  Thus, I decided to retain the unidimensional model as 
the best representation of my data.  
 Next, I shortened the measure to increase its practicality for cancer populations.  I 
decided to retain one item from each conceptual domain for representative content 
coverage; the item with the highest item-total correlation was retained (see Appendix P, 
Table P11 for the final list of items retained).  After shortening the measure to five items, 
I re-ran the unidimensional model with the final five items (see Appendix P, Figure P10).  
The resulting model showed adequate fit overall as determined by the goodness of fit 
indices (i.e., SRMR=0.02; RMSEA=0.11; CFI=0.98; χ2(5)=15.37, p=0.01).  The absolute 
fit (SRMR) for this model was superior to that of all other models examined, whereas the 
adjustment for model complexity (RMSEA) was worse than that of all other models and 
the comparative fit (CFI) was better than that of the longer unidimensional measure 
model.  Overall, the SRMR and CFI fell within the recommended ranges of values, 
whereas the RMSEA fell outside of the recommended range.  The overall model fit was 
deemed to be adequate; thus, I examined the internal consistency coefficient for the 
single-factor scale (goal #4.2), which was excellent (α=0.90). 
 
Cancer-related Negative Social Expectations Scale Construct Validity 
 To assess the construct validity of the Cancer-related Negative Social 
Expectations Scale (goal #4.3), I examined theoretical relationships between cancer-
related loneliness and a number of social and health characteristics.  Zero-order 
correlations appear in Table P12 of Appendix P.  First, as expected (goal #4.3a), negative 
social expectations were positively correlated with general loneliness (r=0.47, p<0.0001), 
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cancer-related loneliness (r=0.70, p<0.0001), social constraints (r=0.67, p<0.0001), 
anxiety symptoms (r=0.41, p<0.0001), depressive symptoms (r=0.41, p<0.0001), sleep 
disturbance (r=0.43, p<0.0001), pain (r=0.36, p<0.0001), and fatigue (r=0.39, p<0.0001).  
Second, as expected (goal #4.3b), negative social expectations were negatively correlated 
with mental quality of life (r=-0.43, p<0.0001), physical quality of life (r=-0.31, 
p=0.001), and emotional support (r=-0.48, p<0.0001).
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QUANTITATIVE STUDY DISCUSSION 
 
 The current study aimed to develop and evaluate the psychometric properties of 
measures of cancer-related loneliness and cancer-related negative social expectations.  
The final products of the project included a 7-item unidimensional Cancer Loneliness 
Scale and 5-item unidimensional Cancer-related Negative Social Expectations Scale.  
Excellent evidence for reliability and validity was found for both measures using a large, 
diverse sample of cancer patients.  The resulting measures have both clinical and research 
utility.   
 
Cancer Loneliness Scale 
 Excellent evidence for reliability and validity was found for the Cancer 
Loneliness Scale.  As expected, the measure was found to be unidimensional and to have 
excellent internal consistency.  Furthermore, the measure was associated with measures 
of mental and physical health theoretically linked to cancer-related loneliness, which 
provided evidence of construct validity.  First, as hypothesized, cancer-related loneliness 
was positively correlated with general loneliness.  The moderately strong relationship 
between general and cancer-related loneliness is expected because both constructs 
involve dissatisfaction with relationships and, thus, the general loneliness measure should 
capture some loneliness attributed to cancer.  Additionally, cancer-related loneliness was
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positively correlated with anxiety and depressive symptoms and negatively correlated 
with mental quality of life.  These findings are consistent with prior theory and research 
linking general loneliness with poor mental health outcomes in cancer patients and other 
populations (Cacioppo & Hawkley, 2009; Cacioppo et al., 2006; Hawkley & Cacioppo, 
2003; Jaremka, Andridge, et al., 2014; Pehlivan et al., 2012; Peplau & Perlman, 1982).  
Furthermore, cancer-related loneliness was positively correlated with pain, fatigue, and 
sleep disturbance and negatively correlated with physical quality of life.  Again, these 
findings are consistent with theory and prior research linking general loneliness to poor 
physical health-related outcomes in cancer patients and the general population (Cacioppo 
& Hawkley, 2009; Cacioppo, Hawkley, Crawford, et al., 2002; Hawkley & Cacioppo, 
2003; Jaremka, Andridge, et al., 2014; Pehlivan et al., 2012).  Loneliness is hypothesized 
to negatively impact both physical and mental health outcomes through mechanisms such 
as reduced immune functioning, sleep disturbance, and poor health behaviors (Cacioppo, 
Hawkley, Crawford, et al., 2002).   
 Construct validity was also assessed by examining theory-driven relationships 
between cancer-related loneliness and measures of social network qualities.  First, 
cancer-related loneliness was positively correlated with social constraints and negatively 
correlated with emotional support, consistent with social cognitive processing theory and 
prior literature (Deckx et al., 2014; Lepore, 2001; Mosher et al., 2012; Sahin & Tan, 
2012; Yildirim & Kocabiyik, 2010).  Specifically, according to social cognitive 
processing theory, a socially constraining environment impedes psychological adjustment 
(i.e., increases loneliness) by preventing successful cognitive and emotional processing of 
cancer-related information, whereas a supportive social environment facilitates the 
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processing of stressor-related information and promotes adjustment (Lepore, 2001).  In 
addition, the positive relationship between social constraints and cancer-related loneliness 
was strong (r=0.80).  There is a lack of consensus in the literature regarding the strength 
of correlations indicating redundancy between constructs, though some statisticians have 
suggested correlations of 0.90 and higher indicate redundancy (Tabachnick & Fidell, 
2001).  The strong correlation between social constraints and cancer-related loneliness is 
consistent with social cognitive processing theory; thus, the high correlation provides 
appropriate evidence of construct validity.   
 Regarding more objective social network qualities, I hypothesized that cancer-
related loneliness would be negatively related to the number of cancer patient contacts 
and unrelated to the number of friend, relative, and coworker contacts based on loneliness 
theory and prior literature (Egestad, 2013; Peplau & Perlman, 1982; Russell et al., 1980).  
Specifically, loneliness theory suggests loneliness is not a result of actual isolation or 
one’s number of social network members, but instead relates to dissatisfaction with 
relationships (Peplau & Perlman, 1982; Russell et al., 1980); however, in qualitative 
research, cancer patients have reported that having more contact with other cancer 
patients reduced their feelings of loneliness (Egestad, 2013).  Overall, results regarding 
objective social network characteristics were not consistent with my predictions.  For 
example, cancer-related loneliness was not associated with the number of cancer patients 
with whom patients reported communicating regularly.  This result suggests that, 
consistent with theory regarding non-patients (Peplau & Perlman, 1982; Russell, 1996), 
the quality of the interaction may be more important than the quantity.  Particularly, 
contact with other cancer patients may be a positive or negative experience depending on 
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a number of factors, such as how well they feel understood by the other patient.  For 
instance, interacting with a patient with very disparate experiences (e.g., better prognosis, 
fewer symptoms, different type of treatment) may heighten feelings of misunderstanding 
and loneliness.  Conversely, a conversation with a patient with similar cancer-related 
experiences and perceptions may be a particularly positive social experience that reduces 
feelings of loneliness.  Thus, the potential for both negative and positive social exchanges 
with other patients provides a possible explanation for the null effect.  
 Also contrary to my hypotheses, the number of friends and relatives with whom 
participants had contact at least once every 2 weeks was positively correlated with 
cancer-related loneliness.  In the general loneliness literature, findings are mixed 
regarding relationships between loneliness and more objective social network 
characteristics (e.g., amount of time spent with others, size of social network), with some 
studies reporting significant associations (Freberg, Adams, McGaughey, & Freberg, 
2010; Green, Richardson, Lago, & Schatten-Jones, 2001; Russell, 1996) and others 
reporting null findings (Peplau & Perlman, 1982; Russell, 1996).  The reasons for these 
mixed findings are unclear and should be studied in future research.  The present study 
findings differed from those of existing studies reporting a significant relationship 
between general loneliness and number of social contacts (Freberg et al., 2010; Russell, 
1996) in that having more friend and relative contacts was associated with greater cancer-
related loneliness.  One potential explanation is that having more contact with others 
provided more opportunities to experience socially constraining behaviors or feel 
misunderstood with respect to the cancer experience, which led to greater loneliness.   
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 Finally, consistent with my prediction, cancer-related loneliness was unrelated to 
the number of coworkers with whom participants had contact at least once every 2 weeks.  
Although this finding is consistent with loneliness theory (Peplau & Perlman, 1982; 
Russell, 1996), it is inconsistent with the results regarding contact with friends and 
relatives.  This inconsistency in findings might be related to a number of factors.  First, 
patients may have different expectations for relationships with coworkers than friends 
and relatives (e.g., may not expect the same level of understanding and therefore may 
have fewer opportunities to be disappointed).  Second, the number of coworkers might be 
confounded with other variables, such as job type (e.g., jobs involving direct service 
provision vs. technical labor with limited social interaction), which may be directly or 
indirectly associated with cancer-related loneliness. 
 Alternate explanations for the inconsistent social network variable findings should 
be considered.  Of note, although most of the items assessing social contact in this study 
have been used in prior research (Cohen et al., 1997; Ellwardt, van Tilburg, Aartsen, 
Wittek, & Steverink, 2015), reliability or validity evidence for these items has not been 
published.  Thus, another possible explanation for the findings is measurement error.  For 
example, patients may have had poor recall for the number of people with whom they 
interacted over the past 2 weeks.  Additionally, patients may have interpreted the 
questions differently (e.g., with some only reporting the number of people with whom 
they interacted frequently or had more substantial conversations and others reporting the 
number of people with whom they had any form of contact), leading to inconsistency in 
reporting.  Notably, results were dramatically different when the winsorization 
transformation was applied, even though few values were changed (2 values for number 
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of cancer patient contacts, 5 values for number of friend contacts, 5 values for number of 
relative contacts, and 1 value for number of coworker contacts).  For the number of 
cancer patient, friend, and relative contacts, the direction of the relationship changed 
when the winsorization transformation was applied.  For the number of cancer patient, 
relative, and coworker contacts, the presence of statistical significance changed.  In some 
cases the winsorization transformation made the results more consistent with my 
predictions, whereas in other cases it made the results less consistent with my predictions.  
As discussed in the methods section, several skew and kurtosis values on the social 
network variables were outside the acceptable range before I applied the winsorization 
transformation, providing a rationale for interpreting the winsorized values.  Overall, the 
ambiguous results might reflect both measurement error and the ambiguous nature of the 
relationship between quantity of social contact and loneliness.  Namely, theory suggests 
that people have different social needs and expectations and that a discrepancy between 
what they want and have is associated with their relationship satisfaction (Peplau & 
Perlman, 1982).  Thus, to some extent, both the quantity and quality of social contacts 
affect loneliness, but these relationships are likely to differ across individuals.  These 
associations are further complicated by the fact that social contact may include both 
positive and negative interactions; at times a patient may feel misunderstood even by 
their most trusted confidant.  Therefore, the relationships between social network 
qualities and loneliness are complex and challenging to examine.  
 Overall, evidence for the construct validity of the Cancer Loneliness Scale was 
deemed to be good, as the majority of theoretical relationships were found.      
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Cancer-related Negative Social Expectations Scale 
 Excellent evidence for reliability and validity also was found for the Cancer-
related Negative Social Expectations Scale.  Three factor structures were examined and 
the unidimensional model exhibited the best fit and was retained.  Results may indicate 
that patients often endorse a single underlying pattern of thinking about relationships 
rather than a tendency to have different types of social expectations for different social 
situations.  Additionally, the high internal consistency for the unidimensional measure in 
this study provides evidence for reliability.  
The Cancer-related Negative Social Expectations Scale was associated with 
measures of health and social well-being theoretically linked to negative social 
expectations, which provides evidence of construct validity.  First, as hypothesized, 
cancer-related negative social expectations were positively correlated with both general 
and cancer-related loneliness.  To my knowledge, this is the first empirical test of the 
relationship between negative social expectations and loneliness in any population, 
providing support for theory suggesting negative social cognitions precipitate and sustain 
loneliness (Cacioppo & Hawkley, 2009).  The correlation (r=0.70) between negative 
social expectations and cancer-related loneliness was stronger than the correlation 
(r=0.47) between negative social expectations and general loneliness, which is expected 
because the negative social expectations and cancer-related loneliness measures both 
focus on cancer-specific experiences.  As discussed previously, high correlations (such as 
between negative social expectations and cancer-related loneliness) are not necessarily 
indicative of construct redundancy.  Again, there is a lack of consensus in the literature 
regarding the strength of correlations indicating redundancy, though some statisticians 
82 
 
 
 
have suggested correlations of 0.90 and higher might indicate redundancy (Tabachnick & 
Fidell, 2001).  The strong correlation between negative social expectations and cancer-
related loneliness is consistent with theory (Cacioppo & Hawkley, 2009) and, thus, the 
high correlation provides appropriate evidence of construct validity.   
Second, the positive relationships between negative social expectations and 
anxiety and depressive symptoms are consistent with cognitive theory suggesting 
negative thought patterns underlie anxiety and depressive disorders (A. Beck, 1970; 
Clark & Beck, 1989).  Specifically, cognitive theory posits that thoughts and feelings are 
linked; unhelpful thoughts are hypothesized to increase distress (A. Beck, 1970; Clark & 
Beck, 1989).  Third, negative social expectations were positively associated with pain, 
fatigue, and sleep disturbance and negatively associated with quality of life, supporting 
theory suggesting negative social expectations impact health outcomes (Cacioppo & 
Hawkley, 2009).  Specifically, negative social expectations are hypothesized to 
negatively affect health outcomes by increasing loneliness, which is associated with a 
number of health risk factors (e.g., HPA axis dysfunction, sleep disturbance, 
inflammation) (Cacioppo & Hawkley, 2009; Cacioppo, Hawkley, Crawford, et al., 2002).   
Finally, negative social expectations were positively correlated with social constraints 
and negatively correlated with emotional support, consistent with theory positing that 
negative social expectations increase social behaviors that elicit negative social 
interactions (Cacioppo & Hawkley, 2009).  Thus, overall, results were consistent with my 
predictions and provided excellent evidence of construct validity.  
 
 
83 
 
 
 
Limitations and Future Directions 
 Limitations of this study include potential response bias and measurement error.  
Although my consent and survey return rates were comparable to similar telephone and 
mail-based survey research (Eakin & Strycker, 2001), only 54% of the 344 presumably 
eligible patients returned their surveys.  It is possible that patients who participated 
differed from those who chose not to participate or could not be contacted.  For instance, 
non-participants often reported feeling too ill or distressed to participate; thus, study 
participants may have had fewer symptoms than non-participants.  Future studies could 
reduce response bias by employing alternate recruitment techniques (e.g., clinic-based 
recruitment) that tend to yield higher response rates.  Furthermore, participants completed 
the surveys at home and may not have completed them independently, although they 
were instructed to do so.  Responding in a socially desirable manner is always a concern 
using self-report methods, but may be of particular concern if patients’ family members 
assist them with completing questions about social functioning.  For example, a patient 
might report greater satisfaction with relationships (e.g., less loneliness, greater social 
support, fewer social constraints) if a family member is present.  Participation in private 
offices could reduce this potential bias in future studies.  Additionally, construct validity 
was determined via correlations with self-report measures, which are subject to a number 
of biases.  For instance, items regarding number of contacts could be self-reported 
incorrectly due to social desirability or forgetfulness.  Thus, use of more objective 
measures (e.g., clinician ratings of video-recorded social exchanges) to assess construct 
validity in future studies may provide more accurate results.  
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 Other limitations related to measure development also should be noted.  First, I 
was unable to obtain qualitative feedback on the items assessing negative social 
expectations prior to administration.  Receiving patient and further expert feedback may 
have led to increased clarity in item wording and prevented the administration of 
confusing items.  For example, two items were immediately eliminated for poor 
performance.  After closer examination, it appeared that the items could have been 
interpreted in multiple ways, which likely led to the low item-total correlations.  Second, 
I was unable to assess test-retest reliability because a longitudinal study was not feasible 
for this project.  Thus, examination of the measures’ test-retest reliability is an important 
direction for future research.  Furthermore, results of this study provide only preliminary 
evidence of the measures’ psychometric properties.  The current analyses should be 
conducted using a larger, more representative sample.  Inclusion of diverse populations 
would allow the assessment of measurement invariance across racial or ethnic groups.  
Additionally, participant burden concerns prevented me from measuring associations 
between the new measures and many other constructs (e.g., stigma, protective buffering, 
social skills, social anxiety, other types of negative expectations) that should be examined 
in future work.  Finally, examining whether cancer-related negative social expectations 
predict cancer-related loneliness over time would provide a more rigorous test of the 
theory (Cacioppo & Hawkley, 2009), as well as a better indication of whether cognitive-
based interventions should be tested to reduce loneliness in cancer patients.  
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Implications 
 The current project has a number of implications for theory, clinical practice, and 
clinical research.  First, to my knowledge, this is the first study to develop and evaluate 
measures of cancer-related loneliness and negative social expectations for any 
population.  Thus, this study provided the first empirical test of the theoretical 
relationship between negative social expectations and loneliness in any population, and 
results were consistent with loneliness theory (Cacioppo & Hawkley, 2009).  
Additionally, this study expands on existing theory by examining these concepts in 
cancer patients, a population that may be at high risk of developing loneliness (Deckx et 
al., 2014; Wells & Kelly, 2008).  In particular, I identified specific cancer-related 
negative social expectations and found a positive association between these expectations 
and loneliness attributed to cancer.  Furthermore, this study provides an initial test of 
aspects of loneliness theory by linking negative social expectations to mental and 
physical health outcomes (i.e., depressive and anxiety symptoms, somatic symptoms, 
quality of life).  Loneliness theory suggests negative social expectations increase 
loneliness, which in turn negatively impacts health (Cacioppo & Hawkley, 2009).   
The project also has a number of clinical implications and applications.  First, the 
Cancer Loneliness Scale has utility for assessing loneliness in clinical settings.  
Loneliness is a known risk factor for poor physical, emotional, and social outcomes in 
general and cancer populations (Cacioppo & Hawkley, 2009; Cacioppo et al., 2006; 
Drageset et al., 2013; Hawkley & Cacioppo, 2003; Jaremka, Fagundes, Glaser, et al., 
2013; Jaremka, Fagundes, Peng, et al., 2013), and in this study I found that cancer-related 
loneliness also is associated with a variety of poor outcomes.  Thus, screening for 
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loneliness may aid the identification of patients that may benefit from a referral to mental 
health treatment.  For instance, the Cancer Loneliness Scale could be used to identify 
patients who may warrant a cancer-specific loneliness intervention.  Distress screening 
has become more commonplace in cancer centers in recent years, with many researchers 
and clinicians recommending that distress screening be incorporated into standard 
guidelines (Carlson & Bultz, 2003; Holland & Bultz, 2007).  Indeed, implementation of 
distress screening into standard practice has shown promise for enhancing patient-
provider communication regarding mental health (Taenzer et al., 2000; Velikova, Brown, 
Smith, & Selby, 2002).  Additionally, the Cancer Loneliness Scale could be used to 
assess whether an intervention reduced cancer-related loneliness.  Furthermore, if the 
current findings are replicated longitudinally, this would suggest that targeting negative 
social expectations in loneliness interventions might be beneficial.  Therapists could 
select negative social cognitions upon which to intervene based on item responses to the 
Cancer-related Negative Social Expectations Scale.  Following the intervention, 
researchers could use the measure to empirically evaluate whether reduced negative 
social expectations mediated the beneficial effects of a cognitive intervention on cancer 
patients’ loneliness. 
 
Conclusions 
Loneliness is associated with poor mental and physical health outcomes in cancer 
patients (Drageset et al., 2013; Jaremka, Fagundes, Glaser, et al., 2013; Jaremka, 
Fagundes, Peng, et al., 2013; Jaremka, Peng, et al., 2014).  Cancer patients may 
experience loneliness specifically related to the cancer experience; thus, loneliness 
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interventions in cancer should be tailored to address illness-related social conditions and 
negative social expectations.  In the current project I developed two cancer-specific tools 
for use in future theory-based loneliness research.  Development of theory-based 
loneliness reduction interventions may be critical to improving cancer patients’ mental 
and physical health outcomes. 
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Appendix A.  Handout with Cancer Loneliness Scale 
 
 
The following statements describe how people sometimes feel after being diagnosed with cancer.  
For each statement, please indicate how often you have felt that way by writing a number in the 
space provided. 
NEVER 
1 
RARELY 
2 
SOMETIMES 
3 
OFTEN 
4 
ALWAYS 
5 
 
1. Since your cancer diagnosis, how often have you felt that people are 
around you but not with you? 
 
______ 
 
2. How often do you feel left out because of your cancer? 
 
______ 
3. Since your cancer diagnosis, how often have you felt that you were not important to 
others? 
 
______ 
 4. How often do you feel that there is no one you can share the ups and downs of cancer 
with? 
 
______ 
 5. How often does having cancer make you feel empty? 
 
______ 
 6. Since your cancer diagnosis, how often have you felt misunderstood even by your closest 
friends and family members?  
 
______ 
 7.  How often do you feel that others cannot provide the support you need to deal with your 
cancer? 
 
______ 
 8. Since your cancer diagnosis, how often have you felt that you don’t 
have a lot in common with the people around you? 
 
______ 
 9. How often do you feel that you cannot share personal thoughts about cancer with 
anyone? 
 
______ 
 10. Since your cancer diagnosis, how often have you felt that you were not needed by 
others? 
 
______ 
 11. How often does having cancer make you feel alone? 
 
______ 
 12. How often do you feel that no one really understands how cancer has 
affected you? 
 
______ 
 13.  Since your cancer diagnosis, how often have you experienced a general sense of 
emptiness? 
 
______ 
 14. How often does your cancer diagnosis make you feel isolated from others? 
 
______ 
 15. Since your cancer diagnosis, how often have you felt that you are no longer close to 
anyone? 
 
______ 
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Please circle questions that: 
 Don’t make sense 
 Aren’t clear enough 
 Are missing something 
 Have any other problem 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for your time! 
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Appendix B. Screening Form for Qualitative Study 
 
Indiana University Simon Cancer Center 
Development of Loneliness Questionnaires for Cancer Patients 
 
 
 
Date: ______/______/______ 
 
Patient’s Name: __________________ 
 
MRN:____________________ 
 
 
 
Eligibility Screening: Record Review and Physician Contact 
 
Yes  No 
1) Person who was diagnosed with cancer and is receiving care at IUSCC? 
 
  
2) Person who is undergoing active treatment for cancer?    
2) 18 years of age or older? 
 
  
3) Attending physician contacted and confirmed eligibility? 
 
     Attending:                                       Date of confirmation: 
 
  
 
     Patient agreed to participate: 
                      
    Consent Date: ___/____/___ 
                
 
 Patient declined participation: (please check ALL that apply) 
 
(1) ___ Not interested 
(2) ___ Not feeling well or has other health reasons 
(3) ___ No time 
(4) ___ Study participation is too much work/Too difficult 
(5)  ___ Other, specify: __________________________ 
 
 
   Patient Age:_____ 
 
               Patient Gender:____ 
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Appendix C. Consent Form for Qualitative Study 
 
INDIANA UNIVERSITY INFORMED CONSENT STATEMENT FOR 
 
Development of a Loneliness Questionnaire for Cancer Patients 
 
You are invited to participate in a research study about the social experiences of cancer patients.  
You were selected as a possible subject because you have been diagnosed with cancer.  We ask 
that you read this form and ask any questions you may have before agreeing to be in the study.  
 
The study is being conducted by Dr. Catherine Mosher, Assistant Professor of Psychology at the 
IUPUI School of Science. It is funded by the National Cancer Institute and the Psychology 
Department at IUPUI.  
 
STUDY PURPOSE 
 
The purpose of this study is to learn about cancer patients’ social experiences. We also want to 
get feedback on a questionnaire about loneliness so that we can improve it.  
 
NUMBER OF PEOPLE TAKING PART IN THE STUDY: 
 
If you agree to participate, you will be one of 30 subjects who will be participating in this 
research. 
 
PROCEDURES FOR THE STUDY: 
 
If you agree to be in the study, you will do the following things: 
 
If you choose to take part in this study, we will give you a paper survey to fill out in the clinic. It 
will take about 5 to 8 minutes. The survey includes questions about you. These include: 
 
- Your education and employment  
- Your mood  
- Your relationships  
- Your experience coping with cancer  
 
After you take the survey, you will have a private interview in the clinic with a researcher. It will 
take about 10 to 30 minutes. First, you will answer questions about your social experiences as a 
cancer patient. Next, you will be asked to provide feedback on a questionnaire about loneliness.  
 
With your permission, we will audiotape your interview. Each tape will have a code number to 
protect your confidentiality. You may ask to turn the tape off at any time. 
 
 If you choose to take part in this study, we will collect the following information from your 
medical record:  
 
- Age 
- Gender 
- The date you were diagnosed with cancer  
- The type of cancer you were diagnosed with 
- The stage of the cancer 
- Your treatments for cancer (surgery, radiation, chemotherapy, or other treatments) 
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RISKS OF TAKING PART IN THE STUDY: 
 
While on the study, there is a risk that you will feel uncomfortable with some of the questions. 
You may skip any of the questions. Another risk of taking part in the study is that you may 
experience some distress, including anxiety, sadness, or negative thoughts. If you do experience 
distress, then you may contact the study investigator and psychologist, Dr. Catherine Mosher 
(phone: 317-274-6769). You may also contact Dr. Mosher with any questions or concerns about 
the study. 
There is also a risk of possible loss of confidentiality. We will protect your information to the 
limit of the law. We will keep your information in passphrase protected electronic files or in 
lockable file cabinets in a private office. When the study ends, we will remove all identifying 
information from study data and materials. There is also a risk of loss of confidentiality since 
members of our research team will know you and the information you share. Your information 
will be kept confidential and only members of the research team will have access to your records. 
Unless law requires us, we will not share that information with anyone. 
 
BENEFITS OF TAKING PART IN THE STUDY: 
 
You may not benefit directly from this study. Your taking part in this study may benefit other 
cancer patients in the future. 
 
ALTERNATIVES TO TAKING PART IN THE STUDY: 
 
You do not have to participate in this study if you do not want to. If you choose not to participate, 
you will receive the same care from your doctor. 
 
CONFIDENTIALITY 
 
Efforts will be made to keep your personal information confidential.  We cannot guarantee 
absolute confidentiality.  Your personal information may be disclosed if required by law.  Your 
identity will be held in confidence in reports in which the study may be published.  Only the 
research team will have access to the tape recordings.  These recordings will be destroyed at the 
end of the study.   
 
Organizations that may inspect and/or copy your research records for quality assurance and data 
analysis include groups such as the study investigator and her research associates, the Indiana 
University Institutional Review Board or its designees, the study sponsor, the IUPUI Psychology 
Department, and (as allowed by law) state or federal agencies, specifically the Office for Human 
Research Protections (OHRP), the National Cancer Institute (NCI), the National Institutes of 
Health (NIH), etc., who may need to access your medical and and/or research records. 
 
COSTS 
 
There are no costs to participate in this study.  
 
PAYMENT 
 
You will receive payment for taking part in this study.  After you have completed the survey and 
interview, you will be handed a $25 Target gift card.  
 
CONTACTS FOR QUESTIONS OR PROBLEMS 
 
For questions about the study or a research-related injury, contact the researcher Dr. Catherine 
Mosher at 317-274-6769.  If you cannot reach the researcher during regular business hours (i.e. 
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8:00AM-5:00PM), please call the IU Human Subjects Office at (317) 278-3458 or (800) 696-
2949. 
 
For questions about your rights as a research participant or to discuss problems, complaints or 
concerns about a research study, or to obtain information, or offer input, contact the IU Human 
Subjects Office at (317) 278-3458 or (800) 696-2949. 
 
VOLUNTARY NATURE OF STUDY 
 
Taking part in this study is voluntary.  You may choose not to take part or may leave the study at 
any time.  Leaving the study will not result in any penalty or loss of benefits to which you are 
entitled.  Your decision whether or not to participate in this study will not affect your current or 
future relations with Indiana University Simon Cancer Center.  
 
Your participation may be terminated by the investigator without regard to your consent in the 
following circumstances: If the investigator feels it is in the best interest of your health and 
welfare. 
 
 
SUBJECT’S CONSENT 
 
In consideration of all of the above, I give my consent to participate in this research study.   
 
I will be given a copy of this informed consent document to keep for my records.  I agree to take 
part in this study. 
 
 
Subject’s Printed Name:  
 
Subject’s Signature: Date: 
                                                                                                                                              (must be dated by the subject) 
 
Signature of Person Obtaining Consent: Date: 
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Appendix D. Medical Record Data Collection Form for Qualitative Study 
 
Medical Record Information: 
 
Patient’s Demographics: 
 
(1) Age: _____ 
 
(2) Gender   Male    Female 
 
 
Patient’s Cancer History: 
 
(1) Cancer Type(s): ___________________ 
 
(2) Date(s) of Diagnosis: ____/____/_____ 
 
(3) Disease Stage(s) (i.e., early vs. late stage) : _________________ 
 
Treatments for Cancer (check all that have been received):    
  
 Surgery 
 Chemotherapy 
 Radiation   
 Chemoradiation (concurrent chemotherapy and radiation)   
 Targeted therapy 
 Stem cell transplant 
 Autologous SCT 
 Allogeneic SCT 
 Bisphosphonate/s 
 Other: ___________  
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Appendix E. Survey for the Qualitative Study 
 
Survey 
 
Please respond to each question or statement by marking one box per row. 
 
In the past 7 days… 
    
    Never Rarely Sometimes Often Always 
1. I felt worthless ...................................... 
 

 

 

 

 

 
2. I felt helpless ......................................... 
 

 

 

 

 

 
3. I felt depressed ...................................... 
 

 

 

 

 

 
4. I felt hopeless ........................................ 
 

 

 

 

 

 
5. I felt fearful .......................................... 
 

 

 

 

 

 
6. I found it hard to focus on anything 
other than my anxiety ............................... 
 

 

 

 

 

 
7. My worries overwhelmed me ............... 
 

 

 

 

 

 
8. I felt uneasy ......................................... 
 

 

 

 

 

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The following statements describe how people sometimes feel.  For each statement, please 
indicate how often you feel the way described by writing a number in the space provided. Here is 
an example: 
 
How often do you feel happy? 
 
If you never felt happy, you would respond “never”; if you always feel happy, you would respond 
“always.”  
NEVER 
1 
RARELY 
2 
SOMETIMES 
3 
ALWAYS 
4 
 
1. How often do you feel that you are “in tune” with the people around you? 
 
______ 
 
2. How often do you feel that you lack companionship? 
 
______ 
3. How often do you feel that there is no one you can turn to? 
 
______ 
4. How often do you feel alone? 
 
______ 
5. How often do you feel part of a group of friends? 
 
______ 
6. How often do you feel that you have a lot in common with the people around you? 
 
______ 
7. How often do you feel that you are no longer close to anyone? 
 
______ 
8. How often do you feel that your interests and ideas are not shared by those around you? 
 
______ 
9. How often do you feel outgoing and friendly? 
 
______ 
10. How often do you feel close to people? 
 
______ 
11. How often do you feel left out? 
 
______ 
12. How often do you feel that your relationships with others are not meaningful? 
 
______ 
13. How often do you feel that no one really knows you well? 
 
______ 
14. How often do you feel isolated from others? 
 
______ 
15. How often do you feel you can find companionship when you want it? 
 
______ 
16. How often do you feel that there are people who really understand you? 
 
______ 
17. How often do you feel shy? 
 
______ 
18. How often do you feel that people are around you but not with you? 
 
______ 
19. How often do you feel that there are people you can talk to? 
 
______ 
20. How often do you feel that there are people you can turn to? ______ 
  
130 
 
 
General Information 
1. How many relatives do you see or talk to at least once every 2 weeks? ____ 
2.  How many friends do you see or talk to at least once every 2 weeks? ____ 
3.  If you are currently employed, how many co-workers do you see or talk to at least once 
every 2   weeks? ____   
     (If you are not currently employed, please skip to question #4.) 
4. How many cancer patients or survivors do you see or talk to at least once  
every 2 weeks? ____ 
5. How many cancer patients or survivors do you know that you feel comfortable sharing 
your  
experiences  with? ____ 
6. On a scale from 1-10, how would you rate the overall quality of your relationships?   
1           2           3           4               5              6             7            8             9            10 
(worst quality you can imagine)                                                         (best quality you can imagine) 
7. What race or ethnicity do you consider yourself to be?         
___White   ___Black or African American    ___Asian-American or Pacific 
Islander    
 ___Native American              ___Hispanic or Latino ___Multi-racial  
  ___Other (please specify)__________________________  
8. Marital Status (check one)   ___Single ___Living with partner     ___Married 
 ___Separated        ___Divorced        ___Widowed 
 
9. Employment status (check one)   ___Employed full-time ___Employed part-time     
___Student     ___Homemaker        ___Retired        
 ___Unemployed, looking for work     ___Unemployed, due to disability 
 ___Other (please specify): ______________________________ 
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10. What is the highest grade or year of school you completed?     
___Never attended school or only attended kindergarten  
___Grades 1 through 8 (Elementary)  
___Grades 9 through 11 (Some high school)  
___Grade 12 or GED (High school graduate)  
___College 1 year to 3 years (Some college or technical school)  
___ College 4 years or more (College graduate)  
___ Graduate school (Master’s degree, Doctorate, etc.)  
 
11. Do you have health insurance coverage now?       
    ____Yes        _____   No 
 
 
               THANK YOU FOR YOUR PARTICIPATION! 
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Appendix F. Qualitative Interview Guide 
Semi-structured Qualitative Interview Guide and Handouts 
 
Now I am going to ask you some questions about your experiences since your cancer 
diagnosis. 
 
1. Many cancer patients say they feel lonely at times. Since your cancer diagnosis, can 
you think of a time when you felt lonely? 
 
2. How would you describe how that felt to someone else? 
 
Thanks for sharing that with me. For this project, loneliness means feeling isolated or 
disconnected from others around you. It isn’t about how much time you spend with others 
or how many friends you have, but more about how connected you feel with others 
overall. Does that make sense? (answer questions as necessary) 
 
3. Have you had an experience when you felt isolated or disconnected from family or 
friends since your cancer diagnosis?  Tell me about that. (do not ask this question if 
previous description clearly refers to my definition of loneliness)   
 
4. What thoughts were going through your head as you had this experience? (do not ask 
this question if they shared thoughts in previous responses) 
 
5. What happened that caused those thoughts [or emotions]? (do not ask this question if 
they shared events in previous responses) 
 
 
Now I’d like to change our focus and talk about a questionnaire on loneliness that we are 
developing. The purpose of the questionnaire is to see if cancer patients are feeling 
lonely. The questionnaire is not perfect and we could really use your help in improving it. 
Here is a copy [hand the patient the questionnaire].  I would like you to read the 
questionnaire and let me know what you like about it and what you do not like.  Some 
people are not comfortable giving negative feedback, but I encourage you to be critical, 
as this will help us improve the questionnaire.   
 
I am interested in how clear the questions are, if they are easy or difficult to read, if they 
make sense to you, and if anything is missing. Please take your time to carefully read 
through them. If a question doesn’t make sense, isn’t clear enough, is missing something, 
or has any problems with it, please circle it. After you have finished, we will discuss it.    
 
6. Overall, how clear are the questions?  
 
7. Now, let’s take a look at any individual questions you circled. What are your thoughts? 
(if applicable) 
 
Probes (if applicable):  
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 What does that question mean to you?  
 How would you phrase that [question or word] in your own words?  
 How easy or difficult was it to answer that question? 
 
 
If a person says they have not been lonely: Ok. A lot of patients say they do feel lonely at 
times. As we continue our conversation, let me know if you think of any times when you 
felt that way. (skip to definition). If a person still says they haven’t experienced it: Ask if 
they’d still be willing to help me by telling me if any questions are hard or easy to read or 
have any problems with them.  
 
Prompt if person has a hard time describing their experience: If you were talking to 
someone, what would you need to tell them so they could understand what it’s like for 
you?  
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Appendix G. Sample Characteristics for the Qualitative Study 
 
Table G1.  
 
Sample Characteristics (N = 15) 
 
Characteristic 
 
N (%) M (SD) Range 
Average age 
 
 62.6 (11.9) 43.0-77.0 
Female gender 
 
  7 (46.7)   
Marital status 
  Never married 
  Married/living with partner 
  Divorced or widowed 
 
 
  2 (13.3) 
10 (66.6) 
  3 (20.0) 
 
  
Race/ethnicity 
  White 
  African American 
 
 
14 (93.3) 
  1 (6.7) 
  
Education level 
  Some high school 
  High school graduate 
  Some college or technical school 
  College graduate 
   
 
  1 (6.7) 
  4 (26.7) 
  3 (20.0) 
  7 (46.7) 
  
Employment status 
  Employed full or part-time 
  Retired 
  Unemployed due to disability 
  Student 
 
  6 (40.0) 
  6 (40.0) 
  2 (13.3) 
  1 (6.7) 
 
  
Cancer type 
  Multiple myeloma 
  Non-Hodgkin’s lymphoma 
 
  8 (53.3) 
  7 (46.7) 
 
  
Cancer stage 
  Early stage 
  Late stage 
 
  5 (33.3) 
10 (66.7) 
 
  
Years since diagnosis 
 
 
 
Table G1 continued next page. 
 2.9 (3.2) 0.2-9.4 
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Table G1 continued. 
 
Characteristic 
 
N (%) M (SD) Range 
Treatments received 
  Chemotherapy 
  Autologous stem cell transplant 
  Targeted therapy 
  Bisphosphonate 
  Other surgery 
  Radiation 
 
 
14 (93.3) 
  7 (46.7) 
  6 (40.0) 
  4 (26.7) 
  1 (6.7) 
  1 (6.7) 
 
 
 
 
 
 
 
 
Loneliness  31.1 (8.3) 21.0-48.0 
Depression 
 
 2.1 (2.1) 0.0-6.0 
Anxiety 
 
 2.7 (2.3) 0.0-7.0 
Social network characteristics 
  Num. relatives 
  Num. friends 
  Num. coworkers 
  Num. cancer patients 
  
5.6 (4.6) 
  9.3 (12.6) 
9.0 (5.9) 
1.2 (1.4) 
 
0.0-18.0 
0.0-50.0 
1.0-20.0 
0.0-5.0 
136 
 
 
Appendix H. Cancer-related Negative Social Expectations Scale Items by Domain 
Domain 1: Expecting others to listen or be available whenever the patient needs 
them. 
 
1. I expect people to always be available for me because of my cancer. 
 
2. I expect people to listen to me whenever I want to talk about my cancer. 
 
3. If people stopped asking about my cancer, I would think that they don’t care. 
 
4. If people avoided discussing my cancer with me, I would think that they didn’t want to 
hear about it. 
 
5. If people avoided seeing or talking to me after my cancer diagnosis, I would think that 
they don’t care.  
 
Domain 2: Expecting a lack of understanding of cancer-related concerns. 
 
6. People will not understand if I share my concerns about cancer. 
 
7. People could not truly understand how I feel about my cancer diagnosis.  
 
Domain 3: Expecting that others will not understand existential thoughts.  
 
8. People would not understand my thoughts about death since my cancer diagnosis. 
 
9. People would not understand my uncertainty about the future since my cancer 
diagnosis.  
 
Domain 4: Expecting sharing cancer-related concerns to burden others. 
 
10. If I shared my concerns about cancer with people then it would be too hard on them.  
 
11. I would burden people if I shared my thoughts and feelings about cancer with them. 
 
Domain 5: Expecting telling others about their diagnosis or cancer-related concerns 
to change their relationships for the worse. 
 
12. If I told people about my cancer experience, they would be nervous and 
uncomfortable around me. 
 
13. If I told people about my cancer experience, our relationship would change for the 
worse.   
 
14. If I shared my concerns about cancer with people then they might hurt me with their 
reactions. 
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Appendix I. Introductory Mailings for Quantitative Study 
 
<DATE> 
 
Dear <TITLE, NAME>, 
 
The physicians and staff at the Indiana University Cancer Center and other Indiana 
University Health hospitals are interested in improving services and meeting the needs of 
our patients.  We would like to know more about the impact of cancer and its treatment 
on patients’ lives. 
 
We are writing to tell you about a new research study which may be of interest to you. 
Cancer patients who have received services at an Indiana University Health hospital are 
invited to participate in this research study.  If you agree to participate, you will be asked 
to complete a mailed questionnaire that asks for information about your background, 
physical health status (pain, energy level, etc.), social relationships, and mood.  We 
understand that the information you may provide is personal and it will be kept private.  
The enclosed consent and authorization forms provide more information about this study. 
 
In the next few weeks, a member of our research team will contact you by phone to 
explain the study, answer your questions, and invite you to take part.  Although you are 
free to choose not to participate in this study, your participation would help the healthcare 
team better understand the experiences of people with cancer.  Additionally, after 
completing the questionnaire, we would mail you a $25 Target gift card to show our 
appreciation.   
 
If you do not wish for us to call, or if you have any questions about the study, please call 
the research fellow, Rebecca Adams, at (317) 278-4009.  Thank you very much for 
taking the time to consider this project. 
 
Sincerely, 
 
 
 
Catherine E. Mosher, Ph.D. 
School of Science 
Indiana University-Purdue University Indianapolis 
 
 
Rafat Abonour, M.D. 
Department of Medicine 
Indiana University School of Medicine 
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INDIANA UNIVERSITY STUDY INFORMATION SHEET FOR 
 
Health and Social Well-Being among Cancer Patients 
 
You are invited to participate in a research study about the social experiences of cancer patients.  
You were selected as a possible subject because you have been diagnosed with cancer.  We ask 
that you read this form and ask any questions you may have before agreeing to be in the study.  
 
The study is being conducted by Dr. Catherine Mosher, Assistant Professor of Psychology at the 
IUPUI School of Science. It is funded by the National Cancer Institute.  
 
STUDY PURPOSE 
 
The purpose of this study is to learn about cancer patients’ health and social experiences. We will 
use the information from this study to improve support services for patients in the future.  
 
NUMBER OF PEOPLE TAKING PART IN THE STUDY: 
 
If you agree to participate, you will be one of 260 subjects who will be participating in this 
research. 
 
PROCEDURES FOR THE STUDY: 
 
If you agree to be in the study, you will do the following things: 
 
If you choose to take part in this study, we will mail you a paper survey to fill out at home. It will 
take about 10 to 20 minutes. The survey includes questions about you. These include: 
 
- Your education and employment  
- Your mood  
- Your physical symptoms 
- Your relationships  
- Your experience coping with cancer  
 
After you take the survey, you will mail it back to the study team. We will provide a postage-paid 
return envelope for you to use.  
 
 If you choose to take part in this study, we will collect the following information from your IU 
Health medical records:  
 
- Age 
- Gender 
- The date you were diagnosed with cancer  
- The type of cancer you were diagnosed with 
- The stage of the cancer 
- Your treatments for cancer (surgery, radiation, chemotherapy, or other treatments) 
 
RISKS OF TAKING PART IN THE STUDY: 
 
While on the study, there is a risk that you will feel uncomfortable with some of the questions. 
You may skip any of the questions. Another risk of taking part in the study is that you may 
experience some distress, including anxiety, sadness, or negative thoughts. If you do experience 
distress, then you may contact the study investigator and psychologist, Dr. Catherine Mosher 
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(phone: 317-274-6769). You may also contact Dr. Mosher with any questions or concerns about 
the study. 
 
There is also a risk of possible loss of confidentiality. We will protect your information to the 
limit of the law. We will keep your information in passphrase protected electronic files or in 
lockable file cabinets in a private office. When the study ends, we will remove all identifying 
information from study data and materials. There is also a risk of loss of confidentiality since 
members of our research team will know you and the information you share. Your information 
will be kept confidential and only members of the research team will have access to your records. 
Unless law requires us, we will not share that information with anyone. 
 
BENEFITS OF TAKING PART IN THE STUDY: 
 
You may not benefit directly from this study. Your taking part in this study may benefit other 
cancer patients in the future. 
 
ALTERNATIVES TO TAKING PART IN THE STUDY: 
 
You do not have to participate in this study if you do not want to.  
 
CONFIDENTIALITY 
 
Efforts will be made to keep your personal information confidential.  We cannot guarantee 
absolute confidentiality.  Your personal information may be disclosed if required by law.  Your 
identity will be held in confidence in reports in which the study may be published.   
 
Organizations that may inspect and/or copy your research records for quality assurance and data 
analysis include groups such as the study investigator and her research associates, the Indiana 
University Institutional Review Board or its designees, the study sponsor, and (as allowed by law) 
state or federal agencies, specifically the Office for Human Research Protections (OHRP), the 
National Cancer Institute (NCI), the National Institutes of Health (NIH), etc., who may need to 
access your medical and and/or research records. 
 
PAYMENT 
 
You will receive payment for taking part in this study.  After you have completed the survey, you 
will be mailed a $25 Target gift card.  
 
CONTACTS FOR QUESTIONS OR PROBLEMS 
 
For questions about the study, contact the researcher Dr. Catherine Mosher at 317-274-6769.  If 
you cannot reach the researcher during regular business hours (i.e. 8:00AM-5:00PM), please call 
the IU Human Subjects Office at (317) 278-3458 or (800) 696-2949. 
 
For questions about your rights as a research participant or to discuss problems, complaints or 
concerns about a research study, or to obtain information, or offer input, contact the IU Human 
Subjects Office at (317) 278-3458 or (800) 696-2949 or by email at irb@iu.edu. 
 
VOLUNTARY NATURE OF STUDY 
 
Taking part in this study is voluntary.  You may choose not to take part or may leave the study at 
any time.  Leaving the study will not result in any penalty or loss of benefits to which you are 
entitled.  Your decision whether or not to participate in this study will not affect your current or 
future relations with Indiana University Health hospitals.  
140 
 
 
INDIANA UNIVERSITY 
AUTHORIZATION FOR THE RELEASE OF HEALTH INFORMATION FOR RESEARCH 
 
Introduction:  You have the right to decide who may review or use your Protected Health 
Information ("PHI").  The type of information that may be used is described below. When you 
consider taking part in a research study, you must give permission for your PHI to be released from 
your doctors, clinics, and hospitals to the research team, for the specific purpose of this research 
study.   
 
What does this authorization relate to? This authorization relates to the following study: 
 
Health and Social Well-Being among Cancer Patients 
TITLE OF THE RESEARCH IRB PROTOCOL #1406239341 
Catherine Mosher, Ph.D.  
PRINCIPAL INVESTIGATOR  (in charge of Research 
Team) 
SPONSOR  # R25 CA117865-06 
  
NAME OF RESEARCH PARTICIPANT BIRTHDATE 
  
STREET ADDRESS CITY, STATE & ZIP CODE 
 
What information will be used for research purposes?  This form is to allow the release of your 
health information to be used for the research described above.  Your health information includes 
information that can identify you.  For example, it can include your name, address, phone number, 
birthday and medical record number.   
 
This permission is for health care provided to you from the time of your cancer diagnosis until the 
end of this research study.  
 
I understand the information listed below will be released and used for this research study: 
 
 Age 
 Gender 
 The date you were diagnosed with cancer 
 The type of cancer you were diagnosed with 
 The stage of the cancer 
 Your treatments for cancer (surgery, radiation, chemotherapy, or other treatments) 
 
In the event of an adverse event, such as injury related to the research, other records may be 
accessed for the purposes of your treatment and/or for reporting purposes. This may include 
records from other health care providers from which you have received medical care, but who are 
not specifically listed in this Authorization.   
 
Specific authorizations:  I understand that this release also pertains to records concerning 
hospitalization or treatment that may include the categories listed below.  I have the right to 
specifically request that records NOT be released from my health care providers to the Research 
Team.  However, I understand that if I limit access to any of the records listed below, I will still be 
able to participate in this research study. Check limitations, if any, below: 
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  Mental health records   Sexually transmitted diseases 
  Psychotherapy Notes   Alcohol / Substance abuse 
  HIV (AIDS)   Sickle Cell Anemia 
  Other: ________________________  
 
Who will be allowed to release this information? 
I authorize the following persons, groups or organizations to disclose the information described in 
this Release of Information/Authorization for the above referenced research study: 
 
 Indiana University Health: University Hospital 
 
Who can access your PHI for the study?  The people and entities listed above may share my PHI 
(or the PHI of the individual(s) whom I have the authority to represent), with the following persons 
or groups for the research study:   
 
 The researchers and research staff conducting the study at Indiana University and IU 
Health  
 Principal Investigator: Catherine Mosher, Ph.D.  
 The members and staff of the Human Subjects Office 
 The members of the Institutional Review Boards (IRB) that approve this study 
 Indiana University and/or Indiana University affiliated institutions with compliance and 
financial oversight, including but not limited to: 
 Office of Research Compliance 
 Office of Research Administration 
 HIPAA Privacy and Security Compliance Office 
 General Counsel’s Office 
 Internal Audit 
 US or foreign governments or agencies as required by law 
 Federal agencies with research oversight responsibilities including but not limited to: 
 The United States Department of Health & Human Services (DHHS) 
 Office for Human Research Protections (OHRP)  
 Office for Civil Rights (OCR) 
 National Institutes of Health (NIH)  
 Data and Safety Monitoring Boards and others authorized to monitor the conduct of the 
study  
 
Expiration date of the authorization:  This authorization is valid until the following date or event 
 
  Date:   __/__/____ 
  When the research ends and required monitoring of the study has been completed.    
  Other: __________________ [insert description of event or other circumstance.  
Examples:  one year after death; one year after you reach age 50]. 
  None, this authorization is valid indefinitely 
 
Efforts will be made to ensure that your PHI will not be shared with other people outside of the 
research study.  However, your PHI may be disclosed to others as required by law and/or to 
individuals or organizations that oversee the conduct of research studies, and these individuals or 
organizations may not be held to the same legal privacy standards as are doctors and hospitals.  
Thus, the Research Team cannot guarantee absolute confidentiality and privacy.   
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I have the right: 
1. To refuse to sign this form.  Not signing the form will not affect my regular health care 
including treatment, payment, or enrollment in a health plan or eligibility for health 
care benefits.  However, not signing the form will prevent me from participating in the 
research study above. 
 
2. To review and obtain a copy of my personal health information collected during the 
study.  However, it may be important to the success and integrity of the study that 
persons who participate in the study not be given access until the study is complete.  
The Principal Investigator has discretion to refuse to grant access to this information if 
it will affect the integrity of the study data during the course of the study. Therefore, 
my request for information may be delayed until the study is complete.   
 
3. To cancel this release of information/authorization at any time.  If I choose to cancel 
this release of information/authorization, I must notify the Principal Investigator for 
this study in writing at: Purdue School of Science, 402 North Blackford Street, LD 
124, Indianapolis, IN 46202.  However, even if I cancel this release of 
information/authorization, the Research Team, Research Sponsor(s) and/or the 
Research Organizations may still use information about me that was collected as part 
of the research project between the date I signed the current form and the date I cancel 
the authorization.  This is to protect the quality of the research results.  I understand 
that canceling this authorization may end my participation in this study.  
 
4. To receive a copy of this form. 
 
I have had the opportunity to review and ask questions regarding this release of 
information/authorization form.  By signing this release of information/authorization, I am 
confirming that it reflects my wishes. 
  
Printed name of Individual/Legal Representative  
  
Signature of Individual/Legal Representative Date 
*If signed by a legal representative; state the relationship and identify below the authority to act on behalf of the 
individual’s behalf. 
 
*Individual is:   a Minor        Incompetent       Disabled 
  Deceased 
 
*Legal Authority:      
   Custodial Parent   Legal Guardian  
   Executor of Estate of the Deceased   Power of Attorney Healthcare  
   Authorized Legal Representative    Other:      
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Appendix J. Telephone Scripts for Quantitative Study 
 
Health and Social Well-Being among Cancer Patients 
 
Note: This script is intended as a guideline only. However, research assistants must 
communicate all material included in the script.   
 
DIRECTIONS FOR RESEARCH ASSISTANT:  
 
“Hello! May I speak with ______________________ (Potential participant’s name)?” 
 
 If not available: Do not leave your name or number to call back. Just say that you 
will call back another time and ask for a good time to reach them. (If they ask, you 
may tell them you are calling from Indiana University Health about a survey.) 
 
 If available: Hello Mr./Ms. _______. My name is _________. I work at Indiana 
University Health with Dr. Mosher and Dr. Abonour. How are you doing today?  
 
I am calling to follow up on a letter we mailed to you about a survey that we are working 
on here. Did you receive our letter and study information forms?  Did you have a chance 
to read these materials? 
 
If not/does not recall receiving a letter from us: The letter we sent was asking for your 
help in an important survey being conducted at the Indiana University Health Cancer 
Center and University Hospital.  
 
Would now be a good time to speak with you regarding this study? Our conversation will 
take about 10 to 15 minutes. 
 
If no: When would be a better time for me to call? 
If refused: say, Okay.  For my records, may I ask the reason you prefer not to 
participate? [Pause and note reason—if it’s based on an inaccurate impression, correct it 
and ask if that would change their mind about participating. Try gently to have the person 
elaborate as much as possible on the reason. Document the patient’s gender, age, and race 
if s/he is willing to provide this information.] Would you be willing to provide your 
gender, age, and race for our records? Thank you.  I appreciate your time.  If you change 
your mind, feel free to call the number for this study—it’s on the letter you were sent.  
 
If yes: Continue to next section. 
 
(As you may have read in the materials we sent you. . .) We are asking you to be in this 
study because you have recently received treatment for cancer at an IU Health hospital. 
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We are doing this study to learn about cancer patients’ health and social experiences. We 
will use the information from this study to improve support services for patients in the 
future. I should tell you that the entire study is done by mail. If you are interested in 
participating in this study, we will mail you a paper survey to fill out at home and a 
postage-paid envelope for returning it to us. It will take about 10 to 20 minutes. The 
survey includes questions about your background, your mood, your physical symptoms, 
your relationships, and your experience coping with cancer. There will be no financial 
costs to you for participating in this study.  Participants will receive a $25 Target gift 
card for participating. Do you have any questions? 
 
I’m going to summarize the study information sheet and authorization form for your 
information, okay? [If patient does not have a copy of the study information sheet, say I 
will mail a copy of the study information sheet for your records (Verify address for 
mailing the Study Information Sheet. You must read the entire form if they did not 
receive it)].   
 
Your participation in this study is completely voluntary.  You may choose either to take 
part or not to take part in the study.  If you decide to take part in this study, you may 
leave the study at any time.   No matter what decision you make, there will be no penalty 
to you and you will not lose any of your regular benefits.  Leaving the study will not 
affect your medical care.    
 
Also, with your permission, we would like to collect some limited health information from 
your medical records, including your age, gender, the date you were diagnosed with 
cancer, the type of cancer you were diagnosed with, the stage of the cancer, and your 
treatment for cancer. The reason we would like to collect this information is to see how 
people’s experiences might be different based upon things like the type of treatment they 
receive. 
 
Every effort will be made to keep your information private. It is the responsibility of the 
research staff to protect your privacy.  If information from this study is used in any 
reports or publications, your name and anything else that could identify you will not be 
used.  Trained staff at Indiana University may review your study records if necessary. 
Access to your study records will be limited to those listed in the Authorization Form. 
 
It’s possible that you may experience feelings when you are completing the survey. These 
may be like the feelings you experience when talking to anyone in your life about your 
experiences with cancer. If that happens, you can always call us if you want to talk about 
it and we can refer you to services if needed.  
Your participation in this study will contribute to a better understanding of the health and 
social well-being of cancer patients, which will lead to better services for cancer patients 
in the future. You may not benefit directly from this study. 
 
You can talk to your study doctor about any questions or concerns you have about this 
study.  Contact your study doctor, Dr. Catherine Mosher, at the number listed on the 
study information sheet. If you cannot reach Dr. Mosher during regular business hours, 
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please call the IU Human Subjects office at the numbers listed on the study information 
sheet.   
 
Do you have any questions?   Do you agree to participate in this study?   
 
(Participants should state YES or NO) 
 
 
AUTHORIZATION CONSENT 
 
There is just one last form I will summarize for your information, okay? It’s called an 
Authorization form.  
 
[If patient does not have a copy of the authorization form, say I will mail a copy of the 
Authorization form for your records (Verify address for mailing the Authorization form. 
You must read the entire authorization form if they did not receive it)].   
 
I already told you about the limited information we collect from your medical records. 
This form tells you who may look at your information. That would just be the research 
team and medical staff who already have access to your records. There are also boards 
at Indiana University who may review this study to make sure your privacy is protected. 
 
Do you have any questions for me about this form? Do you agree to give us permission to 
look at your health information?  
 
(Participants should state YES or NO) 
 
Thank you for agreeing to participate! You should keep both of these forms for your 
records. You should not send them back to us.  
 
Next, we will send you an envelope in the mail with a paper survey for you to fill out at 
home. We will also include a postage-paid envelope for returning the survey to us. To 
protect your privacy, please do not put your name, address, or other information that 
could identify you on the survey or envelope.  We will use a study identification number 
on the top of the survey to identify you.  Once we have received your survey, we will mail 
your $25 Target gift card to you! Do you have any questions for me now? If you have any 
questions in the future, please feel free to call us at the number provided in the letter 
[(317) 278-4009].  
 
We greatly appreciate your interest! It was great to talk to you today. Thank you again!  
 
SCRIPT FOR LEAVING A MESSAGE 
 
Hello, this message is for_________. My name is __________ and I am calling from IU 
Health to follow-up on a letter we sent you about a research study. Please call us back to 
let us know if you are interested in participating or have questions. Our phone number is 
317-278-4009. Thank you so much!  
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Appendix K. Informed Consent Process Documentation Form for Quantitative Study 
 
IRB Protocol 1406239341: Health and Social Well-being among Cancer 
Patients 
 
Informed Consent Process Documentation for Research Assistants 
 
Study ID #:___________ 
 
I spoke with the person regarding the above-referenced study on __________. 
          (date) 
 
 The person was given information regarding study procedures, benefits, 
risks, alternatives to study participation, voluntary nature of research 
participation, confidentiality issues and ability to withdraw from study 
participation, as well as information specific to the HIPAA authorization 
form. 
 
 The person was provided adequate time and opportunity to review the 
Study Information Sheet and authorization form and all questions 
regarding information in these forms were adequately answered. 
 
 The person verbalized understanding of the contents of the Study 
Information Sheet before providing verbal consent for study participation. 
 
 No study-specific procedures were done prior to obtaining verbal consent 
for study participation. 
 
 The person was mailed a copy of the Study Information Sheet and the 
HIPAA Authorization form. 
 
 The Study Information Sheet and authorization form were the latest IRB 
approved versions. 
 
 
Additional Comments: 
___________________________________________
___________________________________________
___________________________________________
___________________________________________ 
 
Consenter’s Signature:_______________________ 
 
Date:__________________ 
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Appendix L. Survey Mailings for Quantitative Study 
 
<DATE> 
 
Dear <TITLE, NAME>, 
 
 
The physicians and staff at the Indiana University Cancer Center and other Indiana 
University Health hospitals thank you again for agreeing to participate in our study.  We 
really value your experiences! 
 
Some reminders about the survey:  
 
 To protect your privacy, remember not to put your name, address, or other 
information that could identify you on the survey or envelope.  We will use a 
study identification number on the top of the survey to identify you.  
 
 When you have completed the survey, please return it to us using the postage-paid 
envelope that is provided.  
 
 Once we have received your survey, we will mail your $25 Target gift card to 
you!  
 
If you have any questions about the study, please call the research fellow, Rebecca 
Adams, at  
(317) 278-4009.  
 
Thanks again for your participation!  
 
 
Sincerely, 
 
 
 
Catherine E. Mosher, Ph.D. 
School of Science 
Indiana University-Purdue University Indianapolis 
 
 
 
Rafat Abonour, M.D. 
Department of Medicine 
Indiana University School of Medicine 
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Study ID # _______  
IU Health Survey  
 
Please respond to each item by marking one box per row. 
 
 Excellent Very Good Good Fair Poor 
1. In general, would you say your 
health is: .... 

5 

4 

3
 

2 

1 
2. In general, would you say your 
quality of 
life is: ....................................... 
 

5 

4 

3 

2 

1 
3. In general, how would you rate 
your physical health? ....................... 
 

5 

4 

3 

2 

1 
4. In general, how would you rate 
your mental health, including your 
mood and your ability to 
think?................................................. 
 

5 

4 

3 

2 

1 
5. In general, how would you rate 
your satisfaction with your social 
activities and relationships? ............. 
 

5 

4 

3 

2 

1 
6. In general, please rate how well 
you carry out your usual social 
activities and roles. (This includes 
activities at home, at work and in 
your community, and responsibilities 
as a parent, child, spouse, employee, 
friend, etc.)............. 
 

5 

4 

3 

2 

1 
7. To what extent are you able to 
carry out your everyday physical 
activities such as walking, climbing 
stairs, carrying groceries, or moving 
a chair?............................................ 
 

5 

4 

3 

2 

1 
In the past 7 days…      
 Never Rarely Sometimes Often Always 
8. How often have you been 
bothered by emotional problems 
such as feeling anxious, depressed or 
irritable? ................................... 

 


 

 

 

 
  
None 
 
Mild 
 
Moderate 
 
Severe 
Very 
severe 
9. How would you rate your fatigue 
on average? ................................. 
 

 

 

 

 

 
149 
 
 
 
 
10. How would you rate your 
pain on average? ................... 
 




0 
No 
pain 




1 
 
 




2 




3




4 




5 




6 




7 




8 




9




10
Worst 
imaginable 
pain
Please respond to each question or statement by marking one box per row. 
 
In the past 7 days… 
  
Not at all 
 
A little bit 
 
Somewhat 
Quite a 
bit 
Very 
much 
1. How much did pain interfere with 
your day to day activities? .............. 
 
 

 


 

 

 
2. How much did pain interfere with 
work around the home? .................... 
 

 

 

 

 

 
3. How much did pain interfere with 
your ability to participate in social 
activities?.... 
 

 

 

 

 

 
4. How much did pain interfere with 
your household chores? ................... 
 


 

 

 

 

 
5. My sleep was refreshing. ............ 
 

 

 

 

 
6. I had a problem with my sleep ...... 
 

 

 

 

 
7. I had difficulty falling asleep ........ 
 

 

 

 

 
8. How run-down did you feel on 
average? ………………………….. 

 

 

 

 

 
9. How fatigued were you on 
average? ........................................ 

 

 

 

 

 
During the past 7 days… 
 
 
 
Not at all 
 
 
A little bit 
 
 
Somewhat 
 
Quite a 
bit 
 
Very 
much 
10. I feel fatigued ............................. 
 

 

 

 

 
11. I have trouble starting things 
because I am tired ............................ 

 

 

 

 

 
  
 
Very poor 
 
 
Poor 
 
 
Fair 
 
 
Good 
 
Very 
good 
12. My sleep quality was 
........................ 

 

 

 

 

 
 
 
    
150 
 
 
In the past 7 days… 
 Never Rarely Sometimes Often Always 
13. I felt worthless ............................ 
 

 

 

 

 

 
14. I felt helpless ............................... 
 

 

 

 

 

 
15. I felt depressed ............................ 
 

 

 

 

 

 
16. I felt hopeless .............................. 
 

 

 

 

 

 
17. I felt fearful ................................. 
 

 

 

 

 

 
18. I found it hard to focus on 
anything other than my anxiety ........ 
 

 

 

 

 

 
19. My worries overwhelmed me .... 
 

 

 

 

 

 
20. I felt uneasy .......................... 
 

 

 

 

 

 
     
 
 
 
In the past 7 days… 
 
 
 
 
Never 
 
 
 
Rarely 
(once) 
 
 
 
Sometimes 
(2-3 times) 
 
 
Often 
(once a 
day) 
 
Very 
often 
(several 
times a 
day) 
21. My thinking has been slow 
................. 

 

 

 
 
22. It has seemed like my brain was 
not working as well as 
usual……………… 
 

 

 

 



23. I have had to work harder than 
usual to keep track of what I was 
doing ............. 
 

 

 

 



24. I have had trouble shifting back 
and forth between different activities 
that require 
thinking………............................. 
 

 

 

 



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The following statements describe how people sometimes feel.  For each statement, please indicate 
how often you feel the way described by writing a number in the space provided. Here is an 
example: 
How often do you feel happy? 
If you never felt happy, you would respond “never”; if you always feel happy, you would respond 
“always.”  
 
NEVER 
1 
RARELY 
2 
SOMETIMES 
3 
ALWAYS 
4 
1. How often do you feel that you are “in tune” with the people around you? 
 
______ 
 
2. How often do you feel that you lack companionship? 
 
______ 
3. How often do you feel that there is no one you can turn to? 
 
______ 
4. How often do you feel alone? 
 
______ 
5. How often do you feel part of a group of friends? 
 
______ 
6. How often do you feel that you have a lot in common with the people around you? 
 
______ 
7. How often do you feel that you are no longer close to anyone? 
 
______ 
8. How often do you feel that your interests and ideas are not shared by those around you? 
 
______ 
9. How often do you feel outgoing and friendly? 
 
______ 
10. How often do you feel close to people? 
 
______ 
11. How often do you feel left out? 
 
______ 
12. How often do you feel that your relationships with others are not meaningful? 
 
______ 
13. How often do you feel that no one really knows you well? 
 
______ 
14. How often do you feel isolated from others? 
 
______ 
15. How often do you feel you can find companionship when you want it? 
 
______ 
16. How often do you feel that there are people who really understand you? 
 
______ 
17. How often do you feel shy? 
 
______ 
18. How often do you feel that people are around you but not with you? 
 
______ 
19. How often do you feel that there are people you can talk to? 
 
______ 
20. How often do you feel that there are people you can turn to? ______ 
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The following statements describe how people sometimes feel after being diagnosed with cancer.  
For each statement, please indicate how often you have felt that way by writing a number in the 
space provided. Please note that the response options are now 1 to 5. 
 
NEVER 
1 
RARELY 
2 
SOMETIMES 
3 
OFTEN 
4 
ALWAYS 
5 
 
1. Since your cancer diagnosis, how often have you felt that people are 
around you but not with you? 
 
______ 
 
2. How often do you feel left out because of your cancer? 
 
______ 
3. Since your cancer diagnosis, how often have you felt that you were not important to 
others? 
 
______ 
 4. How often do you feel that there is no one you can share the ups and downs of cancer 
with? 
 
______ 
 5. How often does having cancer make you feel empty? 
 
______ 
 6. Since your cancer diagnosis, how often have you felt misunderstood even by your 
closest friends and family members?  
 
______ 
 7.  How often do you feel that others cannot provide the support you need to deal with 
your cancer? 
 
______ 
 8. Since your cancer diagnosis, how often have you felt that you don’t 
have a lot in common with the people around you? 
 
______ 
 9. How often do you feel that you cannot share personal thoughts about cancer with 
anyone? 
 
______ 
 10. Since your cancer diagnosis, how often have you felt that you were not needed by 
others? 
 
______ 
 11. How often does having cancer make you feel alone? 
 
______ 
 12. How often do you feel that no one really understands how cancer has 
affected you? 
 
______ 
 13.  Since your cancer diagnosis, how often have you experienced a general sense of 
emptiness? 
 
______ 
 14. How often does your cancer diagnosis make you feel isolated from others? 
 
______ 
 15. Since your cancer diagnosis, how often have you felt that you are no longer close to 
anyone? 
______ 
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Please respond to each item by marking one box per row. 
 Never Rarely Sometimes Usually Always 
1. I have someone who will listen to me when I 
need to talk ..................... 

1 

2 

3
 

4
 

5
 
2. I have someone to confide in or talk to about 
myself or my problems  
 

1 

2 

3
 

4
 

5
 
3. I have someone who makes me feel 
appreciated ........................ 

1 

2 

3
 

4
 

5
 
4. I have someone to talk with when I have a 
bad day ....................... 

1 

2 

3
 

4
 

5
 
5. Do you have someone to help you if you are 
confined to bed? ........... 

1 

2 

3
 

4
 

5
 
6. Do you have someone to take you to the 
doctor if you need it? ............. 

1 

2 

3
 

4
 

5
 
7. Do you have someone to help with your 
daily chores if you are sick? .... 
 

1 

2 

3
 

4
 

5
 
8. Do you have someone to run errands if you 
need it? ................... 

1 

2 

3
 

4
 

5
 
Sometimes, even when people have good intentions, they may say or do things that upset you.  
Think about the PAST WEEK and indicate how often other people did the following things.   
 
In the past 7 days… 
 
Almost 
never 
    
Almost 
always 
1. How often did you feel as though you had to 
keep your feelings about your cancer to 
yourself because they made other people 
uncomfortable? 
 

1 

2 

3
 

4
 

5
 
2. How often did you feel that you could 
discuss your feelings about your cancer with 
other people when you wanted to? 
 

1 

2 

3
 

4
 

5
 
3. When you talked about your cancer, how 
often did other people give you the idea they 
didn’t want to hear about it? 
 

1 

2 

3
 

4
 

5
 
4. How often did you feel that other people let 
you down by not showing you as much love 
and concern as you would have liked? 
 

1 

2 

3

4
 

5
 
5. How often have other people really got on 
your nerves? 
 

1 

2 

3

4

5
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Please respond to each item by marking one box per row. 
 
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
1. If people stopped asking 
about my cancer, I would 
think that they don’t care… 
 

 
 

 
 

 
 

 
 

 
 

 
 
2. People will not understand 
if I share my concerns about 
cancer……………………. 
 

 
 

 
 

 
 

 
 

 
 

 
 
3. If I shared my concerns 
about cancer with people then 
it would be too hard on them.. 
 

 
 

 
 

 
 

 
 

 
 

 
 
4. People would not 
understand my thoughts about 
death since my cancer 
diagnosis ……………… 
 

 
 

 
 

 
 

 
 

 
 

 
 
5. I expect people to always 
be available for me because 
of my cancer ……………… 
 

 
 

 
 

 
 

 
 

 
 

 
 
6. If I told people about my 
cancer experience, they 
would be nervous and 
uncomfortable around me…. 
 

 
 

 
 

 
 

 
 

 
 

 
 
7. If people avoided 
discussing my cancer with 
me, I would think that they 
didn’t want to hear about it … 
 

 
 

 
 

 
 
 
 
 

 
 

 
 
8. People could not truly 
understand how I feel about 
my cancer diagnosis …… 
 

 
 

 
 

 
 

 
 

 
 

 
 
9. I would burden people if I 
shared my thoughts and 
feelings about cancer with 
them…………………….. 
 

 
 

 
 

 
 

 
 

 
 

 
 
10. People would not 
understand my uncertainty 
about the future since my 
cancer diagnosis…………. 

 
 

 
 

 
 

 
 

 
 

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Strongly 
disagree 
 
Moderately 
disagree 
 
Slightly 
disagree 
 
Slightly 
agree 
 
Moderately 
agree 
 
Strongly 
agree 
11. I expect people to listen to 
me whenever I want to talk 
about my cancer …………..... 
 

 
 

 
 

 
 

 
 

 
 

 
 
12. If I told people about my 
cancer experience, our 
relationship would change for 
the worse ……………… 
 

 
 

 
 

 
 

 
 

 
 

 
 
13. If people avoided seeing 
or talking to me after my 
cancer diagnosis, I would 
think that they don’t care ….. 
 

 
 

 
 

 
 

 
 

 
 

 
 
14. If I shared my concerns 
about cancer with people then 
they might hurt me with their 
reactions………………….. 

 
 

 
 

 
 

 
 

 
 

 
 
 
General Information 
1. How many relatives do you see or talk to at least once every 2 weeks? ____ 
(If you are not sure, please give your best guess.) 
 
2. How many friends do you see or talk to at least once every 2 weeks? ____ 
(If you are not sure, please give your best guess.) 
3. If you are currently employed, how many co-workers do you see or talk to at least once  
every 2 weeks? ____   
(If you are not currently employed, please skip to question #4.) 
 
4. How many cancer patients or survivors do you see or talk to at least once every 2 weeks? 
____ 
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5. How many cancer patients or survivors do you know that you feel comfortable sharing 
your experiences with? ____ 
 
6. On a scale from 1-10, how would you rate the overall quality of your relationships?   
           1           2           3           4               5              6             7            8             9            10 
       (worst quality you can imagine)                                                                 (best quality you can imagine) 
 
7. Have you attended a support group for cancer patients?   ____ Yes   _____No 
 
8. What race or ethnicity do you consider yourself to be?         
      ___White  ___Black or African American    ___Asian-American or Pacific Islander 
        ___Native American    ___Hispanic or Latino       ___Multi-racial  
              ___Other (please specify)__________________________  
 
9. Marital Status (check one)    
      ___Single ___Living with partner     ___Married ___Separated        ___Divorced             
___Widowed 
 
10. Employment status (check one)    
___Employed full-time ___Employed part-time       ___Student     ___Homemaker        
___Retired       ___Unemployed, looking for work     ___Unemployed due to disability 
            ___Other (please specify) ______________________________ 
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11. What is the highest grade or year of school you completed?     
___Never attended school or only attended kindergarten  
___Grades 1 through 8 (Elementary)  
___Grades 9 through 11 (Some high school)  
___Grade 12 or GED (High school graduate)  
___College 1 year to 3 years (Some college or technical school)  
___ College 4 years or more (College graduate)  
___ Graduate school (Master’s degree, Doctorate, etc.)  
 
12. Do you have health insurance coverage now?       
    ____Yes        _____   No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THANK YOU FOR YOUR PARTICIPATION! 
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Appendix M. Quantitative Study Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure M1.  
 
Quantitative Study Flow Chart 
 
Note. Multiple reasons could be selected for non-participation.  
# declined participation 
for the following 
reasons (n=47): 
- Opted out before we 
called (n=3) 
- No time (n=9) 
- Lack of interest 
(n=20) 
- Concerned about 
privacy (n=7) 
- Not feeling well 
enough emotionally 
or physically (n=7) 
- Don’t know (n=5) 
- Other (n=1) 
# unable to contact for 
the following reasons 
(n=82): 
- Did not answer 
phone after 15 calls 
(n=52) 
- Address or phone 
number incorrect, or 
phone disconnected  
(n=19) 
- Family member 
would not allow us 
to speak to patient 
(n= 10) 
- Other (n=2) 
 
# consented to participate (n=215) 
# returned surveys (n=186) 
# lost to follow-up 
(n=27) 
# withdrawn or 
deceased (n=2) 
# discovered to be 
ineligible after phone 
call for the following 
reasons: (n=36): 
- Deceased (n=16) 
- Cognitive 
impairment (n=1) 
- Vocal/auditory/visual 
impairment (n=6) 
- Cannot read or write 
(n=1) 
- Cannot read or speak 
English (n=9) 
- Believed they did not 
have cancer (n=3) 
# sent introductory mailing (n=380) 
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Appendix N. Sample Characteristics and Preliminary Analyses for Quantitative Study 
 
Table N2.  
 
Sample Characteristics (N = 186) 
 
Characteristic 
 
N (%) M (SD) Range 
Average age 
 
 59.3 (12.6) 21.0-87.0 
Female gender 
 
95 (51.1)   
Race/ethnicity 
  White 
  Black or African American 
  Multi-racial 
  Hispanic or Latino 
  Asian-American or Pacific Islander 
 
 
138 (74.2) 
 41 (22.0) 
3 (1.6) 
2 (1.1) 
2 (1.1) 
  
Marital status 
  Married/living with  partner 
  Divorced, separated, or widowed 
  Never married 
 
126 (67.7) 
39 (21.0) 
21 (11.3) 
  
  
Education level 
  Elementary or some high school 
  High school graduate 
  Some college or technical school 
  College graduate 
   
 
14 (7.5) 
 63 (33.9) 
 56 (30.1) 
 53 (28.5) 
  
Employment status 
  Employed full or part-time 
  Retired 
  Unemployed due to disability 
  Homemaker   
  Unemployed, looking for work 
  Student 
  Other 
  Missing 
 
 
 
 
 
 
 
Table N2 continued next page. 
 
77 (41.4) 
64 (34.4) 
31 (16.7) 
6 (3.2) 
3 (1.6) 
2 (1.1) 
2 (1.1) 
1 (0.5) 
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Table N2 continued. 
 
Characteristic  N (%) M (SD) Range 
Cancer stage 
  Early stage 
  Late stage 
  N/A staging system 
  Missing 
 
 117 (62.9) 
  46 (24.7) 
 9 (4.8) 
14 (7.5) 
  
 
Months since diagnosis 
 
  
16.7 (3.2) 
 
1.0-24.3 
Treatments received 
  Surgery 
  Chemotherapy 
  Radiation  
  Hormone therapy 
  Immunotherapy 
  Stem cell transplant 
  Other 
 
154 (82.8) 
  71 (38.2) 
  61 (32.8) 
 36 (19.4) 
  15 (8.1) 
4 (2.2) 
2 (1.1) 
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Table N3.  
 
Descriptive Statistics for Health and Social Well-being Variables (N=186) 
 
Variable n Mean Standard 
deviation 
Range Skew Kurtosis t-scorea 
Cancer-related 
loneliness 
 
185 13.7  6.6 7.0-35.0  0.99   0.30  
Negative social 
expectations 
 
185 13.9  6.9 5.0-30.0  0.32  -0.91  
Emotional social 
support 
 
184 17.0  3.7 4.0-20.0 -1.3   1.0  
Depression 
 
185  7.1  3.5 4.0-18.0  1.0   0.0 51.0 
Anxiety 
 
185  7.3  3.4 4.0-19.0  1.0   0.3 51.5 
Pain 
 
185  7.8  4.5 4.0-20.0  0.9  -0.4 51.7 
Fatigue 
 
185  9.8  4.0 4.0-20.0  0.5  -0.5 52.4 
Sleep disturbance 
 
185  9.9  3.9 4.0-20.0  0.5  -0.4  
Mental quality of life 
 
186 14.2  3.1 6.0-20.0 -0.4  -0.3  
Physical quality of life 
(4-item) 
 
186 12.3  2.3 6.0-17.0 -0.5  -0.4  
Physical quality of life 
(3-item) 
 
186 10.1 2.7 3.0-15.0 -0.4 -0.5  
Social constraints 
 
185  9.5  4.2 5.0-25.0  1.2   1.1  
Loneliness 
 
184 37.0 11.3 20.0-78.0  0.5  -0.1  
Num. relatives 
 
183  5.9  4.3 0.0-30.0  2.6  11.0  
Num. relatives 
(winsorized) 
 
183  5.8  3.6 0.0-18.7  1.4   2.8  
Num. friends 
 
182  7.9 11.1 0.0-100.0  4.5 29.0  
Table N3 continued next page. 
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Table N3 continued. 
 
            
Variable n Mean Standard 
deviation 
Range Skew Kurtosis t-scorea 
Num. friends  
(winsorized) 
 
182 7.4 8.3 0.0-41.2 2.3 6.2  
Num. coworkers 
 
77 12.4 13.0 0.0-60.0  1.9   3.5  
Num. coworkers 
(winsorized) 
 
77 12.3 12.6 0.0-51.6  1.8   2.8  
Num. cancer patients 
 
177  1.6  2.5 0.0-25.0  5.6 45.3  
Num. cancer patients 
(winsorized) 
177  1.5  1.7 0.0-9.2  1.7   4.4  
Note.  
aT-scores are provided when the representative cancer patient sample data were available 
for calibration. See www.nihpromis.com for more information.  
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Appendix O. Proposed Confirmatory Factor Analysis Models 
 
 
 
 
Figure O2.  
 
Cancer Loneliness Scale (Unidimensional) 
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Figure O3.  
 
Cancer-related Negative Social Expectations Scale (5-dimensional) 
 
Note. Horizontal lines indicate that the pathways were constrained to be equal.  
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Figure O4.  
 
Cancer-related Negative Social Expectations Scale (4-dimensional) 
 
Note. The horizontal line indicates that the pathways were constrained to be equal.  
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Figure O5.  
 
Cancer-related Negative Social Expectations Scale (Unidimensional) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
167 
 
 
Appendix P. Quantitative Study Results 
 
Table P4.  
 
Descriptive Statistics for Cancer Loneliness Scale Items 
 
Item M SD Item-total 
correlation 
1. Since your cancer diagnosis, how often have you felt that 
people are around you but not with you? 
 
2.2 1.2 0.79 
2. How often do you feel left out because of your cancer? 
 
1.7 1.0 0.73 
3. Since your cancer diagnosis, how often have you felt that 
you were not important to others? 
 
1.7 1.0 0.82 
4. How often do you feel that there is no one you can share 
the ups and downs of cancer with? 
 
2.0 1.2 0.81 
5. How often does having cancer make you feel empty? 
 
2.1 1.2 0.78 
6. Since your cancer diagnosis, how often have you felt 
misunderstood even by your closest friends and family 
members? 
 
2.0 1.2 0.86 
7. How often do you feel that others cannot provide the 
support you need to deal with your cancer? 
 
1.9 1.2 0.79 
8. Since your cancer diagnosis, how often have you felt that 
you don’t have a lot in common with the people around 
you? 
 
1.9 1.0 0.73 
9. How often do you feel that you cannot share personal 
thoughts about cancer with anyone? 
 
2.1 1.2 0.82 
10. Since your cancer diagnosis, how often have you felt 
that you were not needed by others? 
 
1.8 1.1 0.82 
11. How often does having cancer make you feel alone? 
 
2.0 1.1 0.83 
12. How often do you feel that no one really understands 
how cancer has affected you? 
 
2.5 1.4 0.84 
13. Since your cancer diagnosis, how often have you 
experienced a general sense of emptiness? 
 
2.1 1.1 0.81 
14. How often does your cancer diagnosis make you feel 
isolated from others? 
 
2.0 1.1 0.86 
15. Since your cancer diagnosis, how often have you felt 
you are no longer close to anyone? 
1.7 1.0 0.81 
Note. All ns= 185. All ranges = 1.0-5.0.
 
 
 
 
 
Table P5.  
 
Inter-item Correlations for the Cancer Loneliness Scale Item Pool 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. —               
2. 0.60 —              
3. 0.67 0.65 —             
4. 0.71 0.57 0.71 —            
5. 0.58 0.70 0.63 0.52 —           
6. 0.70 0.67 0.73 0.76 0.66 —          
7. 0.64 0.57 0.69 0.73 0.60 0.74 —         
8. 0.57 0.55 0.63 0.60 0.62 0.63 0.58 —        
9. 0.67 0.56 0.70 0.74 0.61 0.77 0.66 0.65 —       
10. 0.65 0.60 0.80 0.75 0.57 0.74 0.66 0.60 0.72 —      
11. 0.70 0.60 0.65 0.65 0.76 0.72 0.63 0.55 0.68 0.68 —     
12. 0.68 0.59 0.67 0.76 0.68 0.78 0.73 0.67 0.74 0.71 0.71 —    
13. 0.64 0.58 0.66 0.59 0.79 0.67 0.63 0.62 0.67 0.65 0.80 0.70 —   
14. 0.73 0.69 0.71 0.66 0.75 0.74 0.61 0.64 0.72 0.71 0.81 0.73 0.77 —  
15. 0.70 0.62 0.71 0.65 0.66 0.66 0.69 0.58 0.65 0.69 0.76 0.63 0.66 0.75 — 
Note. All ns=185. All ps<0.01. 
 
 
 
 
 
 
 
 
 
1
6
8
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Table P6.  
 
Item Selection for the Cancer Loneliness Scale 
 
Items grouped by content Item-total 
correlations 
Item 
retained 
1. Since your cancer diagnosis, how often have you felt 
that people are around you but not with you? 
 
2. How often do you feel left out because of your 
cancer? 
 
11. How often does having cancer make you feel 
alone? 
 
14. How often does your cancer diagnosis make you 
feel isolated from others? 
 
15. Since your cancer diagnosis, how often have you 
felt you are no longer close to anyone? 
0.79 
 
 
0.73 
 
0.83 
 
0.86 
 
 
0.81 
#14 
3. Since your cancer diagnosis, how often have you felt 
that you were not important to others? 
 
10. Since your cancer diagnosis, how often have you 
felt that you were not needed by others? 
0.82 
 
 
0.82 
 
#10a 
4. How often do you feel that there is no one you can 
share the ups and downs of cancer with? 
 
9. How often do you feel that you cannot share 
personal thoughts about cancer with anyone? 
0.81 
 
 
0.82 
 
#9 
5. How often does having cancer make you feel empty? 
 
13. Since your cancer diagnosis, how often have you 
experienced a general sense of emptiness? 
0.78 
 
0.81 #13 
6. Since your cancer diagnosis, how often have you felt 
misunderstood even by your closest friends and family 
members? 
0.86 
#6 
7. How often do you feel that others cannot provide the 
support you need to deal with your cancer? 
0.79 
#7 
8. Since your cancer diagnosis, how often have you felt 
that you don’t have a lot in common with the people 
around you? 
0.73 
#8 
12. How often do you feel that no one really 
understands how cancer has affected you? 
0.84 
Noneb 
aItem #10 was selected after examining additional indicators of item performance (e.g., 
distribution of participant responses).  
bAlthough item #12 performed well, I decided to exclude it because the content is too 
similar to items in the Cancer-related Negative Social Expectations item pool.  
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Figure P6.  
 
Test of the Cancer-related Loneliness Model 
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Table P7.  
 
Descriptive Statistics for the Cancer-related Negative Social Expectations Scale Items 
 
Item n M SD Item-total 
correlation 
1. If people stopped asking about my cancer, I would think 
that they don’t care. 
 
185 2.0 1.4 0.56 
2. People will not understand if I share my concerns about 
cancer. 
 
185 2.4 1.5 0.71 
3. If I shared my concerns about cancer with people then it 
would be too hard on them.  
 
185 2.5 1.5 0.69 
4. People would not understand my thoughts about death 
since my cancer diagnosis. 
 
185 2.9 1.7 0.75 
5. I expect people to always be available for me because of 
my cancer. 
 
185 2.0 1.4 0.16 
6. If I told people about my cancer experience, they would 
be nervous and uncomfortable around me. 
 
185 2.3 1.4 0.79 
7. If people avoided discussing my cancer with me, I would 
think that they didn’t want to hear about it. 
 
185 2.7 1.6 0.67 
8. People could not truly understand how I feel about my 
cancer diagnosis.  
 
185 3.1 1.8 0.77 
9. I would burden people if I shared my thoughts and 
feelings about cancer with them. 
 
185 2.7 1.6 0.76 
10. People would not understand my uncertainty about the 
future since my cancer diagnosis.  
 
185 3.0 1.8 0.78 
11. I expect people to listen to me whenever I want to talk 
about my cancer. 
 
185 2.6 1.7 0.29 
12. If I told people about my cancer experience, our 
relationship would change for the worse.   
 
185 1.7 1.2 0.57 
13. If people avoided seeing or talking to me after my 
cancer diagnosis, I would think that they don’t care.  
 
185 2.4 1.6 0.65 
14. If I shared my concerns about cancer with people then 
they might hurt me with their reactions. 
185 1.8 1.2 0.64 
 
 
 
 
Table P5. 
 
 Inter-item Correlations for the Cancer-related Negative Social Expectations Scale 
 
 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 
1. —              
2. 0.44** —             
3. 0.45** 0.61** —            
4. 0.43** 0.70** 0.70** —           
5. 0.13 0.01 0.06 0.00 —          
6. 0.43** 0.63** 0.68** 0.67** 0.10 —         
7. 0.46** 0.43** 0.42** 0.49** 0.12 0.62** —        
8. 0.44** 0.61** 0.57** 0.67** 0.16* 0.60** 0.56** —       
9. 0.40** 0.61** 0.65** 0.70** 0.07 0.72** 0.61** 0.69** —      
10. 0.42** 0.64** 0.61** 0.70** 0.14 0.66** 0.55** 0.72** 0.69** —     
11. 0.33** 0.15* 0.04 0.08 0.33** 0.18* 0.26** 0.20** 0.10 0.21** —    
12. 0.31** 0.50** 0.48** 0.48** 0.12 0.51** 0.40** 0.45** 0.50** 0.41** 0.14* —   
13. 0.42** 0.46** 0.37** 0.46** 0.11 0.53** 0.58** 0.51** 0.45** 0.53** 0.45** 0.40** —  
14. 0.37** 0.48** 0.45** 0.52** 0.06 0.58** 0.45** 0.54** 0.50** 0.54** 0.22** 0.46** 0.52** — 
Note. Ns=185-186.  
* p<0.05 
**p<0.0 
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Figure P7.  
 
Test of the 5-dimensional Cancer-related Negative Social Expectations Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D1	
1	 7	 13	 2	 8	 4	 10	 3	 9	 6	 12	 14	
D2	 D3	 D4	 D5	
1 11	 1	 1	
0.59	 0.78	 0.73	 0.79	 0.75	 0.85	 0.82	 0.80	 0.81	 0.87	 0.61	 0.66	
0.65	 0.39	 0.46	 0.38	 0.43	 0.28	 0.32	 0.37	 0.34	 0.25	 0.63	 0.56	
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Table P9.  
 
Standardized Psi Correlation Matrix for the 5-dimensional Cancer-related Negative 
Social Expectations Scale 
 
Domain 1 2 3 4 5 
1 —     
2 0.85 —    
3 0.80 1.05 —   
4 0.79 1.00 1.01 —  
5 0.88 0.94 0.91 0.98 — 
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Figure P8.  
 
Test of the 4-dimensional Cancer-related Negative Social Expectations Model 
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Figure P9.  
 
Test of the Unidimensional Cancer-related Negative Social Expectations Model 
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Table P10.  
 
Fit indices for the Cancer-related Negative Social Expectations Models 
 
Model Fit Indices 
 SRMR RMSEA CFI 
5-dimensional model 0.06 0.07 0.99 
4-dimensional model 0.04 0.07 0.99 
Unidimensional model (12 items) 0.04 0.09 0.94 
Unidimensional model (5 items) 0.02 0.11 0.98 
Note. SRMR= standardized root mean square residual. RMSEA= root mean square error 
of approximation. CFI= comparative fit index.  
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Table P11. 
 
 Item Selection for the Cancer-related Negative Social Expectations Scale 
 
Domain Items Item-total 
correlations 
Item 
retained 
1: Expecting 
others to listen or 
be available 
whenever the 
patient needs 
them.   
1. If people stopped asking about my cancer, I 
would think that they don’t care. 
 
5. I expect people to always be available for me 
because of my cancer. 
 
7. If people avoided discussing my cancer with 
me, I would think that they didn’t want to hear 
about it. 
 
11. I expect people to listen to me whenever I 
want to talk about my cancer. 
 
13. If people avoided seeing or talking to me after 
my cancer diagnosis, I would think that they 
don’t care.  
 
0.56 
 
 
0.16 
 
 
0.67 
 
 
 
0.29 
 
 
0.65 
#7 
2: Expecting a 
lack of 
understanding of 
cancer-related 
concerns 
2. People will not understand if I share my 
concerns about cancer. 
 
8. People could not truly understand how I feel 
about my cancer diagnosis.  
 
0.71 
 
 
0.77 
#8 
3: Expecting that 
others will not 
understand 
existential 
thoughts.   
4. People would not understand my thoughts 
about death since my cancer diagnosis. 
 
10. People would not understand my uncertainty 
about the future since my cancer diagnosis.  
 
0.75 
 
 
0.78 
#10 
4: Expecting 
sharing cancer-
related concerns 
to burden others.   
3. If I shared my concerns about cancer with 
people then it would be too hard on them.  
 
9. I would burden people if I shared my thoughts 
and feelings about cancer with them. 
 
0.69 
 
 
0.76 
#9 
5: Expecting 
telling others 
about their 
diagnosis or 
cancer-related 
concerns to 
change their 
relationship for 
the worse.   
6. If I told people about my cancer experience, 
they would be nervous and uncomfortable around 
me. 
 
12. If I told people about my cancer experience, 
our relationship would change for the worse.   
 
14. If I shared my concerns about cancer with 
people then they might hurt me with their 
reactions. 
 
0.79 
 
 
 
0.57 
 
 
0.64 
#6 
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Figure P10.  
 
Test of the Final Cancer-related Negative Social Expectations Scale Model 
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Table P12. 
 
 Correlations for Assessment of Construct Validity 
 
 
Cancer-related 
Loneliness 
Cancer-related Negative 
Social Expectations 
Cancer-related Negative 
Social Expectations —   0.70** 
 
Emotional Support -0.66** -0.48** 
 
Depression  0.54**   0.41** 
 
Anxiety  0.55**   0.41** 
 
Pain  0.50**   0.36** 
 
Fatigue  0.45**   0.39** 
 
Sleep Disturbance  0.51**   0.43** 
 
Mental Quality of Life -0.54** -0.43** 
 
Physical Quality of Life 
(4-item) -0.24** -0.25** 
 
Physical Quality of Life 
(3-item) -0.33** -0.31** 
 
Social Constraints 
 
 0.80** 
 
  0.67** 
 
General Loneliness  0.67**   0.47** 
 
Num. Relatives 
 
               -0.12 
 
— 
 
Num. Relatives 
(winsorized)  0.41** — 
 
Num. Friends                -0.19* — 
 
Num. Friends (winsorized)   0.44** — 
 
Num. Coworkers (n=77)  0.26** — 
 
Num. Coworkers (n=77, 
winsorized)                -0.14 — 
 
Num. Cancer Patients -0.21** — 
 
Num. Cancer Patients 
(winsorized)                -0.14 — 
Note. N=186 unless otherwise specified.  
*p < 0.05. **p < 0.01.
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2. Cohee, A.A., Adams, R.N., Von Ah, D., Monahan, P., Zoppi, K., Fife, 
B.,…Champion, V.L. (in press). Relationship between depressive symptoms and 
social cognitive processing in partners of long-term breast cancer survivors. Quality 
of Life Research. 
 
3. Adams, R.N., Mosher, C.E., Abonour, R., Robertson, M.J., Champion, V.L., & 
Kroenke, K. (in press). Cognitive and situational precipitants of cancer patients’ 
loneliness: A qualitative analysis. Oncology Nursing Forum.  
 
4. Winger, J.G., Adams, R.N., & Mosher, C.E. (2016). Relations of meaning in life 
and sense of coherence to distress in cancer patients: A meta-analysis. Psycho-
Oncology, 25, 2-10. doi: 10.1002/pon.3798 
 
5. Mosher, C.E., Adams, R.N., Helft, P.R., O’Neil, B.H., Shahda, S., Rattray, N.A., 
& Champion, V.L. (2015). Family caregiving challenges in advanced colorectal 
cancer: Patient and caregiver perspectives. Supportive Care in Cancer. Advance 
online publication. doi: 10.1007/s00520-015-2995-z 
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6. Cohee, A.A., Adams, R.N., Johns, S.A., Von Ah., D., Zoppi, K., Fife, B., . . . 
Champion, V.L. (2015). Fear of recurrence in long-term breast cancer survivors 
and partners. Psycho-Oncology. Advance online publication. doi: 
10.1002/pon.4008 
 
7. Adams, R.N., Winger, J.G., & Mosher, C.E. (2015). A meta-analysis of the 
relationship between social constraints and distress in cancer patients. Journal of 
Behavioral Medicine, 38, 294-305. doi: 10.1007/s10865-014-9601-6 
 
8. Adams, R.N., Mosher, C.E., Blair, C.K., Snyder, D.C., Sloane, R., & Demark-
Wahnefried, W. (2015). Cancer survivors’ uptake and adherence in diet and 
exercise intervention trials: An integrative data analysis. Cancer, 121, 77-83. doi: 
10.1002/cncr.28978 
 
9. Adams, R.N., Mosher, C.E., Cannady, R.S., Lucette, A., & Kim, Y. (2014). 
Caregiving experiences predict changes in spiritual well-being among family 
caregivers of cancer patients. Psycho-Oncology, 23, 1178-1184. doi: 
10.1002/pon.3558 
 
10. Santoro, M.S., Van Liew, C., Cronan, T.A., Franks, H.M., Adams, R.N., Roesch, 
S.C., Wooldridge, J.S., & Tomita, M. (2014). Physical function and quality of well-
being in fibromyalgia: The applicability of the goodness-of fit hypothesis. Health 
Psychology and Behavioral Medicine, 2, 496-508. doi: 
10.1080/21642850.2014.905205 
 
11. Santoro, M.S., Cronan, T.A., Adams, R.N., & Kothari, D.J. (2012). The 
relationship between fibromyalgia and hysterectomy: The impact on health status 
and health care costs. Clinical Rheumatology, 31, 1585-1589. doi: 10.1007/s10067-
012-2051-z 
 
12. Franks, H.M., Cronan, T.A., Santoro, M.S., Roesch, S.C., Devos-Comby, L., 
Wooldridge, J.S., & Adams, R.N. (2012). Is coping goodness-of-fit related to 
depression and mood disturbance in women with fibromyalgia syndrome? Journal 
of Musculoskeletal Pain, 20, 183-193. doi: 10.3109/10582452.2012.704144 
 
13. Freberg, K., Adams, R., McGaughey, K., & Freberg, L. (2010). The rich get richer: 
Online and offline social connectivity predicts subjective loneliness. Media 
Psychology Review, 3, 103-115.  
 
Manuscripts Submitted for Publication 
14. Cohee, A.A., Adams, R.N., Von Ah, D., Monahan, P., Zoppi, K., Fife, 
B.,…Champion, V.L. (under review). Relationship between depressive symptoms 
and social cognitive processing in partners of long-term breast cancer survivors. 
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Posters Presented at Scientific Meetings  
 
With published abstract proceedings:  
 
1. Adams, R.N., Cohee, A.A., & Champion, V.L. (2015). The impact of social 
constraints from health providers on breast cancer survivors’ symptom burden. 
Poster presented at the 2015 Society of Behavioral Medicine Annual Meeting, San 
Antonio, TX. 
 
2. Winger, J.G., Adams, R.N., & Mosher, C.E. (2015). Relations of meaning in life 
and sense of coherence to distress in cancer patients: A meta-analysis. Poster 
presented at the 2015 Society of Behavioral Medicine Annual Meeting, San 
Antonio, TX.  
 
3. Adams, R.N., Mosher, C.E., & Ostroff, J.S. (2013). Caregiving burden, alcohol 
use, smoking, and distress among family caregivers of lung cancer patients. Annals 
of Behavioral Medicine, 45 s104. Poster presented at the 2013 Society of 
Behavioral Medicine Annual Meeting, San Francisco, CA. 
 
4. Adams, R.N., Wooldridge, J.S., & Cronan, T.A. (2012). Does appraised risk and 
susceptibility mediate the relationship between health locus of control and 
intentions to be screened for CRC? Annals of Behavioral Medicine, 43, s5. Poster 
presented at the 2012 Society of Behavioral Medicine Annual Meeting, New 
Orleans, LA.  
 
5. Adams, R., Brown, K., Santoro, M., & Cronan, T. (2011). The effects of ethnicity 
and educational level on willingness to pay a health care advocate. Annals of 
Behavioral Medicine, 41, s115. Poster presented at the 2011 Society of Behavioral 
Medicine Annual Meeting, Washington D.C. 
 
Without proceedings: 
(*Student/Mentee work) 
 
6. Adams, R.N. & Mosher, C.E. (2015). Cognitions related to cancer patients’ 
loneliness: A qualitative analysis. Poster presented at the 2015 Association of 
Psychological Science Convention, New York, NY.  
 
7. *Stout, M., Adams, R.N., & Mosher, C.E. (2015). Associations between loneliness 
and cancer patients’ pain and fatigue. Poster presented at the 2015 IUPUI Research 
Day, Indianapolis, IN. 
  
8. Adams, R.N. & Mosher, C.E. (2014). The relationship between social constraints and 
distress among cancer patients: A meta-analysis. Poster presented at the 2014 Indiana 
University Simon Cancer Center Cancer Research Day, Indianapolis, IN. 
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9. Adams, R.N. & Mosher, C.E. (2014). The relationship between social constraints and 
distress among cancer patients: A meta-analysis. Poster presented at the 2014 Society 
of Behavioral Medicine Annual Meeting, Philadelphia, PA. 
 
10. Adams, R.N., Mosher, C.E., & Ostroff, J.S. (2013). Caregiving burden, alcohol use, 
smoking, and distress among family caregivers of lung cancer patients. Poster 
presented at the 2013 Indiana University Simon Cancer Center Cancer Research Day, 
Indianapolis, IN. 
 
11. Freberg, K., Adams, R., McGaughey, K., Blume, M., Werter, B., Menon, A. Rust, 
M., & Freberg, L. (2010). Leaders or snakes in suits: Perceptions of today’s CEOs. 
Poster presented at the Association of Psychological Science Convention, Boston, 
MA. 
 
12. Williams, J., Blume, M., & Adams, R. (2010). Uniform color affects attributions of 
success in sporting teams. Poster presented at the Association of Psychological 
Science Convention, Boston, MA. 
 
13. Ainley, B., Freberg, K., Adams, R., Enrique, C., & Freberg, L. (2009). Loneliness 
predicts perceptions and use of social networking sites. Poster presented at the 
Association of Psychological Science Convention, San Francisco, CA. 
 
 
Membership in Professional Associations 
2011-Present Student member of the American Psychological Association, 
Division 38 (Health Psychology) 
 
2010-Present Student member of the Society of Behavioral Medicine 
 
2008-2011; 
2014-Present 
 
Student member of the Association of Psychological Science 
 
2008-Present Psi Chi, the National Honor Society in Psychology 
 
Editorial Activities: Mentored Ad Hoc Reviews 
December 
2015 
Palliative and Supportive Care 
November 
2015 
Palliative and Supportive Care 
February 
2015 
Journal of Behavioral Medicine 
October 2014 Psycho-Oncology 
April 2014 Journal of Pain and Symptom Management 
 
May 2013 Psycho-Oncology 
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February 
2013 
Journal of Health Psychology 
 
May 2012 Sex Roles 
 
August 2010 Cyberpsychology, Behavior, and Social Networking 
 
Research Experience 
August 2011-
Present 
Graduate Research Assistant 
 Indiana University-Purdue University Indianapolis, Behavioral 
Oncology Laboratory 
 Duties: Screen cancer patients for study 
eligibility, consent patients at the 
Indiana University Simon Cancer 
Center, University Hospital, and VA, 
conduct phone assessments with study 
participants, supervise undergraduate 
students, review grant proposals, and 
assist with data analyses and 
manuscript preparation.  
 Supervisor:                  Catherine E. Mosher, Ph.D. 
July 2010-July 
2011 
Research Assistant 
 San Diego State University, Health Outcome Studies Lab 
 Duties: Trained and supervised the 
undergraduate RAs in data collection 
and input. Assisted in the preparation 
of a grant proposal for a healthcare 
intervention and co-authored 
manuscripts related to coping in 
fibromyalgia patients. 
 Supervisor: Terry A. Cronan, Ph.D. 
June 2009-
June 2010 
Senior Project Research Assistant 
 California Polytechnic State University, San Luis Obispo, SLO 
Perception and Attention Lab 
 Duties: Developed and conducted an original 
research study on mood and visual 
information processing. Created the 
protocol using SuperLab experimental  
software, scheduled/ran participants, 
analyzed data, and wrote final Senior 
Project paper. 
 Supervisor: Jason A. Williams, Ph.D. 
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October 2008-
June 2010 
Undergraduate Research Assistant 
 California Polytechnic State University, San Luis Obispo, Laura 
Freberg’s Lab 
 Duties: Assisted with data coding and input, 
questionnaire construction, 
interviewing participants, conducting 
Block’s Q-sort, literature compilation, 
and manuscript preparation. 
 Supervisor: Laura A. Freberg, Ph.D. 
 
 
  
Selected Workshops and Training Experiences in Research and 
Writing 
September 
2014 
Mediation, Moderation, and Conditional Process Analysis Workshop 
(2 days) 
Andrew F. Hayes, Ph.D., Professor, The Ohio State University  
 
June 2014 Dyadic Data Analysis Workshop (5 days) 
Deborah Kashy, Ph.D., Professor, Michigan State University 
 
August 2013 Introduction to Meta-analysis Workshop (3 days) 
Noel Card, Ph.D., Associate Professor, University of Arizona 
 
August 2013-
June 2015 
Cancer Control Educational Series 
Monthly lectures on research topics related to cancer prevention and 
control.  
 
July 2013 Writing from the Reader’s Perspective 
George D. Gopen, PhD., Professor Emeritus, Duke University 
 
July 2013 Grant Writers’ Seminars and Workshops 
David C. Morrison, Ph.D., Professor, University of Missouri Kansas 
City 
 
August 2012 Introduction to Structural Equation Modeling Workshop (3 days) 
Gregory Hancock, Ph.D., Professor, University of Maryland 
 
August 2011-
June 2015 
Oncology Faculty Research Group 
Attend monthly faculty research group meetings led by Victoria 
Champion, Ph.D., RN, FAAN. Attendees provide feedback on peers’ 
research proposals and grant applications.  
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Clinical Experience 
July 2015-
Present 
Psychology Intern (Health and Behavior) 
 UCLA Semel Institute for Neuroscience and Human Behavior, David 
Geffen School of Medicine at UCLA 
 Adult Consultation-Liaison Psychiatry Service (July 2015-Present) 
 Duties: Field consultation requests, assess and 
diagnose medical patients with 
psychiatric comorbidities, develop 
treatment recommendations, document 
clinical impressions and convey them 
to the primary medical team, provide 
brief psychotherapeutic interventions. 
 Supervisors: John Brooks, Ph.D., M.D. 
Jennifer Kruse, M.D. 
David Wellisch, Ph.D. 
 Revlon/UCLA Breast Center (July 2015-Present) 
 Duties: Psychological assessment of women 
who are either recently diagnosed with 
breast cancer or at high-risk for breast 
cancer. Convey clinical impressions 
and treatment recommendations to the 
multi-disciplinary treatment team.  
 Supervisor: David Wellisch, Ph.D. 
 Medical Psychology Assessment Center (July 2015-Present) 
 Duties: Administer, score, and interpret a range 
of psychodiagnostic tests. Assist with 
clinical interviews, feedback sessions, 
and preparation of integrative reports 
for referring physicians. 
 Supervisors: Marilyn Jacobs, Ph.D. 
Jeffrey Lulow, Ph.D. 
Delaney Thrasher, Ph.D. 
January 2014- 
August 2014 
Psychology Practicum Student 
 Richard L. Roudebush VA Medical Center 
 Duties: Provided individual therapy to adult 
clients in integrated primary care 
setting. Documented clinical 
impressions and conveyed them to the 
Veterans’ primary care physicians. Co-
led Managing Overweight/Obese 
Veterans Everywhere (MOVE!) and 
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Pain Management groups. 
Administered, scored, and interpreted 
personality and neuropsychological 
assessments. Assisted with transplant 
evaluations and preparation of 
integrative reports. 
 Supervisor: Jennifer Chambers, Ph.D. 
May 2013- 
December 
2013 
Psychology Practicum Student 
 Neuropsychology Clinic at Department of Psychiatry, Indiana 
University School of Medicine  
 Duties:  Administered, scored, and interpreted a 
range of neuropsychological 
assessments. Assisted with clinical 
interviews, feedback sessions, and 
preparation of integrative reports for 
referring physicians.  
 Supervisor:  Daniel Rexroth, Psy.D., HSPP 
January 2013- 
May 2013 
Psychology Practicum Student 
 Consultation-Liaison Psychiatry Service at Indiana University Health 
University Hospital, Department of Psychiatry, Indiana University 
School of Medicine 
  Duties:  Fielded consultation requests, assessed 
and diagnosed medical patients with 
psychiatric comorbidities, developed 
treatment recommendations, 
documented clinical impressions and 
conveyed them to the primary medical 
team, provided psychotherapeutic 
interventions. 
 Supervisor:  David Fingerhut, Ph.D., HSPP 
August 2012-
December 
2012 
Psychology Practicum Student 
 Larue D. Carter Memorial Hospital 
 Duties: Served as a clinician within adolescent 
female, adolescent male, and child 
inpatient state psychiatric units. 
Provided individual psychotherapy to 
individuals with mood, conduct, 
psychotic, and developmental 
disorders. Attended weekly supervision 
session, participated in team treatment 
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Selected Clinical Workshops and Training Experiences 
September 
2015-Present 
Advanced Neuropsychological Syndromes and Psychodiagnostic 
Seminar 
Weekly seminar at UCLA Semel Institute in psychodiagnostic 
assessment, advanced interpretive strategies for evaluating a variety 
of complex neuropsychiatric conditions, and differential diagnosis of 
the most common neurological, general medical, and neuropsychiatric 
disorders that impact neuropsychological status, as well as disease 
pathophysiology.  
 
July 2015-
Present 
Psychology Intern Seminar 
Weekly seminar at UCLA Semel Institute covering current topics in 
clinical psychology (e.g., psychopathology, diagnostic evaluation and 
modalities of treatment).  
 
March 2015 Acceptance and Commitment Therapy Workshop 
Jennifer Lydon-Lam, Ph.D., Psychologist, Richard L. Roudebush VA 
Medical Center 
 
April 2014 Biofeedback Workshop 
Eric Scott, Ph.D., Assistant Professor, Indiana University 
 
April 2013 Self-Hypnosis for Chronic Pain Management Workshop 
Mark P. Jensen, Ph.D., Associate Professor, University of Washington 
 
August 2012-
June 2015 
Meta-Supervision 
Attended monthly supervision meetings at IUPUI with students 
enrolled in practicum and a licensed clinical psychologist. Received 
supervision on clinical work and reported intervention progress. 
Received feedback on a transcribed therapy session. Received 
didactics and supervision on clinical peer supervision.  
 
August 2011-
June 2015 
Proseminar on Professional Issues in Clinical Psychology 
Weekly professional development course at IUPUI covering advanced 
clinical topics such as case conference/case conceptualization and 
clinical practice issues. Relevant topics included: supervision, 
consulting, diversity, ethics, professionalism, teaching, research 
methods, licensure, and grant writing. 
 
 
meetings, and wrote clinical progress 
notes.  
 Supervisor: John Spanke, Ph.D., HSPP 
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Teaching Experience and Training 
September 
2014-June 
2015 
Undergraduate Research Mentor 
Mentored an undergraduate research assistant for an independent 
study psychology research course.   
 
September 
2014 
Guest Lecturer: Undergraduate Introductory Psychology Course 
Topic: Learning.   
 
August 2012 Seminar in Teaching Psychology 
Learned best practices for undergraduate learning. Practiced course 
preparation by creating an undergraduate Abnormal Psychology 
course syllabus. 
 
January 
2011-May 
2011 
Tutor 
Led weekly group tutoring for advanced graduate-level statistics. 
Hired by the San Diego State Research Foundation to instruct 
minority undergraduate students in the NIMH-funded Career 
Opportunities in Research Program at San Diego State University. 
 
October 
2010- May 
2011 
Instructor 
Taught weekly preparation course for the Graduate Record 
Examination (GRE) Verbal subtest. Hired by the San Diego State 
Research Foundation to instruct minority undergraduate students in 
the NIMH-funded Career Opportunities in Research Program at San 
Diego State University. 
 
 
 
 
